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The work described in this thesis was carried out at the University of Bath between 
October 1986 and September 1989, and is concerned with the preparation of suitably 
functionalised carbazoles and their further elaboration to 6H-Pyrido[4,3-fr]carbazoles.
A model study was successfully carried out for the synthesis of the natural product 
olivacine (2).
Thus, gramine (166) was condensed with a substituted ketone (165) to yield an 
intermediate (167) which was elaborated to 3-formyl-l-methyl carbazole (205). 
Condensation of this aldehyde (205) with aminoacetaldehyde dimethylacetal and 
subsequent methylation yielded
3-[N-(2,2-Dimethoxyethyl)ethylamino]-l-methylcarbazole (207).
N-Tosylation of this compound (207) and treatment with acid yielded
1,2-dihydro-l,5-dimethyl-2-(4-tosyl)-6H-pyrido[4,3-&]carbazole (208). Reaction of this 
compound (208) with sodium in liquid ammonia yielded olivacine (2).
A versatile intermediate, ethyl 3-(5-benzyloxy-3-indolyl)-2-cyanobutanoate (235) 
was synthesised by the acid catalysed addition of ethyl 2-cyano-but-2-enoate (240) to
5-benzyloxyindole.
This intermediate (235) can be alkylated by various substrates and then further 
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Introduction
Isolation andBiogcncsis of Ellipticine and its Derivatives _
The alkaloid ellipticine, 5,1 l-dimethyl-6H-pyrido[4,3-fr] carbazole (1) was first 
isolated in 19591 from the leaves of Ochrosia elliptica Labill (Apocynaceae), an evergreen 
tree which grows wild in Oceania. Subsequently, further quantities of ellipticine, along with 
9-methoxyellipticine, and olivacine (2), 1,5-dimethyl-6H-pyrido[4,3-&] carbazole, were 
isolated from varoius plants in the Aspidosperma, Ochrosia, Strychnos and Tabernaemontane . 
genera of the Apocynaceae family2*3.
In 1967, during an examination of Australian plants for anticancer activity, 
ellipticine and 9-methoxyellipticine were obtained from the extracts of two other shrubs, 0. 
moorei F. Muell and Excavatia coccinea (Tejs. and Bin.) Mgf4.
Together, the two ellipticines were shown to account for the activity of the crude 
plant extracts towards the experimental tumours Sarcoma 180, Adenocarcinoma, and 
Lymphoid L1210 leukaemia implanted in mice, and human carcinoma of the nasopharynx 




Ellipticine and its natural isomer olivacine (2) usually co-occur with uleine6 (3) and 
apparacine (4)7 (Scheme 2). It is therefore presumed that these alkaloids have the same 
biological progenitor*.
(4)
It is well established that the biosynthesis of bases, such as tetrahydroalstonine 
(di-desmethoxyisoreserpiline) (5), involves the coupling of a tryptamine unit [from 
tryptophan or tryptamine ((6), R = C02H, or R = H respectively)] and a C9, or CIO fragment 
which is terpenoid in origin and is utilised by the plant in the form of the glucoside 
secologanine9,10 (7).
The major obstacle to discerning the link between the ellipticines and the main body 
of indole alkaloids is the fact that in the former, three carbon atoms separate the 
indolic-3-position and the pyridine N-atom. In the typical indolic bases, the tryptamine unit 
is preserved intact, and only two carbon atoms are interposed between the 3-indole carbon 
atom and the basic nitrogen atom of the piperidine ring. This problem has generated some 
debate and some experimental work but the question of how the two biosynthetic processes 







The first detailed proposal on the biogenesis of ellipticine and related alkaloids was 
by Wenkert11, He postulated a common precursor (8) (Scheme 1), derived from 
glycosylidene anthranilic acid (9), a tryptophan progenitor, and a 
secoprephenateformaldehyde (SPF) unit (10) or secologanine (7), as possible biogenetic 
intermediates for these alkaloids. Cyclisation of an SPF unit at C-19 (c) or C-21 (b) with the 
indolic (3-position (a), followed by extrusion (via refro-aldolisation of the (3-glycosyl 
function) could give rise to the Aspidosperma skeleta of ellipticine (1), olivacine (2) and 
uleine (3) (Scheme 1). It should be noted that apparacine (4) is not included.
The most recent and widely accepted hypothesis was postulated by Potier and 
Janot12. They envisaged that stemmadenine-N-oxide (11) is the key intermediate. This is 
then presumed to undergo a modified Polonovski type reaction13'16 to give a number of 
indolenium products which can cyclise to the four congeners ellipticine (1 ^ olivacine (2), 
apparacine (4) and uleine(3) (Scheme 2).
As stated earlier, tryptophan is considered to be the usual source of the indole ring of 
most alkaloids and there has been some controversy over which, if either, scheme is correct.
Labelling experiments with both tryptophan and stemmadenine indicated a 
significant incorporation of both these compounds into apparacine (4). However, a very weak 
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Scheme 2
both ellipticine and olivacine.17,18 The incorporation of labelled substrates into higher plants, 
however, is notoriously difficult so this result is not surprising.
In the light of these observations, the Potier and Janot hypothesis seems more 
attractive at the present time, although further experimental support is still required to show 
its validity.
Syntheses of Ellipticine and its Analogues
The synthesis of ellipticines has been the subject of continuous research for the last 
thirty years, and these efforts have been thoroughly reviewed through to March 1985.19*21,8
Hence, this introduction will only pick out these syntheses which highlight the 
various approaches to the tetracyclic system and cover any new syntheses reported since the 
last review.
It has been shown that 9-hydroxyellipticine (12), a major metabolite of ellipticine in 
the rat22, is forty times more active than ellipticine against leukaemia L1210 implanted in 
mice23,24 and recently, other more active ellipticine derivatives have also been reported.25
HO HO
(12) (13)
9-Hydroxyellipticine (12), in the form of its metho salt (13), has proceeded through 
clinical trials to its use in France for the treatment of human solid tumours. However, in 
Britain and the United States, there remains doubts about the long term toxicity of these
-7-
drags, especially their mutagenic action. Therefore, to date, no ellipticine analogue has 
received recognition as a major drug.
As a result, current synthetic interests have shifted towards the construction of 
derivatives that contain substituents more likely to impart even greater activity or to improve 
solubility in aqueous media.
Sainsbury19 has classified the synthetic approaches to ellipticines into three classes: 
B, C and D, based upon the last ring to be constructed. Since a new synthetic method26 
involving the simultaneous construction of two rings (B+C) has recently been discovered, 
routes to ellipticines can be classified into four classes B,C,D and B+C.
(1)
As the ellipticine molecule is now readily accessible by total synthesis,new 
synthetic methodology is evolving which allows direct and specific functionalisation. Hence, 
an additional classification will be contained in this introduction, covering the general 
derivatization of ellipticine.
B-Type Syntheses
This bond forming strategy was first employed by Woodward and Stillwell27 who 
used a Fischer indolisation reaction to synthesise an octahydroellipticine (15) in 82% yield 
from the decahydroisoquinolin-6-one (14). N-Demethylation and oxidation was effected by 
hydrogenolysis over palladium on charcoal. (Scheme 3). Although the initital reaction was











Miller et a/.28,29 reported a B-type synthesis using the benzotriazoles (16a) and (16b) 
as key intermediates. (This approach was originally employed by Bisagni et a/.30"33 for the 
synthesis of 9-azaellipticine). (Scheme 4).
Thus, substituted nitroanilines were coupled with
6-bromo-5,8-dimethylisoquinoline, under Goldberg conditions, to yield the corresponding 
diarylamines (17a) and (17b) in 54% and 53% yield respectively. Reduction of the nitro 
group with hydrazine hydrate-Raney nickel, followed by diazotisation gave the required 
benzotriazoles (16a) and (16b) in yields of 97% and 94% respectively. Pyrolytic 
decomposition of these intermediates at 500°C yielded ellipticine (1) and 
9-methoxyellipticine (18) in yields of 69% and 62% respectively.
The major criticisms of this synthesis are the difficulties in obtaining large supplies 
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Scheme 4
Recently, Miller and co-workers29 devised a synthetic approach to ellipticine (1) 
involving a nitrene insertion. (Scheme 5).
(1)
Scheme 5
The azido compound (19) was chosen as the nitrene precursor. However, on heating 
in dodecane at 180-200°C, two products were isolated. The minor product (20% yield) was 
identified as ellipticine (1). Unfortunately the major product was characterised as the








A similar approach had been developed by Shudo et al?A
These workers had devised a procedure for the reductive phenylation of nitroarenes 
and successfully applied the method to the synthesis of ellipticine (1).
Treatment of an inseparable mixture of
2-acetyl-1,2,3,4-tetrahydro-5,8-dimethyl-6-nitroisoquinoline and
2-acetyl-1,2,3,4-tetrahydro-5,8-dimethyl-7-nitroisoquinoline (21) in benzene and 
trifluoromethanesulphonic acid (TFSA) with iron pentacarbonyl gave the 
phenylaminotetrahydroisoquinolines (22) (44%) and (23) (22%). Conversion of the primary 
amine in (22) to an azide function, followed by a thermal cyclisation furnished the 
intermediate (23) (43%), which was aromatised to ellipticine (1) in 46% yield by using 10% 
Pd/C. (Scheme 7).
Miller et al35 have further extended this methodology by synthesising the 
aminobromoisoquinoline (128) and, using the methodology of Suzuki36, effecting a coupling 
with phenylboronic acid to afford 6-amino-5,8-dimethyl-7-phenylisoquinoline (129) (99%). 
The amine (129) was converted to the azide (130) (85%), which was subjected to solvent 







































This class has produced the most synthetic routes to date.
Woodward37 was the first to see the attractiveness of using indole (24) and 
3-acetylpyridine (25) as starting materials. (Scheme 9) However, the overall yield of the 
synthesis was less than 2%. Consequently, the synthesis has never been used but its 













Sainsbury38 pointed out that the extra indolyl unit is only removed with difficulty, 
under pyrolytic conditions, in the final oxidative cyclization (Scheme 9). He consequendy 
developed an approach to ellipticine, in which indole magnesium bromide is reacted with
3-( 1 -chloroethyl)pyridine (26) to yield the adduct (27). (Scheme 10).
Functionalisation of the pyridine nitrogen of this adduct (27) with O-mesitylene 
sulphonyl hydroxylamine (MSH), acetic anhydride and methyl iodide facilitates the already
electron deficient pyridine ring to regioselective nucleophilic attack by sodium cyanide. This 
gives a dihydropyridine intermediate which degrades on photolysis to yield the nitrile (28). 
Treatment of the nitrile (28) with methyllithium and subsequent mild hydrolysis, with dilute 



















Sainsbury et al,39 have reported an improved synthesis of the key intermediate (27), 
using a Fischer indolisation reaction upon the accessible aldehyde (29). (Scheme 11).
More recently, Chinese workers40 have prepared the intermediate (27) in a three step 
































Thus employing the same reaction that Woodward had used, but using hydrogen 
chloride as catalyst, the adduct (25a) was obtained in 81% yield. Vacuum pyrolysis of this 
adduct (25a) produced the single indole species (30) in 50% yield. Catalytic hydrogenation 
of this species afforded the key intermediate (27) in 90% yield.
When the reductive acetylation of compound (27) was attempted, by reaction with 
acetic anhydride and zinc, the expected product (31) presumably reacts further, under the 
conditions employed, as 2-acetyl- 1,2-dihydroellipticine (33) was isolated in 48% yield. This 
product (33) was hydrolysed and aromatised by heating with 10% aqueous sulphuric acid in 
refluxing methanol and bubbling with air, to afford ellipticine (1) in 68% yield.
Another example of this approach was reported by Bergman and Carlsson.41 Here, a 
vinyl indole (35) is prepared by the condensation of 2-ethylindole (34) and 3-acetylpyridine 
(25). After quatemisation with n-butyl bromide the intermediate (36) is heated at 500-600°C 
to afford ellipticine in 72% yield. (Scheme 13). The quaternary salt (36) presumably 
undergoes thermal isomerisation to the triene (37) prior to cyclisation to the intermediate 
(38), which, under the severe conditions employed loses hydrogen bromide and butane to 
yield ellipticine (1).
Weller and Ford42 have developed this methodology to give a less severe route to 
ellipticine (1). (Scheme 14).
Thus, condensation of 2-methoxycarbonylmethylindole (39) with 3-acetylpyridine 
(25), under conditions first used by Bergman41, gave the adduct (40) (81%). Methylation and 
immediate exposure of the resulting pyridinium salt to methoxide generated the labile 
dihydropyridine (41) (62%), which on direct treatment with the oxidising agent
3-ethyl-nicotinate-methiodide (42) gave the quatemised salt (43) (78%). Reduction of the 
product (43) with sodium bis-(2-methoxyethoxy)aluminium hydride (RED-AL), followed by 
oxidation with (42), furnished N-2-methylellipticinium iodide (44) (85%). Demethylation of 
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Isolation of Weller’s pyridium salt (43) would give a useful intermediate for 
5-substituted ellipticines. However, Archer43 attempted the demethylation of the salt (43) 
using sodium thiophenoxide but found the conditions too drastic to prevent the 
methoxycarbonyl group surviving unchanged.
This problem was circumvented by quaternising the adduct (40) with 4-nitrobenzyl 
bromide (Scheme 15). Treatment of this quaternary salt with sodium methoxide followed by 
oxidation with 3-ethyl-nicotinate-methiobromide (45) furnished the salt (46) (80%). This salt 
was found to undergo debenzylation on treatment with 4-nitroso-N,N-dimethylaniline to 
afford the ester (47) (47%). Archer et a l25 have utilised this compound (47) to derive 
various 5-substituted analogues of ellipticine.
(40)
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Scheme 15
Moody et a l44 have developed a new concise synthesis of ellipticine by utilising a 
Diels-Alder reaction. The prerequisite diene, l,4-dimethylpyrano[3,4-b]indol-3-one (48), 
was prepared in 44% yield by the reaction of a-methylindole-3-acetic acid with acetic 
anhydride in the presence of boron trifluoroetherate. A Diels-Alder reaction of the diene (48)
with 3-(3,3-dimethyltriazen-l-yl)pyridine-4-carboxylic acid (49), a precursor of 3,4-pyridyne 
(50), gave ellipticine (1) (20%) together with an equal amount of isoellipticine (51). (Scheme 
16).













Joule et a l45 have developed a versatile quinone intermediate (56) which allows 
selective functionalisation at the 5- and 11- position of ellipticines.(The intermediate (56) 
was first synthesised by Snieckus et a l46). Joule45 has shown that the pyridolactone (52) 
reacts with 2-lithio-l-benzenesulphonylindole (53) to afford the hydroxylketone (54). This 
was then oxidised to afford the ketoaldehyde, which as the acetal (55) , was 
N-deprotected and cyclised to the quinone (56), by treatment with hydrochloric acid in the 
presence of air. (Scheme 17).
-20-
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A similar approach has been developed by Gribble etal,47 (Scheme 18).
O
(58)
S02PhO c o 2h
+
(59a) (59b)










Thus, reaction of 2-lithio-l-benzenesulphonylindole (53) with cinchomeronic 
anhydride (58) affords a mixture of keto acids (59a) and (59b). (92:8,78%). The major 
isomer (59a), on hydrolysis with potassium carbonate-methanol, followed by treatment with 
hot acetic anhydride furnished the keto lactam (60). This compound (60) again proves to be a 
key intermediate for the selective functionalisation of 5- and 11- substituted ellipticines (57).
f -  S SiMe3
'— S 1
(61)
The use of 24ithio-2-trimethyIsilyl-l,3-dithiane (61) as a formyl anion synthetic 
equivalent led to the first total synthesis of the naturally occurring










Thus, stepwise treatment of the keto lactam (60) with (61), methyllithium and then 
sodium borohydride gave 5-(l,3-dithian-2-yl)-ll-methyl-6H-pyrido[4,3-fc]carbazole (62)
H CHO
(62)
(25%). Cleavage of the dithianyl function with aqueous silver nitrate gave the aldehyde (63) 
(100%).
The synthesis of the aldehyde (63) has been improved by Gribble55 by a variation on 









Thus, treatment of the intermediate (60) with vinyllithium, followed by 
methyllithium and reduction with sodium borohydride afforded the vinyl compound (74) in 
78% yield. Oxidation with chromic acid in the presence of a dispersing agent furnished the 
required aldehyde (63) (74%).
This alkaloid (63) was first isolated and characterised by Koch et at49 from the 
African tree Strychnos dinklagei. Since its discovery and synthesis, the alkaloid has been 
isolated as a metabolite during the incubation of ellipticine (1 ) will cell cultures of several 
Choisya ternata strains.50
Gribble et al51 have formulated another new synthesis of the key intermediate 
quinone (56) by applying a similar acylation reaction, but with an acid chloride (65). 
(Scheme 20). A base induced cyclisation reaction of the resulting keto ester (6 6 ) yielded the 
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The cyclisation step was most efficiently achieved using the anion derived from 
N,N,N’-trimethylethylenediamine, followed by treatment with lithium 
bis(trimethysilyl)amide.
In recent years, attention has been focussed on the introduction of more elaborate 
groups into the C ring in order to improve the therapeutic index of the ellipticines. A 
illustration is provided by Pandit et al?2 By exploiting the presence of an 11-keto group in 
the previously synthesised intermediate (67).53,54 (prepared in six steps from 
N-methyl-indole), they have prepared a large number of 6 -methylellipticine derivatives, 
[(69a-d) and (73a-d)] (Scheme 21).
Reaction of the keto ester (67) with an excess of a Grignard reagent (CH3 MgI, 
BuMgl, PhCH2MgI or PhMgl) afforded the 6 -methyl-11-substituted ellipticine derivatives 
(69a-d). 6 -Methylellipticine (59a) was also obtained by the reaction of (67) with 
methylenetriphenyl phosphorane, followed by hydrolytic decarboxylation of the resulting 
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(b) R’ = n - C4H9
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(73) (a) X = NHCH2 CH2OH
(b) X = N(CH2CH2OH) 2
(c) X = N(CH2CH2C1) 2
(d) X = Sugar
Scheme 21
Furthermore, treatment of the intermediate (6 8 ) with N-chlorosuccinimidet, followed 
by hydrolytic decarboxylation furnished the alcohol (71) (45%) which on reaction with 
thionyl chloride gave the chloro derivative (72) (100%).
The displacement of chloride with various nucleophiles (substituted amines or 
sugars) furnished various ll-substituted-6 -methylellipticine derivatives (73a-d) (Scheme 21).
Pandit et al57 have further developed this methodology for the synthesis of ring D 
modified 6 -methylellipticine and 6 -methylolivacine (Scheme 22).
Thus, acylation of the indole moiety of synthon (8 6 ), by 6 -methylnicotinoyl chloride 
hydrochloride in sulfolane, afforded the ketone (81) (74%). Formation of the 
pyridocarbazole skeleton was then completed by N-benzylation and subsequent 
base-catalysed cyclisation of the resulting salt (82), which was not isolated. The product (83) 
was oxidised by N-benzylacridinium bromide (84) to yield the salt (85) (95%) which was 
then reductively debenzylated to yield the keto ester (8 6 ) (41%).
Reduction of (8 6 ) with Red-Al gave 3,5,6 trimethyl-6H-pyrido[4,3-fr]carbazole (87) 
(39%). Conversion of (8 6 ) to 3,6-dimethylellipticine (8 8 ) was achieved in one practical step 
by reaction with an excess of MeMgl, followed by basic elimination.
Kutney et a / 5 6  have described a synthesis of olivacine (2) where the crucial step in 
the synthetic sequence utilises a tricarbonylchromium (0 ) complex of a suitable 
dihydropyridine (Scheme 23). Reaction of the complex (76) with the Vilsmeier reagent, 
prepared from DMF andphosphorusoxychloride resulted in a mixture of products (77) and 
(78). Hydrogenation of this mixture afforded a mixture of unconverted (77) and the 
pyridocarbazole (79). The former was demethylated to (79) by treating with 
triphenylphosphine in DMF.
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with iodine afforded olivacine (2) (54%).
The remarkable antitumour properties of compounds (89) and (90)58,59 prompted 
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(90) R = H
-30-
Thus, reaction of 3-formyl-5-methoxy-l-methylindole (91) with the 3-lithio 
derivative of 4-acetyl-2-chloropyridine ethylene glycol ketal (92)61 furnished the alcohol (93) 
(65%).
Reduction of the alcohol (93) was performed in triethylsilane-trifluoroacetic acid 
medium. This procedure, however, yielded a complex mixture due to partial hydrolysis of 
the ketal (94) into the ketone (94a), followed by spontaneous acid catalysed cyclisation, 
resulting in traces of the required tetracyclic derivative (95). For this transformation to go to 
completion, the crude mixture was treated with 50% sulphuric acid at 60°C to afford
l-chloro-9-methoxy-5,6-dimethyl-6H-pyrido[4,3-b]carbazole (95) (54%).
From this intermediate (95), six further amino derivatives have been synthesised by 
Paoletti and Bisagni.7 6
D-Type Syntheses
No new examples of this class of synthesis has appeared recently. The reaction 
sequences are essentially the same as described in the modified6 2 ,6 3 Cranwell and Saxton64  
synthesis. New efforts, however, arc being made to synthesise suitably functionalised 
carbazoles on which ring D can be elaborated.
Murakami et al.66 havesynthesisedthe 3-formylcarbazoles (97a) (39%) and (97b) 
(45%), by carrying out a Vilsmeier-Haack reaction with substituted 
1,2,3,4-tetrahydro-N-benzylcarbazoles (96). The carbazole (97a) was converted into 
ellipticine (1), in poor yield by adaption of the modified6 2 ,6 3 Cranwell and Saxton6 4  
methodology and debenzylation. (Scheme 25).
The aldehyde (97b) was converted into the ketone (98) by reaction with 
methyllithium, followed by oxidation. A similar sequence of reactions, as above, on the
-31-
R R
(96) (a) R = CH3 
(b) R = H
(97a)




(i) H2NCH2 CH(OEt) 2
(ii) Li / Liq. NH3
(iii) TsCl / NaHC03
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ketone (98) afforded a mixture of olivacine (2) (12%) and isoolivacine (100) (10%).
Narasimhan et al.65 have developed a method to synthesise 3-formyl- and 
3-acetylcarbazoles, using the cycloaddition reaction of l-methylpyrano[3,4-£]indol-3-one 
(48a) with appropriately substituted haloalkenes, in high yield. The resulting carbazoles 
( 1 0 2 a) and (1 0 2 b) have been converted to olivacine (2 ) and 1 1 -desmethylellipticine (7 9 ) 






(102a) R = CHO 
(102b) R = COCH3
(i) H2NCH2CH(OMe) 2
(ii) [H]_____________
(iii) TsC1/K2 C0 3
(iv) HC1 / Dioxane
(2) R = CH3
(79) R = H
Scheme 26
Ninomiya et al.61 have developed a route to pyridocarbazoles by utilising a 
heteroarlation reaction between indole and 4-substituted pyridines (Scheme 27).
Thus, reaction of indole and 4-acetylpyridine in the presence of acetyl chloride, 
afforded the adduct (104) (39%). Catalytic dehydrogenation of this adduct (104) yielded the 
cw-piperidine (105).
Treatment of this product with p-toluene sulphonic acid in chloroform afforded the 
carbazole (107) (62%), presumably via the intermediate (106), followed by spontaneous ring 
opening. The carbazole (107) was converted to olivacine (2) (40%) by a standard68 ,6 9  


















B + C Type Synthesis
A new synthetic approach to ellipticine (1) has recently been reported by Differding
an intramolecular Diels-Alder cycloaddition of an acetylenic vinylketenimine as the key step. 
Heating the alkyne (108) with triphenylphosphine and bromine in the presence of 
triethylamine generates the vinylketenimine (109), in situ, which undergoes an intramolecular 
cycloaddition to afford the carbazole (110) (50%). Ellipticine (1) was obtained by mixed 
hydride reduction of the ester (1 1 0 ), followed by dehydrogenation - dealkylation of the 
carbazole (111). (Scheme 28).










Derivitisation of Ellipticine and its analogues
Bisagni et al.7 0  have synthesised a number of l-aminomethylpyrido[4,3-fr]carbazole 
derivatives from 9-methoxyolivacine (112). (Scheme 29).
Thus, selenium dioxide oxidation of (112) gave 1-formyl-ll-desmethylellipticine
(113).
Condensation of this aldehyde with amines gave the corresponding imines (114a) 
(6 6 %) and (114b) (6 6 %). Reductive amination of the intermediate (113) gave the amines 
(115a) (67%) and (115b) (60%).
Pandit et al?1 have developed a method for introducing functional substituents at the 
C^-methyl group of 6 -methylellipticine. Subsequently, they have utilised this approach for 
the synthesis of several sugar derivatives. (Scheme 33).
As the Ci r methyl ellipticine is conjugatively analogous to the methyl group of
2-methylpyridine, Pandit considered the possibility of applying the known chemistry7 2  of 
pyridine-N-oxide to the pyridocarbazole system. (Scheme 30).
OAc
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Scheme 30
However, when 6-methylellipticine-2-oxide (116) was treated with acetic anhydride, 
no substitution at C-l 1 was obtained. Two products were isolated and characterised as (117) 
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However, reacting 6 -methylellipticine (119) with one equivalent of lithium diisopropylamide 
(LDA) and subsequent quenching with formaldehyde gave the hydroxymethylation product 





(116) (117) R = H
(118) R = Ac
Scheme 31
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The hydroxyl group in (120) provides a convenient function for coupling the 
ellipticine unit to diverse substrates and this was carried out by reaction of (1 2 0 ) with 
appropriately derivadsed sugars (121) using tin tetrachloride as catalyst (Scheme 33).
Apart from one report desribing the low yielding synthesis of 9-hydroxyellipticine (12) from 
ellipticine (l)73, the introduction of a hydroxyl group at position 9 of the ellipticine skeleton 
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Scheme 33
Pandit et al.74, however, have recently developed a practical method for the 
introduction of a hydroxyl group at the C-9 position of 6 -methylellipticine. This involves a 
reaction sequence which includes regioselective C-9 formylation, followed by a 
Baeyer-Villiger rearrangement (Scheme 34).
(i) ClCH2OCHCl2  OHC









However, it should be noted that the utility of all the methodologies developed by 
Pandit5 2 ,5 7 ,7 1 ,7 4  depend greatly on the success of removing the 6 -methyl group as
6 -substituted ellipticines are not effective anticancer agents. 133
In an attempt to improve the solubility of ellipticine derivatives, Honda et al.15 have 
reported the synthesis of a number of 9-hydroxyellipticine-2-glycosides (127) for 
pharmacological evaluation. 9-Acetoxyellipticine glycosides (126) were stereoselectively 
prepared by heating 9-acetoxyellipticine (125) and the appropriately peracylated glycosyl 
halide (128) with cadmium carbonate in refluxing nitromethane.
Deprotection was achieved with methanolic ammonia to give the desired 
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Meunier et a l7 7 have recently reported the synthesis of manganese-, iron-and zinc- 
porphyrins linked to 9-methoxyellipticine (18) as potential DNA cleavers.
Alkylation at the 2-position of 9-methoxyellipticine (18) with ethyl 5-bromovalerate 
yielded the salt (131) (87%), which was saponified with dilute hydrochloric acid to 
quantitatively afford the free acid (132). The mixed anhydride (133) was generated by 




D M F /120 °C
1NHC1
(131)








Reacting the mixed anhydride (133) with the aminoporphyrin (134), using 
triethylamine as an acid trap, afforded the free base hydrid molecule (135). Metallation of 
the hybrid (135) is achieved by heating it with a large excess of the required metal salt in the 
presence of 2,4,6-collidine at 140°C. (Scheme 37).
Although the "metalloporphyrin-ellipticine" molecules (136a-c) exhibit efficient binding to 









(135) A = H2
(136) a A = Fe(HI) - OAc ; b A = Mn(HI) - OAc ; c A  = Zn(II)
Scheme 37
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The Biochemical Properties of Ellipticine and its Derivatives
The antineoplastic activity of the ellipticines is now well documented, 4 ,7 8 ' 8 4  but, 
although much information regarding the physical effects of ellipticine and its derivatives 
on the structure of DNA is known, the mechanism of their cytotoxicity action in vivo and 
in vitro is still not well understood.
A common feature of this class of compounds is their intercalative binding to 
DNA. Nevertheless, in various series of closely related derivatives, many compounds 
having the same apparent affintiy for DNA differ in their biological properties.5 8 ,7 8
The ability of ellipticine to intercalate into DNA was inititally established from 
viscosity, sedimentation and electric dichroism experiments85, and later confirmed by 
n.m.r studies of a DNA-ellipticine complex86. In addition, Jain et a lP  co-crystallised 
ellipticine with 5-iodocytidylyl(3’-5’)guanosine.
All ellipticine derivatives are highly cytotoxic to malignant cultured cells4. Most of 
the 9-hydroxy derivatives are also active on standard experimental tumours24. The 
quatemised drug 2N-methyl-9-hydroxyellipticinium acetate (13) exhibits promising 
results for the treatment of osteolytic breast cancer metastases, kidney sarcoma, and 




The main reasons for interest in ellipticines for clinical purposes are their limited 
toxic side effects and their complete lack of hematological toxicity90.
Although it is still not certain exactly what the role(s) of the ellipticine drugs are, 
three possible biological properties have been identified: (i) intercalation and binding to 
DNA and involvement with the normal functions of the topoisomerase enzymes which 
regulate DNA; (ii) oxidation to potential alkylating agents and (iii) the intracellular 
formation of radicals.
(i) Intercalation and binding of DNA and Involvement with Topoisomerase
The assumption that DNA may act as the primary target for ellipticines was 
initially based on the following physiochemical and biological evidence91: The size and 
shape of the ellipticine chromophore closely resemble those of a purine-pyrimidine 
complementary base pair, providing favourable conditions for its intercalation in double 
stranded DNA. Furthermore, the polycyclic aromatic character of the molecule may result 
in tight interactions with appropriately conformed hydrophobic regions in DNA.
An indirect action on nucleic acids in cells also appeared to be likely because 
ellipticines have been found to interfere with the activity of the enzymes DNA 
polymerase, RNA polymerase,9 1 ,9 2  RNA methylase9 3 and, more recently, topoisomerase 
II94. These effects could be attributable either to the binding of the drugs to double-helical 
nucleic acids or to their direct effect on the enzymes.
On the basis of crystallographic data, hydroxylation of the ellipticine nucleus at 
position C-9 was predicted to increase the apparent binding affinity of the new derivatives 
to DNA, 5 8 ,8 4  through the appearance of a hydrogen bond between the phenolic proton and 
the negatively charged phosphates.9 6  This assumption has been experimentally verified 
for both basic and quatemised ellipticines. Compared to their unhydroxylated 
counterparts, the 9-hydroxy derivatives exhibit a higher cytotoxicity towards L1210
-45-
cultured cells.
However, many compounds in the series, including 9-aminoellipticine and 
6 N-alkylellipticinium derivatives, which have similar or even higher affintiy values for 
DNA, display low cytotoxic activity and no antitumour effect.
A number of ellipticines substitutes at C-l by aminoalkylamino groups have been 
synthesised and their cytotoxicity assessed.9 7  The best compound in the series is the 
9-methoxylated derivative [(137), R = Me]. The hydroxy analogue [(137), R = H] is less 




This also appears to be the case for the azaellipticine (138)98, which is a candidate 
for clinical evaluation.
One important fact is that whereas all ellipticines which show activity in vivo 
exhibit DNA binding, DNA binding alone, as noted for 9-aminoellipticine25, does not 
guarantee anticancer activity. Hence, additional parameters appear to be required for the 
expression of the cytotoxicity of ellipticines.
The hypothesis that intercalation of ellipticines between DNA base pairs could be 
responsible for antitumour activity has been supported by the fact that all ellipticine 
derivatives not able to intercalate exhibit a low cytotoxicity against cultured cells and no
significant antitumour activity. Non-intercalative ellipticines have been provided by 
structural modifications either by the hydrogenation of the pyridine ring which distorts the 
planar ellipticine nucleus or the substitution of the hydrogen at position C-9 by bulkier 
functional groups such as a bromine atom or a nitro function.
The major ambiguity in the interpretation of such results is that the inability of 
drugs to intercalate is always accompanied by the loss of other properties such as the 
ability to generate oxyradicals and to undergo covalent binding to macromolecules. These 
effects will be discussed later.
Hence, the work undertaken so far clearly indicates that intercalation appears to be 
a necessary, but not a complete requirement for antitumour activity."
Ross et a i100 observed a unique type of DNA strand break, termed a protein 
associated strand break, following exposure of ellipticine to mouse leukaemia L I210 cells. 
Single strand DNA breaks also occurred, but only prior to DNA enzymatic 
deproteinisation. These protein associated strand breaks were further shown to have the 
protein tightly, if not covalently, bound to the DNA in a spatial and stoichiometric 
relationship. This suggests that the protein is bound at or near the break site.
It has also been demonstrated101 that these protein associated DNA breaks are not 
observed for non-intercalating DNA binding compounds.
Other results obtained by various groups of workers indicate that several of the 
more successful drugs in clinical use are compounds that cause potential breaks in the 
nuclear DNA of cells.9 3 ,9 4 ,1 0 2 ,1 0 3  A considerable amount of evidence indicates that the 
drug induced DNA breaks occur through alteration of topoisomerase II activity.
DNA topoisomerases are enzymes which are important in the regulation of DNA 
topology and facilitate such processes as DNA replication, transcription, transposition and
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viral integration. 104 ,105 Two types of topoisomerases are known, type I and type II. The 
biological role of type I topoisomerase seems to centre around single strand fission and 
reunification, but its mechanism of action is poorly understood and as yet, there is little 
known about it which could be used to aid the improvement of the design of anticancer 
drugs.
More data is available regarding type II topoisomerase. This enzyme possesses the 
ability to transiently break and reseal both DNA strands simultaneously. Also, by virtue 
of a phosphotyrosine linkage, it can bind to free DNA ends during the breakage-reunion 
process.
It is thought that ellipticines, and other drugs, prevent the enzyme from resealing 
the breaks it has introduced in the DNA, which result in the formation of a cleavable 
DNA-topoisomerase complex. 106-109
Liu et a / . 110 have shown that the enzyme remains bound at one end of the cleavage 
site via a phosphotyrosine bond. DNA cleavage by topoisomerase, however, does not 
require a topologically restrained substrate, thus suggesting that drug intercalation may not 
be an essential requirement. This has now been confirmed110 by the demonstration that 
some non-intercalative drugs also induce protein linked DNA breaks, both in vivo and in 
vitro.
As an alternative,it has been suggested110 that drug intercalation into DNA enables 
the drugs to interact specifically with topoisomerase II, and thus interfere with the 
resealing action of topoisomerase II by stabilisation of the cleavable complex.
It is noteworthy that, so far, the ability to induce cleavable complexes is only 
observed with ellipticines bearing an hydroxyl group at C-9.
The ellipticine molecule, thus substituted, has two oxidisable groups in a para
relationship, and is therefore a substrate for peroxidases which are known to convert it into 
an iminoquinone. (Scheme 39). The oxidation of 9-hydroxyellipiticines to their 
corresponding iminoquinones has been demonstrated to occur in vitro111 and this has led 





(ii) Oxidation to Potential Alkylating Agents
Auclair et a / . 111 have shown that if 9-hydroxy-2-methylellipticinium acetate (13) is 
treated either with horse radish peroxidase or with human myeloperoxidase, in the 
presence of hydrogen peroxide, a phenoxy radical is generated which decays by a 
dismutation process to yield the iminoquinone (139). This species acts to trap potential 
nucleophiles such as pyridine, cysteine and glutathione regiospecifically at the sterically 
more hindered but electronically favoured112 C-10 position113. (Scheme 40).
Meunier et al.u l  have recently reported electrochemical data which make it clear 
that all hydroxylated ellipticine derivatives are easily oxidised. This correlates with the 
facile peroxidase oxidation of these molecules by the horse radish peroxidase/HjC^ 
system.
It was also reported that when the phenolic group (i.e. the 9-hydroxy of ellipticine) 
is blocked or absent, then the oxidation potential is higher and may not then be achieved 














(141) Nu = - SCH2 (C02H)NHR
(142) Nu = -SCH2 CH(C0NHCH2C0 2H)NHC0(CH2 )2CH(C02H)NH2
Scheme 40
The adducts (140), (141) and (142) have been isolated and tested, in vitro, on 
leukaemia L1210 cells and found to be less cytotoxic than the starting compound (13)114
Meunier114 argued that the biological activity of the adducts were in line with the 
possibility that the iminoquinones represented the activated forms of the 
9 -hydroxyellipticines, and that the molecules were subsequently alkylated by biological 
nucleophiles. This species (139) behaves as an electrophile, analogous to models 
proposed for other anticancer drugs. 115
Interestingly, the urinary metabolites of the drug (13) in mammals are the cysteinyl 
adduct ((141), R=H), its N-acetylcysteinyl derivative ((141), R = Ac), the O-glucuronide
(143) and the S-glutathione (142). The formation of both C- and O-bonded compounds
-50-






Further studies1 1 6 1 2 0  have established that, under oxidative conditions, the 
quatemised iminoquinone (139) reacts with ribonucleosides and ribonucleotides to 
produce adducts of the type (144) and (145) respectively, where B2  and B3 represent 























Koch et a / . 121 have recently reported the occurrence of the first ellipticine-derived 
bisindole, strellidimine (146), isolated from Strychnos dinklagei (Loganiaceae).
The isolation of strellidimine is interesting from both biological and chemical 
points of view since the reaction sequence involved in its formation seems similar to that 
implied in the alkylation of nucleosides by ellipticine derivatives.
From a biogenic point of view, strellidimine (146) may be considered as arising 
from a condensation of the two monomeric units which co-occur in S. dinklagei bark. The 
mechanism shown in Scheme 41 can be envisaged for the dimerisation : oxidation of 
9-hydroxyellipticine leads to theelectrophiliciminoquinone (147) which undergoes 
addition of dihydroellipticine (148) through its nucleophilic dihydropyridine nitrogen.
The quaternary adduct obtained rearranges, leading to the fused oxazole system of (146).
In view of these results it has been suggested that the hydroxylated ellipticines may 
exert some of their antitumour activity through alkylation of either t- or m- RNA, leading 
to an inhibition of protein synthesis.
It has been shown122 recently, however, that adducts of the type (149) are formed 
between the iminoquinone (147) [from 9-hydroxyellipticine] and alkylamines (RCH2 NH2 ) 





It is therefore possible that the oxidised forms of the 9-hydroxyellipticines might 
act to trap biogenic amines, amino acids, peptides and proteins, in vivo, and thus inhibit 
protein biosynthesis. 123 Similarly, in vitro experiments have demonstrated that bovine 
serum albumin (BSA) and other proteins bind to 9-hydroxy-N-2-methylellipticinium 
acetate (13) irresversibly under bio-oxidative conditions. 123
Conflicting evidence has been reported by Roy et a/.124, stating that if (13) is 
incubated with LI210 murine leukaemia cells, covalent binding occurs to both DNA and 
RNA but not to proteins.
However, despite the above findings, the validity of the various hypotheses has 
recently been challenged by Archer et a l25 He has shown that
9-hydroxy-6H-pyrido[4,3-£]carbazole (150) is inactive against murine P388 lymphocytic 
leukaemia. The absence of the methyl groups does not, however, prevent oxidation to an 








For anticancer action, Archer argues that a 5-methyl group is necessary. He 
suggests that ellipticine (1) is metabolically converted to 9-hydroxyellipticine (12), a
-54-
known metabolite of (I ) . 2 2 *125 This species, in turn, is enzymically converted first to the 
carbinol (152), which is then transformed into a phosphate or sulphate (153). This 
compound, which now possesses a good leaving group, alkylates a nucleophilic 
macromolecule such as DNA or possibly topoisomerase II to give the adduct (154). 
(Scheme 44).
(1) ► ( 12)
OR
(152) R = H




(iii) The Intracellular Formation of Radicals
As described earlier, 9-hydroxyellipticines can be oxidised to generate phenoxy 
radicals (155) which can decay by a dismutation process to yield iminoquinones (139).
Such phenoxy radicals could be responsible for DNA strand breaks, resulting in 
irreversible damage to the DNA. 126 The cytotoxic activity of a number of 
benzanthraquinones and N-heterocyclic quinones has also been explained on the basis of 
the formation of transitory phenoxy radicals. 127 ,128
The formation of the phenoxy radicals, in the case of 9-hydroxyellipticine and (13) 
has been shown by in vitro experiments in the presence of NaOH/DMSO or peroxidase 
-H2O2 111. However, phenoxy radicals are also reported to be very stable129 and therefore 
not responsible for DNA strand breaks. 8
The in vivo formation of these phenoxy radicals could be explained by the 
reduction of molecular oxygen to superoxide ions. Such species could be responsible for 
DNA strand breaks. For example, the reaction of superoxide ions with water could furnish 
highly reactive hydroxyl radicals ( OH) which could damage DNA and may also initiate 






In conclusion,there is evidence that the cytotoxicity of antitumour agents operates 
at the DNA level and that DNA serves as the ultimate target for these compounds.
Furthermore, it has become clear that most classes of antitumour drugs, including 
ellipticines, display multiple properties causing DNA damage.
At the moment, there is no evidence that the ellipticines currently available show 
selectivity of action. This could change, however, as biological targets are recognised and 
become more clearly defined, and particularly as our understanding of the role of the 
topoisomerases in regulating the behaviour of nucleic acids develops.
Discussion and Results
A detailed series of computer molecular modelling determinations were recently 
carried out131 ,1 3 2 on the docking modes of ellipticines within DNA. The results 
demonstrated that only substitution at the 4-,5-, and 7-positions does not result in 
steric clashes within the base pair pockets. A free NH group at position 6  is required 
for anticancer effect as it has already been shown2  that N- 6  alkylated ellipticines are 
less active than the parent compound.
An approach to pyrido[4,3-&]carbazoles which is both short and specifically designed 
to provide access to 4-,5- and 7-substituted analogues, was recently initiated by a 
worker in our group at Bath134.
The proposed route is outlined in Scheme 46.
The route outlined involves the synthesis of a specifically substituted acyl carbazole
(161), which can then be elaborated, by a modified6 2 ,6 3 ‘D-ring’ synthesis6 4  to the 
required 6H-pyrido[4,3-fc]carbazole (164).
The first step in the synthetic route involves the synthesis of the suitably substituted 
ketone (156). The criteria for the choice of X and Y are as follows: They must both 
be electron withdrawing groups to exclusively form the anion required for reaction 
with the gramine quaternary salt (157); Y must be a group that can be eliminated to 
effect the aromatisation of dihydrocarbazole (159) to the carbazole (160); X must 
either be an acyl group or a unit that can easily be converted into an acyl group.
To test the feasibility of this methodology, a model study was undertaken to 
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Olivacine (2) was chosen as the target because the required starting 
material,gramine (166), is cheap and readily available. Also, the intermediate 
3-acetyl-1-methylcarbazole (170) has recently been synthesised and converted to 
olivacine (2 ) in low yield65.
Interestingly, the penultimate compound to olivacine (2) in Scheme 47, is the 
acetal (172). This compound has two possible sites for cyclisation, to give olivacine





However, the angular product (100) was not reported by Narasimham and 
Gokhale65. It was stated that the tosyl compound (172) was converted to olivacine (2) 
in 65% yield.
This is surprising as there is contradictory precedent in the literature. Okuyama
-61 -
and co-workers66 attempted to synthesise olivacine (2) from the precursor (99).
The reagents and conditions employed were as follows:
(i) 6 N HCl/dioxane; (ii) Na/liquid NH3 and (iii) Pd-C/Tetraline. Both products (2) 
and ( 1 0 0 ) were obtained in yields of 1 2 % and 1 0 % respectively.
The requirement for a three step procedure rather than simple acid treatment 
followed, by deprotection implies that the first, acid mediated, reaction causes the 






The second step, treatment of this product with Na/liquid NH3, would then be
needed to remove the N-phenylsulfonyl group.
NH-Dihydroisoquinolines are known to aromatise spontaneously by 
disproportionation, giving both the isoquinoline and the tetrahydroisoquinoline.This 
limits the yield of each product to 50% so it is therefore better to react the mixed 
products with a dehydrogenating agent such as palladium on charcoal in tetralin, 
thereby producing only the isoquinoline.
Another interesting discrepancy between the work of Narasimham and 
Gokhale,and other workers, is the report by Viel and co-workers137 that the 




The first step in our synthesis of the 3-acetylcarbazole (170) was the formation 
of suitably substituted ketones (165).
Bearing in mind the criteria outlined earlier, three ketones were deemed useful 
substrates: 2-cyano-4-oxopentanonitrile (165a); ethyl 2-cyano-4-oxopentanoate 
(165b) and ethyl 2-acetyl-4-oxopentanoate (165c).
The synthesis of these compounds follow from the general reaction of 
chloroacetone with the respective anions of malononitrile (X = Y = CN); ethyl 
cyanoacetate (X = CN, Y = C0 2Et) and ethyl acetoacetate (X = C 0 2Et, Y = COCH3) 
(Scheme 47).
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Ketones (165a) and (165b) had previously been synthesised in these 
laboratories134. The procedures were repeated to give the products in 79% and 64% 
yield respectively on multigram scale.
The ketone (165c) was previously reported in the literature135. This procedure
was repeated to give (165c) in 6 6 % yield, again on multigram scale.
With these ketones in hand, an efficient method of condensing them with 
gramine (166) was considered. The previous worker134, Dr. Hogan, had achieved this 
type of reaction by forming the anion of the ketone and reacting it with the quaternary 
salt of gramine in dry THF.(Scheme 50).
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This method worked well in our hands and yields of 84% for (167a) (using 
HMPA as co-solvent) and 99% for (167b) were achieved.
The quaternary salt of gramine (166) is an insoluble gum and this created 
practical problems with stirring, especially during large scale reactions.
Another method that we tried was modelled on a literature method: Plieninger 
et a / . 136 achieved a similar reaction, between a gramine (177) and a malonate type 














The reaction in THF at ambient temperature, gave the prodct (179) in 72%
yield.
One equivalent of DMAD is used and the mechanism of the reaction is 
considered to involve the following steps. (Scheme 52).













This mechanism gives similar intermediates (180) and (181) as that most 





Plieninger purified the product (179) (Scheme 51) by column chromatography 
after evaporating the reaction solvent. No mention was given to the isolation or the 
detection of the expected by-product (182).
This method seemed a simpler and cleaner alternative to that which uses the 
quaternary salts of gramine (166) and we applied it to the synthesis of compounds 
(167a), (167b) and (167c).
The reactions were performed by adding a solution of the ketone (165) and 
DMAD (1 equivalent each) in THF to a cooled solution of gramine (166) (1.1 
equivalent) in THF.
The reactions were monitored by t.l.c. and in each case, consumption of the 
ketone (165) was complete after l-2h. The indole compounds (167a) and (167b)
were isolated in 71% and 98% yield respectively, on a multigram scale.
However, when the procedure was used for the synthesis of the indole (167c), 
the product was contaminated with another compound. Through extensive column
-67-
chromatography, it was possible to partially separate the two compounds, which 
proved to be the required product (167c) and the enamine (182) (Scheme 52).
The enamine is actually an enaminoester and acidic work-up did not remove it 
from the indole (167c). Consequently, this procedure was deemed unsatisfactory for 
the preparation of (167c).
Fortunately, the pure indole (167c) was available in 79% yield by the reaction 
of the anion of (165c) with the methosulphate salt of gramine (166) (Scheme 54).
The next step in the synthetic sequence was the acid catalysed cyclisation of the 
indoles (167) to the dihydrocarbazoles (168).
The conditions of choice for these transformations involved heating them in 
refluxing 50% aqueous acetic acid. 134
There are two possible mechanisms for this ring closure. The simplest involves 
direct attack onto the protonated ketone at the 2 -position of indole, followed by loss 
of a proton (Scheme 55).
The second course, often argued by Jackson and co-workers, 1 3 9 ,1 4 0  suggests that 







a 3,3’-spirocyclic indolenine (185). This is then followed by a Wagner-Meerwein141 
























In substituted precursors such as ours, a problem could arise if the wrong bond 
migrates i.e. bond (a) instead of bond (b) (Scheme 57). The resultant carbazole would 
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Migration of the correct bond (b) should be facilitated by electron release from 
the oxygen according to precedents cited by Jackson and Smith139.
Sainsbury et al}A1 have also studied this problem with the ring closure of 
ketone (191). They have shown, on the basis of spectral evidence, that ellipticine and 
not isoellipticine (51) is obtained as the sole product.
(191) (51)
(192) (168)
Heating the indoles (167a) and (167b) in 50% aqueous acetic acid produced the 
carbazoles (168a) and (168b) in 99% and 98% yield respectively.
Although the expected product was the endocyclic 3,4-dihydrocarbazole (192), 
n.m.r. analysis indicated retention of both the chain methylene groups of the 
precursors (167) and two, not one, olefinic protons. The only explanation for these 
data is that dehydration of the cyclised alcohol (184) had occurred through loss of a 
terminal proton producing an exocyclic double bond, and leading to the isomeric
-71-
structure (168). (Scheme 58).
X X
Y - h 2o Y
(184) (168)
Scheme 58
A comparison of models of the two isomers did not suggest any steric reasons 
why the exocyclic double bond should predominate.
To check the authenticity of structure (168b), a nuclear Overhauser 
enhancement (n.O.e.) difference lH n.m.r. spectrum was taken. The compound was 
irradiated at the indole nitrogen proton frequency (8.32 ppm). Should the compound 
have structure (168b), then the signal of one of the two olefinic protons (Ha) should, 
because of its spacial proximity, be enhanced. With compound (190) (Scheme 57), 
this would not be the case. The result of this n.m.r. experiment confirmed 
3-cyano-3-ethoxycarbonyl-l,2,3,4-tetrahydro-l-methylenecar bazole (168b) to be the 
sole product, as an enhancement of 8 % was observed at 5.30 ppm, the resonance 
frequency of the olefinic proton , Ha, (Spectrum 1).
When the indole compound (167c) was subjected to boiling in 50% aqueous 
acetic acid, a mixture of two compounds homogeneous by t.l.c, was obtained.
Inspection of the TH n.m.r. spectrum of the mixture revealed two singlets at 
5.04 ppm (1H) and 5.24 (1H) ppm together with a doublet at 5.88 ppm (1H). The rest 
of the spectrum was also indicative of a 1 :1  mixture of the isomeric compunds (168c) 
and (193).
Spectrum One n.O.e. experiment on (168b)
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The mixture was isolated as an oil from which pure (193) could be obtained as a 
colourless solid by crystallisation from ethyl acetate/pet.ether. However, the mixture 
could be used in subsequent experiments without further purification.
The required carbazoles (169) could now be obtained by elimination of one of 
the groups X or Y from the compounds (168).
The dinitrile (168a) was converted smoothly to the required carbazole (169a) by 
simple thermolysis. 134
A typical experiment was is follows: 
3,3-dicyano-l,2,3,4-tetrahydro-l-methylenecarbazole (168a) was absorbed onto silica 
and heated to 250°C under a stream of nitrogen for one hour. On extraction and 
chromatography, 3-cyano-l-methylcarbazole (169a) was obtained in 22-61% yield. 
The reaction, whether ionic or radical in nature, presumably proceeds via the 
elimination of hydrogen cyanide and a subsequent 1,5-hydrogen shift to afford the 






A similar thermolysis was performed on 
3-cyano-3-ethoxycarbonyl-1,2,3,4-tetrahydro-1 -methylenecarbazole (168b). After 
two hours heating and subsequent extraction and chromatography of the product, two 
compounds were isolated. The expected product,
3-ethoxycarbonyl-l-methylcarbazole (169b) was obtained in 30-55% yield along with 
10% of the cyanocarbazole (169a).
The formation of the latter compound can be explained by the occurrence of 
water in the acidic silica gel which hydrolyses the ester to the corresponding acid. 
This then decarboxylates under the high temperature of the reaction conditions.
It should be noted that the yields in these thermolysis reactions were quite 
variable and often dropped quite significantly when the reaction was carried out on 
greater than about ten gram scale.
An alternative method to obtain the cyanocarbazole (169a) would be to 







Traditionally, this type of transformation has been effected via a base or acid 
mediated hydrolysis, followed by a thermal decarboxylation of the product acid or 
diacid. If another, non-activated, ester functionality is present in the molecule it is 
then necessary to re-esterify it, once the decarboxylation step has been achieved.
A process developed by Krapcho and his co-workers1 4 3 ,1 4 4  involves the use of 
water, water with added salts {eg LiCl, NaCl, KCN), or anhydrous salts in dipolar 
aprotic media such as dimethyl sulfoxide. Under these conditions, activated esters 
such as malonate, p-keto and a-cyano esters are dealkoxycarbonylated (Scheme 61). 
The pathway outlined in Scheme 62 appears to be the dominant mechanistic route for 
the de-ethoxycarbonylation of disubstituted malonate esters in the presence of KCN 
and wet dipolar aprotic solvents.
When our substrate (168b) was heated at 160°C with lithium chloride (one 
equivalent) and water (one equivalent) in dimethyl sulfoxide for 48 hours, 
3-cyano-l,2,3,4-tetrahydro-l-methylenecarbazole (194) was obtained in 50% yield.
A small amount of the aromatic compound (169a) was also isolated from the reaction.
The formation of the fully aromatic compound (169a) must have been due to a 
thermal disproportionation of the intermediate (194), although we did not detect the 
corresponding tetrahydrocarbazole. The pure compound (194) was oxidised to the 
carbazole (169a) by boiling with 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ) 
in dry benzene. After 14 hours, the required carbazole (169a) was isolated in 80% 
yield.
To improve the yield in our reaction by avoiding losses due to 
disproportionation, the crude product from the de-ethoxycarbonylation reaction was 
oxidised with DDQ.
The required carbazole (169a) was now isolated in an overall yield of 75% for
-76-
R1R2CC02 R3 ---------------► R ^ C H X
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When the mixture of (168c) and (193) was heated at 120°C with lithium 
chloride, water and DMSO for 48 hours, the two compounds (169b) and (170) were 





The ketone (170) was formed by the expected de-ethoxycarbonylation, followed 
by thermal disproportionation.
However, the formation of the ester (169b) must have occurred by (a) a 
deacylation, and (b) a thermal disproportionation reaction. There is precedent for this 
result. Brocard et a / . 145 obtained a similar outcome whilst attempting to 




DMSO C 02Et COCH3
(197) 20% 70%
Scheme 64
The first target compound of this project, 3-acetyl-1-methylcarbazole (170), was thus
synthesised.
It was also prepared by the following methods:
Reaction of the nitrile (169a) with 2.2 equivalents of methyl lithium, 134  
followed by acid hydrolysis of the intermediate imine (198) produced the ketone 










Two equivalents of methyl lithium were required as the first equivalent would 
simply deprotonate the acidic carbazole NH group.
An efficient method of preparing ketones from carboxylic esters has been 
developed by Corey and co-workers146. This method involves attack on the 
carboxylic ester by the methylsulfinyl anion (CH3SOCH2') to form the P-keto 
sulfoxide (199).Subsequent reduction of this function, by aluminium amalgam gives 
the ketone. (Scheme 6 6 ).
o o
RCO2R1 + 2  CH3 SOCH2
c h 3
(200)






Two equivalents of the methyl sulfinyl anion are needed as the second molecule 
of the anion deprotonates the acidic proton a- to the carbonyl in the p-keto sulfoxide, 
in preference to attacking the ester.
As described in Scheme 6 6 , the intermediate (200) can either be quenched by 
water or by an alkyl halide to give the methyl ketone or an alkyl ketone respectively.
This would be a useful method for introducing C-l substituents in our 
pyridocarbazole synthetic route. If, however, both C-l and C-11 are substituted then 
problems may arise, as peri interactions between the two groups could prevent the 
amine (163) from obtaining the required conformation for cyclisation.
H r , OMeOMe
(163) (201)
For example, Sainsbury and Smith147 recendy attempted to prepare
-80-
1 -butylellipticine but failed to effect the final cyclisation of the intermediate (2 0 1 ).
The P-keto sulfoxide (202) was prepared in 72% yield by reaction of the ester 
(169b) with three molecular equivalents of the methylsulfinyl anion, followed by an 
acidic work up. It should be noted that, an extra equivalent of the methylsulfinyl 
anion was needed due to the acidic nature of the carbazole NH.
The p-keto sulfoxide (202) was reduced to the ketone (170) by the aluminium 












We were now in a position where the ketone (170) could be synthesised in 71% 
yield (for the 5 steps from gramine and ketone (165b), on large scale) and next its 
elaboration to olivacine (2 ) was studied.
Narasimham and Gokhale reported65  converting the ketone (170) to olivacine
(2) in poor yields (Scheme 47), despite stating that the tosyl deriative (172) was 
successfully cyclised to olivacine (2) in 65% yield.
-81-
In our hands, reaction between the ketone (170) and aminoacetaldehyde 
dimethylacetal proved unsuccessful. Various conditions were employed, including 
the use of Dean-Stark apparatus and activated molecular sieves, to try and drive the 
condensation in the forward sense by removing product water. However, monitoring 
of the reaction by i.r. spectroscopy showed little or no reaction to have occurred. This 
was supported by XH n.m.r. spectroscopic analysis.
The ketone (170) is a vinylogous amide and this factor can explain its lack of 
reactivity. (Scheme 6 8 ).
Indeed, the infra red stretching frequency of the carbonyl functionality of 
compound (170) lies at 1650 cm*1, a value more characteristic of an amide than a 
ketone.
Recent work in our group147 has shown that imines of the type (203) can be 
successfully alkylated.
The imine (203) was treated with 2 equivalents of butyl lithium to yield the 














Therefore, a method of avoiding the poor reactivity of the methyl ketone (170) 











This method would not add an extra step to the synthesis as alkylation of the 
imine (206) gives the same product,amine (207),as reduction of the imine
(171).(Scheme 47).
The aldehyde (205) was obtained in 94% yield by reduction of the nitrile (169a)
-83-
with diisobutyl almuminium hydride (DiBAL) and acidic hydrolysis of the 
intermediate imine.
Boiling a mixture of aminoacetaldehyde dimethylacetal and the aldehyde (205) 
in dry benzene, using Dean-Stark apparatus, for 4 hours yielded the required imine 
(206) in 96% yield.
The reaction was monitored by i.r. spectroscopy as tl.c. analysis (using either 
silica or neutral alumina) causes hydrolyses of any product back to the aldehyde.
Loss of the C=0 stretch at 1670 cm' 1 was observed along with the emergence of 
the C=N stretch at 1635 cm'1.
Treatment of the imine (206) with 2.2 equivalents of methyllithium yielded the 
amine (207), in 65% yield, after aqueous work up. Standard conditions (tosyl 
chloride/Na2 C0 3 /THF/H20 ) 63 were employed to convert (207) to its tosyl derivative 
(172) in 84% yield.
Narasimham and Gokhale65 reported the synthesis of olivacine (2), from the 
sulphonamide (172), by heating it in dioxane with aqueous hydrochloric acid. It was 
noted, to achieve good yields, that the water content must be reduced.
In our hands, similar conditions did not yield olivacine. The only identifiable 
product obtained, even after prolonged heating for 48h, was 
1 ,2-dihydro-1,5-dimethyl-2-tosylpyrido[4,3-fr]carbazole (208). Optimum conditions 
of heating for 6  hours produced this compound in 45% yield. (Scheme 71).
Decoupling and n.O.e. experiments were carried out on this product to 
authenticate its structure as (208).
-84-




RESONANCE IRRADIATED (6 ) DECOUPLING EFFECT
6  • 8  ppm TsNCH=CH 6  *3 ppm d x d  —* d , /  = 3Hz
6  • 3 ppm TsNCH=CH 6  * 8  ppm d x d  — d , /  = 2  -5Hz
5 4 ppm CH3CHNTs 1 *4 ppm d —►s
1 -4 ppm CH3 CHNTS 5 4  ppm m—»d , J  -  1 Hz
In the n.O.e. experiment, when the C-5 CH3  singlet at 2.45 ppm was irradiated, 
an enhancement of 14% for the C-4 olefinic proton at 6.3 ppm plus a 6 % 
enhancement for the N-H proton at 8.0 ppm were observed.(Spectrum Two)
(209)
Thus, these experiments proved the structure to be (208) and not the alternative
Spectrum Two
n.O.e. experiment on (208)
-86 -
isomer (209).
This type of intermediate has been isolated previously in studies on 
ellipticines.62 ,63
Literature precedent6 6 ,1 3 7  and models, however, suggest that formation of the 
angular isomer is not precluded, but we did not detect it, and a possible reason is that 
steric hindrance occurs in the necessary intermediate. For example, as carbazoles are 















Having successfully completed the model study, an attempt to synthesise 
functionalised 6 H- pyrido[4,3-6]carbazoles was undertaken.
As described earlier (Scheme 46), a suitably substituted gramine derivative 
(157) and ketone (156) are required as the starting materials for this synthesis.
-87-
Another worker in our group148 had recendy obtained encouraging biological 
results for the dimer (212). Hence, we decided to initially concentrate our efforts 
towards 5-substituted ellipticines.
The previous worker148 encountered difficulty in O-demethylating the 
9-methoxylated ellipticine unit, so we considered that a benzyl function would be a 
better protecting group for the 9-hydroxy of ellipticine. This group could then easily 
be removed by hydrogenolysis at the end of the synthesis.







Gramine (166) is normally synthesised by the Mannich reaction. 150
Initially, an iminium species (214) is formed which is then attacked by indole, 
acting as m  enamine, to form the so-called Mannich base (166). (Scheme 74).
H+ +
HCHO + HNMej ---------------► H2C =N M e 2
(214)




Attempts to use aldehydes other than formaldehyde to form Mannich bases have 
met with limited success, partly due to the reduced activity of the carbonyl species. 
However, a-substituted indole-3-methylamines of the Mannich type have been 
obtained151 ,1 5 2 by the addition of indoles to preformed aldimines (215) in the presence 
of an acid catalyst, usually glacial acetic acid. (Scheme 75).
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A search of the literature revealed that l-(3-indolyl)-N,N-dimethylaminoethane 
(216) had been prepared by Le Goffic and co-workers by two methods. 149
The first involves a standard Mannich reaction. Thus, indole was stirred in a 
mixture of dimethylamine hydrochloride, potassium carbonate, acetic acid and 
acetaldehyde at 4°C for 5 days to give the Mannich base (216) in 59% yield.
In the second approach, an iminium species, formed by a Vilsmeier-Haack 
reaction153, was attacked by indole (Scheme 76). Reduction of the intermediate 















Both these procedures were applied to the synthesis of the 5-benzyloxy 
derivative (213). The reactions were monitored by t.l.c. analysis and proceeded quite 
smoothly. However, isolation of the pure compound was very difficult. The product 
was a viscous oil and attempts to crystallise the compound by trituration with various 
solvents failed. When heated in these solvents, the odour of dimethylamine was 
detected. Thus indicating that the vinyl indole (218) was formed by decomposition of 
the gramine (213). However, this product (218) was not detected so presumably it 












The p-hydrogen available in the a-methyl group of the Mannich base (213) 
allows this transformation to proceed. As gramine (166) does not have an available 
p-hydrogen, it is more stable.
In view of our results, we were surprised to read that the gramine (216) was a 
stable crystalline solid. 149 Presumably, the instability of our benzyloxy gramine (213) 
is due to the electron donating effect of the oxygen substituent which promotes the
elimination of dimethylamine from the molecule.
In view of this, the crude benzyloxy gramine (213) was always prepared just 
prior to use.
Whilst attempting to reduce the intermediate (217), an interesting result was 
obtained. Before the addition of sodium borohydride, the reaction mixture was 
basified with 0.88 ammonia. However, transamination must have occurred, as the 
product isolated was 1-amino-l-(5-benzyloxy-3-indolyl)ethane (219).
H
(219)
The product (219) was a stable solid and could be used in subsequent 
condensation reactions with the required ketones (156).
Considering the synthesis of a suitably substituted ketone (156), we concluded 
that an ester functionality as R5 (Scheme 46) would be useful. A series of 
transformations could then be applied to it, in order to vary the nature of the side 
chain of the final ellipticine.
Hence, the synthesis of the ketone (220) was undertaken, with a view to its 
elaboration to the carbazole (2 2 1 ).
Following our earlier procedure, we attempted to react the anion of ethyl 










Unfortunately, the reaction gave a complex mixture of products. We assumed 
that the anion was indiscriminate in its reactivity and attacked the keto function of the 
pyruvate as well as coupling through the displacement of bromide ion, as required.
A similar reaction was carried out with the anion of malononitrile, but again, a 
complex mixture was obtained.
Shortly after we carried out this work, a report by Mansour154 confirmed that 
such a reaction does indeed occur with this type of substrate and nucleophiles.
Mansour, in an attempt to condense benzoylacetonitrile (223) with ethyl 
bromopyruvate (2 2 2 ), isolated
4-cyano-3-ethoxycarbonyl-2,3-dihydro-3-hydroxy-5-phenylfuran (224) in 57% 
yield. (Scheme 78).
Formation of the dihydrofuran (224) was explained by nucleophilic addition of 
the anion of (223) to the reactive carbonyl group of the pyruvate. This addition is 
followed by either direct displacment of bromide ion or, more likely, through the 
intermediacy of the epoxide (225). (Scheme 79).
A ^ c n  + Br- V C0 2 E t_ A ! l
Ph , ° -
Ph + n  ► >-----f -  C02Et










CN C02Et ph O




Protection of the ketone function of ethyl bromopyruvate (222) was now 
considered necessary.
The dioxolane (226) was obtained in 47% yield by reaction of ethyl 
bromopyruvate (2 2 2 ) with ethylene glycol and p-toluene sulphonic acid in boiling 
benzene.
However, attempted reactions between the anion of ethyl cyanoacetate and the 
dioxolane (226), even under severe conditions, failed. This lack of reactivity is due to 
the neo-pentyl like structure of the dioxolane (226), which provides steric interference 

























A search of the literature revealed that Gilchrist and his co-workers156 have 
been successful in reacting ethyl 3-bromo-2-hydroxyiminopropanoate (227) with a 
range of nucleophiles in the presence of sodium carbonate. (Scheme 80).
Such reactions can, in principle, take place either by direct nucleophilic 
displacement or by elimination of hydrogen halide, followed by addition of the 
nucleophile. (Scheme 81).
The elimination-addition mechanism (path B) can be brought about by use of an
-95-
extemal base, or, if the nucleophile is sufficiently basic, by the nucleophile itself.
Evidence for an elimination-addition mechanism in such reactions is provided
A typical procedure for these reactions ivolves stirring the bromoester with an 
excess (2-5 molecular equivalents) of the substrate, in the presence of sodium 
carbonate, in dichloromethane.
The bromoester (227) is a colourless, crystalline solid and was prepared by the 
method of Ottenheijm et a / . 157
However, when we attempted the standard reaction between the bromoester 
(227) and ethyl cyanoacetate, no identifiable product could be isolated.
The *H n.m.r. spectrum of the crude product showed that a complex mixture 
had formed, none of which contained an oxime function.
Alternative methods of generating the anion of ethyl cyanoacetate with different 
bases in various solvents and adding it to the bromoester gave similar negative results. 
(These results are summarised in Table 1).
Noting the loss of the oxime proton signal in the !H n.m.r. spectrum we 
envisaged that the first equivalent of the ethyl cyanoacetate anion was deprotonating 
the oxime and then cyclisation reactions were occurring.









C02Et Na2 C0 3 CH2C12  /  24h
CN Na2 C03 CH2Cl2/16h
C02Et Na+ ~OEt E tO H /lh
C02Et NaH DM F/5 min
C02Et Na+ ~OEt EtOH / 5 °C /  5 min
C02Et n-Bu4+ —OH CH2C12  /  H20  / 3 min
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With this in mind, we considered preparing the methoxime derivative of ethyl 
bromopyruvate (229), and attempting nucleophilic substitution of the bromide.
Ethyl 3-bromo-2-methoxyiminopropanoate (229) had not previously been 
reported, but was efficiently obtained by adaption of the method used for the synthesis 
of the hydroxyimino ester (227).157
Thus, a mixture of methoxyamine hydrochloride, ethyl bromopyruvate, 
chloroform and methanol was stirred vigorously at ambient temperature for 16 hours. 
After work-up, the methoxyimino ester (229) was obtained as a colourless oil in 8 8 % 
yield.
When the methoxyimino ester (229) was treated with the anion of ethyl 
cyanoacetate in DMF, two products were detected by t.l.c. (consumption of the 
starting methoxyimino ester (229) was complete in less than 5 minutes at ambient 
temperature.).
Separation of the two products by column chromatography and subsequent 
characterisation revealed their structures to be the expected monoalkylated product 
(230) and the dialkylated product (231). (Scheme 82).
The yields of (230) and (231) were 26% and 60% respectively. After 
chromatography, the monoalkylated product (230) was found to be contaminated by 
ethyl cyanoacetate reformed by deprotonation of the product (230). Pure product 
(230) could be obtained by bulb to bulb distillation.
Attempts to try and optimise the yield of the monoalkylated product, by varying 
the conditions of the reaction were made. However, no real success was attained.
The best yield of the monoalkylated product (230) obtained was 51%. This
-98-
result was achieved by stirring ethyl cyanoacetate and the bromoester (229) in 
dichloromethane/water with 1.5 molecular equivalents of the phase transfer catalyst, 
tetra-n-butylammonium hydroxide, for 30 minutes.
(All the experiments tried are summarised in Table 2.)
^  C02Et +
Br Y  + Na CH(CN)C02Et  ►
NOMe
(229)
CN NOMe MeON CN NOMe
C o d ^ ^ C O jE , + C 0 ^ a ^ ^ C 0 2Et
(230) (231)
Scheme 82
Reaction of the bromoester (229) with the anion of malononitrile was carried 
out, but again, a mixture of the monoalkylated product (232, 29% yield) and the 
dialkylated product (233,54% yield) was obtained. (Scheme 83).
Having obtained some of the methoxime (230), we now attempted to convert it 
to the required ketone (2 2 0 ).
Oximes are typically converted to their respective ketones by reduction with 
titanium (III) 159 or thallium(III) 160 compounds and subsequent acid hydrolysis.
In our hands, however, treating the methoxime (230) with either titanium(III) 






CN NOMe MeON CN NOMe
C O ^ t ^ ^  C02Et
(230) (231)
C 02Et C02Et C02Et





NaH DMF / 0 °C / 5 min 26% 60%
Na+ _ OEt EtOH / 0 °C / lh 30% 52%
n-Bu4N+_OH CH2 C12  /  H20  / 30 min 51% 41%
NaH TH F/-78 0 °C /4h 23% 54%
n-Bu4 N+ - F CH2 C12  /  H20  / THF / 48h 24% 47%
n-Bu4 N+ ~ f DMF /10  min 24% 49%
n-Bu4 N+“OH 
(1.5 equivs.)
CH2C12  /  H20  / 6  days 52% 30%
-100-
(220).
If the reaction mixture was heated, consumption of the starting material was 
observed by t.l.c. analysis, but a complex product resulted(these results are 
summarised in Table 3.).
B r ^ V
NOMe
C02Et +








Despite these disappointing results, it was decided to condense the methoxime






This condensation was achieved in 41% yield by stirring a mixture of the 
methoxime (230), the gramine (213) and dimethyl acetylenedicarboxylate (DMAD) in 
dry THF for 16 hours.
-101-
Table Three
CN NOMe CN °
C°2 Et C0^Et'~/ ^ C 0 2Et
(230) (2 2 0 )
Reagents Conditions Result
TiCl3 / HC1 H20  / AcOH / NH4 OAc 
Dioxane / 48h
No Reaction
TiCl3 / HC1 / ZnCl2 DMF / AcOH/H20 /1 6 h No Reaction
TiCl3 / HC1 / ZnCl2 DM F/AcOH/H20  
100 ° C /90 min
Complex Product
TiCl3 DM F/AcOH/H20  
NH4 OAc / 60 °C / 2h
No Reaction
TiCl3 Dioxane / AcOH / H20  
NH4OAc / 60 °C / 35h
Complex Product
T1(N03 ) 3 Methanol / 2h No Reaction
-102-
The indole (234) was obtained as a light beige oil. *H n.m.r. analysis proved 
the product to be an equal mixture of two diastereomers. Attempts to separate the two 
compounds by crystallisation failed and the mixture was used in subsequent 
experiments.
Having synthesised the indole (234), we observed that another method was 













Following the earlier procedure, we attempted to prepare the indole (235) by 
reacting the benzyloxy gramine (213) with ethyl cyanoacetate in the presence of 
DMAD in dry THF.
After column chromatography, the product of this reaction afforded the indole 
(235), as a mixture of two diastereomers, in 28% yield.
This disappointing result could not be improved and alternative methods for the 
preparation of this compound were considered.
To try and discover why the above reaction did not proceed cleanly, the anion 
of ethyl cyanoacetate was reacted with the methiosulphate salt of the gramine (236). 
(Scheme 8 6 ).
- 103-
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After column chromatography of the product, two compounds were isolated. 
These proved to be the expected product (237), in 24% yield, along with the 
dialkylated product (238), in 47% yield. (The reaction between the gramine (236) and 
ethyl cyanoacetate in the presence of DMAD produced the indole (237) in 19% yield).
This was a disappointing result and the tendency for ‘dialkylation’ to occur is 
probably the reason why the DMAD reactions gave such poor yields for the 
preparation of indoles (235) and (237).
Not deterred by these results, a literature search was undertaken and we were 
encouraged by a recent publication by Jackson et a / . 140 in which the reaction of indole 
and methyl vinyl ketone in the presence of montmorillonite clay (an acidic clay 
catalyst) in boiling dichloromethane is reported to yield the adduct (239). (Scheme 
87).
The same reaction has also been reported by Szmuszkovicz161 but using acetic
- 104 -
acid/acetic anhydride as the reaction medium.
We envisaged that the same reaction could be carried out with the 
a,|3-unsaturated ester (240) and 5-benzyloxyindole to produce the desired indole 
(235). (Scheme 8 8 ).

















The a,P-unsaturated ester (240) was prepared according to the method of Popp 
and Catala162 in 38% yield,and when a mixture of 5-benzyloxy indole, ethyl
2-cyanobut-2-enoate (240) and montmorillonite clay was heated in boiling 
dichloromethane or toluene the required indole (235) was formed in 26% and 27% 
yield respectively. In each case, a significant amount of starting indole was 
recovered.
-105-
However, when we attempted the same reaction in a mixture of acetic acid and 
acetic anhydride, at 90°C for eight hours, total consumption of the starting indole 
occurred and now the desired indole (235) was isolated from the reaction product in 
6 8 % yield.
This compound was obtained as a light beige oil, and its n.m.r. spectrum 
indicated it to be a mixture of two diastereomers. Crystallisation from ethyl 
acetate/pet.ether gave a pure diastereomer in the form of colourless crystals. The 
diastereomeric mixture was used in subsequent experiments(alkylation of the pure 
diastereomer (235) gave the product (234) as a mixture of diastereomers-scrambling 
of one chiral centre having occurred through deprotonation).
Heating the indole (235) with bromoester (229) and potassium carbonate in dry 
DMF at 100°C gave the desired indole (234) in 74% yield. (Scheme 89).










We were now in a position to synthesise the intermediate indole (234), on large 
scale. Typically in 50% yield for the two steps from 5-benzyloxyindole.
We considered two possible ways of effecting the ring closure of indole (234) to 




Initially we attempted to reduce and hydrolyse the methoxime to the p-keto
-106-
ester (242) and then to ring close this compound to the dihydrocarbazole in the 
presence of acid. (Scheme 91).
BnO
C 02Et











However, treatment of the methoxime (234) with either thallium(IH) nitrate or 
titanium(IIT) chloride did not cause the required deprotection.
Alternatively, we considered that acidic conditions might induce the required 
ring closure by direct loss of methoxyammonia as indicated below. (Scheme 92).
The first conditions employed to attempt this transformation involved heating 
the methoxime (234) in refluxing 50% aqueous acetic acid. The reaction was 
monitored by t.l.c. analysis and the formation of a new, less polar product was 
observed.
After 50 minutes, the reaction was worked up and the product purified by
-107-
column chromatography. However, the *H n.m.r. spectrum of the new product 
showed it to be the methoxime (230). (Scheme 93).
CNBnO

















Et02 C T v^ / ^  C02Et
(234) (230)
Scheme 93
We subsequently decided to avoid high temperatures to prevent this ‘reverse*
-108-
reaction occurring.
However, treatment of the methoxime (234) with trifluoroacetic acid; aqueous 
trifluoroacetic acid; acetic acid or aqueous acetic acid at ambient temperature either 
gave no reaction or a complex product mixture. (These results are summarised in 
Table 4).
Partial success was achieved by stirring the methoxime (234) in dioxane 
saturated with hydrogen chloride. This procedure led to a mixture of products from 
which the required dihydrocarbazole (241) was isolated, as a mixture of two 
diastereomers, in 2 1 % yield.
Similarly, when the methoxime (234) was treated with polyphosphate ester, in 
refluxing chloroform, a complex mixture was again obtained. Careful column 
chromatography afforded the required dihydrocarbazole (241) but only in 25% yield. 
N.O.e. experiments were carried out on this compound to authenticate its structure.If 
the product was the isomeric compound (244),an enhancement of the C-l methyl 
signal at 1.52 ppm should have been observed when the N-H signal at 10.20 ppm was 
irradiated.However,as no enhancement was seen,the product was assumed to have the 
required structure (241).
The low yield of the dihydrocarbazole (241) was a very disappointing result and 
we concluded that one factor behind it is that there are two bonds, (a) and (b), in the 
presumed reaction intermediate (243) which may migrate. This would give rise to 
two products, either of which are able to react further. (Scheme 94).
Migration of the correct bond, (b), should be promoted by electron release from 
the nitrogen. 139 However, in the intermediate (243), this effect may be offset by the 









50% Aqueous AcOH Reflux / 50 min Mixture of (234) and (229)
c f 3c o 2h 30 min Complex Product
50% Aqueous CF3 C02H 18h Complex Product
TiCl3 NH4 OAc / AcOH / H20  
DMF /  20h
No Reaction
T1(N03 ) 3 Methanol / 30h No Reaction
HC1 Dioxane / 36h (241),21%
AcOH 5 days No Reaction
50% Aqueous AcOH 5 days No Reaction
Polyphosphate Ester CHC13/Reflux/48h (241),25%
HC1 50 °C/21h (241),7%














In order to confirm this view, extensive column chromatography was carried out 




We were, however, able to obtain the required dihydrocarbazole (241) free from 
contaminants, but the *H n.m.r. spectrum of the crude reaction mixture showed 
the presence of at least six indole compounds.
A report by Fried and Nutile163 described that the C-3 methoxime of the steroid
-11*-
(245) proved to be extremely stable toward a number of acidic hydrolytic reagents. 
Eventually the free C-3 ketone (246) was obtained by conversion of the methoxime to 
the semicarbazone, followed by aqueous acetic acid hydrolysis. (Scheme 95).
(i) H2 NC0NHNH2 HC1






Heating our methoxime (234) with semicarbazide hydrochloride in water and 
ethanol proved no more successful than many other reagents and the starting material 
was again returned unchanged.
When the dihydrocarbazole (241) was heated with lithium chloride, water and 
DMSO at 100°C for 26 hours the required carbazole (221) was obtained in 45% yield. 
(Scheme 96).
CNBnO




We now considered the worth of reducing the 1-ethoxycarbonyl function in the 
methoxime (234) prior to the ring closure. This would establish whether the electron 
withdrawing property of this group affects the cyclisation procedure. However, due 
to the presence of another ethoxycarbonyl function in the molecule (234)(geminal 
with the nitrile),problems of selective reduction were envisaged.
Also, presuming that elimination of methoxyamine (rather than water) might 
also be affecting the ring closure, we decided to synthesise a new synthon of general 
structure (247) specifically designed to avoid the difficulties cited above.
Due to the general insolubility of the ellipticine derivatives, we decided to 
synthesise a compound (247) where R was a group involving one or more amino 




On this basis, the diamine (248) (R1 = alkyl) was chosen, as this unit could eventually 
be deprotected, by hydrogenolysis, to give a primary amine.
O R*
(248)
This primary amine would then be useful in the further elaboration of the side
chain in the final ellipticine or for the coupling of two ellipticine units via a diacid or 
dialdehyde. (Scheme 97).
Having reactive halo, keto and amino functions in this synthon (248) might 
present stability problems and the ketone function would have to be protected 
throughout the synthesis, as our retrosynthetic analysis describes. (Scheme 98).
OHC




The aldehyde (252) was prepared by an adaption of the method of Chari and 
Kozarich. 164 (Scheme 99).
Thus, heating ethyl bromopyruvate with trimethyl orthoformate in refluxing 
methanol yielded the ester (253) which was converted to the aldehyde (252) by 
reduction with lithium aluminium hydride and Moffat oxidation of the intermediate 
carbinol (254).The overall yield for this three step procedure was 32%.
O Pr








































When the aldehyde (252) was heated with n-propylamine in refluxing benzene, 
the imine (255) was obtained and reduction (NaCNBH^methanol/acetic acid) of this 







B r^Jx^N H Pr
OMeOMe
(251)
PrNH2 /C 6H6 NaCNBH,




In an alternative preparation, the aldehyde (252) and n-propylamine were stirred 
with sodium cyanoborohydride in acetic acid and methanol (1 : 1 0 ) at ambient 
temperature for 7 hours to produce the required amine (251) directly in 62% yield.
-116-
(Scheme 100).
The synthesis of the amino aldehyde (250) was addressed next. A search of 
the literature revealed that dibenzylamines of the type (256) had been 
synthesised, 165 ,168 where R is either alkyl or aryl.
R
(256)
Using an adaption of the procedure employed by Sainsbury et a / . , 168 the 
aldehyde (250) was prepared by a two step procedure. (Scheme 101).
B„,NH .  L \  m ' °  .
OH ° H
NaI04
--------------------- ► Bn2 NCH2CHO
(250)
Scheme 101
Thus, a mixture of dibenzylamine and glycidol was heated at 100°C for three 
hours. The mixture was then allowed to cool before chloroform and an aqueous 
solution of sodium metaperiodate were added. The pH of the aqueous phase was 
adjusted to approximately eight and the two phase system vigorously stirred for three 
hours. Finally, the chloroform layer was separated and evaporated, at reduced 
pressure, to yield the required aldehyde (250), as a light orange oil. This compound
-117-
proved to be unstable and was used immediately in subsequent work. Hence, a 
mixture of the acetal (251) and the aldehyde (250) was stirred with sodium 
cyanoborohydride in acetic acid and methanol for five days. After work up, the 
desired amine (257) was obtained, as a near colourless solid, in 65% yield. (Scheme 
102).
Pr
KTTipr NaCNBH3Br ^  NHPr + Bn2NCH2CHO ------------------------ ► Br ^  N ^
OMe OMe AcOH/MeOH OMeOMe
(251) (250) (257)
Scheme 102
Hydrolysis of the acetal (257) to the ketone (249) was now required before 
alkylation of the indole (235).
Acetals are generally converted to their corresponding aldehydes or ketones by 
mild acidic hydrolysis or transacetalisation. 166 Acids typically used for this 
transformation are hydrochloric, 167 sulphuric, 171 trifluoroacetic acid167 and 
pyridinium tosylate. 174 Deacetalisations have also been undertaken in acidic media 
using solid catalysts such as wet silica gel172 or Amberiyst 15 resin. 173 Non-aqueous 
deacetalisations have been achieved by using trimethylsilyl iodide, 175 boron 
tribromide176 and titanium tetrachloride. 177
However, treatment of our acetal (257) with various acids to effect hydrolysis or 
transacetalisation produced no reaction. Treatment of the acetal (257) with Lewis 
acids in non-aqueous media did not produce the desired ketone (249) either. (These 
experiments are summarised in Table 5).
The only experiment which produced a new, identifiable product was that in 





B r ~  ^  ^  ^
OMeOMe O
r ^ ^ N / NBn2 ________________ ► B r ' ^ Y ^ N
(257) (249)
Reagent Conditions Result
50% Aqueous CF3C02H CHC13 /  5h No Reaction
98% HC02H 85 °C / 3days No Reaction
(CH3)3SiI (M  Equivs) 90 min (258),95%
(CH3)3SiI (2 2 Equivs) 2 1 h (258),99%
Si02  / 2N H2 S04 2  days No Reaction
Amberlyst 15 Resin Acetone / 5 days . No Reaction
2NHC1 80 °C / 6 h No Reaction
BF3 OEt2  /  NaBr CH2 C12  /  3 days No Reaction
TiCl4 CH2Cl2 /2days No Reaction
BBr3 CH2C12  / 24h Complex Product
-119-
dry DCM. T.l.c. analysis of the reaction indicated total consumption of the starting 
acetal, within ten minutes, and the appearance of a less polar product. The crude 
product, after work up, gave a colourless foam. JH n.m.r. spectral analysis of this 
material showed it to be almost identical to the starting material (257). Thus, the 
spectrum contained two singlet resonances at 3.17 and 3.14 ppm, corresponding to the 
two sets of acetal methoxy protons.A mass spectrum of the product,however, 






Repitition of the experiment, now with 2.2 molecular equivalents of 
trimethylsilyl iodide, gave a similar result.
These results were extremely disappointing and it was decided to develop a new 
approach.
As an amino group in the side chain was desirable, we considered using the 
phthalimide group as a protected primary amine.
Hydrolysis of phthalimides, using either acid or base catalysis, regenerates 
corresponding primary amines. Acid catalysis can be used but this is usually a 
very slow reaction. Better methods include the Ing-Manske procedure, 178 in which 
the phthalimide is heated with hydrazine in an exchange reaction. (Scheme 104).
Hence, we chose to synthesise the bromo ketone (259) [(247), R = 


























A search of the literature revealed that the bromo ketone (259) had already been 
reported. 179 (Scheme 106).
Thus, reaction of potassium phthalimide with epichlorohydrin in DMF produces 
the epoxide (261) in 52% yield. In our hands, when a solution of the epoxide (261) in
-121-
DCM was treated with hydrogen bromide, a quantitative yield of the bromo compound
(262) was obtained. Jones oxidation of this compound (262) gave the required bromo 















An alternative procedure was employed for large scale preparation of the chloro 
















Heating phthalimide in epichlorohydrin produced the chloro compound 
(264).180 Jones oxidation of this product gave a 72% yield of the required chloro 
ketone (263).
Alkylation of the indole (235) with haloketones (263) and (259) was then 
attempted. Disappointingly, this reaction was unsuccessful. Various methods were 











The reaction was then attempted in boiling DMF, in the presence of Na2C03, to 
try and force the reaction to proceed. Monitoring the reaction by t.l.c. indicated total 
consumption of starting material after two hours and the formation of a less polar 
product.
This product was isolated and characterised as 5-benzyloxyindole (265), 
indicating that under the high temperatures employed, the indole compound (235) had 
degraded.
The reason for this unsuccessful alkylation was presumed to be due to steric 
hindrance since the indole (235) had reacted successfully with other alkylating agents
-123-
such as chloroacetone and ethyl 3-bromo-2-methoxyiminopropanoate (229). The 
phthalimidyl bromo ketone (259), however, is much bulkier and it seems probable 
that its approach to the indole is impaired.
This setback was solved by reverting to our original strategy. (Scheme 109). 




Hence, the anion of ethyl cyanoacetate was alkylated by the chloro ketone (263) 
in dry DMF to produce the ketone (266) as a colourless solid in 82% yield.
Reaction of the ketone (266) with the gramine (236) in the presence of DMAD 
produced the indole (267), as a pale yellow solid, in 80% yield.
We were now in a position to attempt the acid catalysed ring closure of the 
indole (267) to the dihydrocarbazole (268). (Scheme 110).
We were curious to see whether this ring closure would occur smoothly, in 




















Initial conditions employed gave slightly disappointing results but when the 
indole (267) was heated with p-toluene sulphonic acid in boiling toluene, a mixture of 
the two isomers (268) and (269) were isolated in 96% yield. (These reactions are 
summarised in Table 6 ). The nature of these isomers was confirmed by n.m.r. 
spectral analysis, but when the mixture was allowed to crystallise from ethyl 
acetate/pet.ether, a pale yellow solid was obtained which proved to be exclusively the 
exocyclic double bond compound (269), in 18% yield. The mother liquor contained a 






This efficient cyclisation of the indole (267) is in direct contrast to that 
observed with the indole (234). One reason for this smooth reaction could be due to 
the lack of an electron withdrawing function in the spirocyclic intermediate (270), 
allowing the migration of bond (b), to occur more readily. (See earlier discussion).











50% Aqueous AcOH 
p-TsOH
CHC13 / Reflux/ llh  
Reflux / 9h
THF/Reflux/9h 










Unfortunately, when a mixture of carbazoles (268) and (269) was heated in 
DMSO containing lithium chloride, no reaction occurred and led only to a poor 
recovery of starting material. We thought that perhaps it would need less stringent 
conditions to demethoxycarbonylate our compound rather than to effect a 
de-ethoxycarbonylation.
Hence, we attempted to transesterify the ethyl ester (269) and obtain the methyl 





After twenty-four hours reaction time, the solvent was removed and a more 
polar product was isolated by column chromatography. However, the product was not 
the expected methyl ester (272), but rather the amide (273). (Scheme 111).
A trace of the methyl ester (5%) could be detected by ]H n.m.r. analysis, but the
-127-
amide (273) was obtained as a yellow solid in 93% yield (based on recovered starting 
material).
To authenticate the structure of the product as that of the tetrahydrocarbazole
(273), a nuclear Overhauser enhancement (n.O.e.) experiment was undertaken. When 
the amide (N-H) doublet at 10.33 ppm was irradiated, an enhancement at 7.72 ppm, 
corresponding to the resonance of the olefinic proton, was observed.
A decoupling experiment was also carried out Thus, when the amide (N-H) 
doublet at 10.33 ppm was irradiated, the doublet at 7.72 ppm collapsed to a singlet, 
thus confirming the assigned structure.
The formation of this product (273) can be explained by nucleophilic attack, 
and subsequent ring opening of the phthalimide, by methanol.
This type of nucleophilic attack on the carbonyl functions of phthalimides is 
utilised in the hydrolysis of such compounds to amines.
In our hands, reaction of the tetrahydrocarbazole (269) with hydrazine gave the 














Scheme 1 1 2
CNBnO
(275)
While these experiments were undertaken, efforts were still being made to 
de-ethoxycarbonylate the carbazoles (268) and (269). Thus, heating the mixture of 
the compounds (268) and (269) with potassium cyanide in hexamethylphosphoramide 
(HMPA) at 125°C for 48h led to the isolation of 
6-benzyloxy-3-cyano-l-methylcarbazole (276). (Scheme 113).
BnO CN
KCN
(268) + (269)  ■
H M PA /125 °C
(276)
Scheme 113
This transformation can be envisaged as proceeding via the required
-129-
de-ethoxycarbonylation, but the intermediate anion (277) now eliminates phthalimide 
anion to afford the diene (278). This compound undergoes a 1,5-hydrogen shift to 









Although this result was disappointing, it has illustrated another limitation of 
our methodology.





A possible way of surmounting this problem would be to alkylate intermediates 
of the type (280), where E represents an electron withdrawing group such as a nitrile 
or an alkoxycarbonyl unit.
This would then prevent the dealkoxycarbonylation step and leave only an 
oxidation of the dihydrocarbazole (283) to afford the corresponding carbazole (284). 
(Scheme 115).
There is literature precedent for this type of alkylation of nitriles181 and 
esters. 182 As only one activating group is present, a strong base such as lithium 
diisopropylamide (LDA) is preferred, but phase transfer catalysis or heating with 
weaker bases have also been employed.











In the limited time left at the end of this project, the author attempted to alkylate 
these compounds. However, successful conditions were not found.
For example, due to the acidic nature of the indole N-H, two equivalents of base 
and alkylating agent were employed. (These results are summarised in Table Seven). 
In most cases, the starting materials were returned unchanged, but when higher 
temperatures were employed, the alkylating agent was destroyed.
Recourse to phase transfer conditions were equally unsuccessful, and under the 
conditions employed, the ester (286) was saponified to the free acid (287). (Scheme 
116).
BnEt3N+ Cl ‘ /  NaOH








R’ R” R’” Base Conditions
PhCH20 c h 3 H Na2C03 DMF /  lh
PhCH20 c h 3 H Na2C 03 DMF /  100 °C / lh
H C2H5 H NaH THF/24h
H C2H5 H NaH THF/70 °C /7h
H C2H5 H LDA THF/  - 78 —»25 °C /24h
H C2H5 H NaH DMF /  110°C / 14h
H C2H5 Phth NaH DMF/ 100°C /10h
-133-
There are obviously several experiments outstanding and one could, for 
example, protect the indolic nitrogen of (285) by sulphonylation.
It is expected that the challenge presented by these results will be taken up by 
future workers joining our group at Bath, as there is continuing international interest 




Melting points were recorded on an Electrothermal Mark II apparatus and are 
uncorrected. I.r. spectra were recorded on Perkin-Elmer 197 or 1310 grating 
spectrophotometers. U.v. spectra were recorded on Perkin-Elmer 402 and Lambda 3 
instruments. *H N.m.r. spectra were run at 60 MHz on Perkin-Elmer R24B and Varian 
EM360 spectrometers; at 250 MHz on a Bruker instrument using the facility at Glaxo 
Group Research, Greenford; at 270 MHz on a JEOL JNM Fourier Transform 
spectrometer. 13C N.m.r. were recorded at 67.8 MHz on a JEOL JNM Fourier Transform 
spectrometer. Chemical shifts are expressed in parts per million downfield from 
tetramethylsilane (TMS) as internal standard. Mass spectra and high resolution accurate 
mass measurements were determined on a VG 7070E instrument with VG 2000 data 
system. T.l.c. analysis was performed on Merck DC-Alufolien plates coated with 
Kieselgel 60 F2 5 4 . Visualisation of reaction components was by u.v. light. Column 
chromatography was performed in short path columns packed with Merck 7736 Kieselgel 
and the solvent was eluted under pressure provided by hand bellows. Dry column 
chromatography was performed in cylindrical sinters packed with Merck 7736 Kieselgel 
and the solvent was eluted under water pump vacuum. Evaporations were carried out 
under water pump vacuum unless otherwise stated. Ethyl acetate, dichloromethane and 
pet. ether used for chromatography were distilled prior to use. The term pet. ether refers 
to light petroleum ether boiling at 60-80°C.
Reagents
Tetrahydrofuran was dried by distillation from sodium/benzophenone ketyl. 
Diethyl ether and benzene were dried by standing over sodium wire for at least 1 day. 
Dichloromethane was dried by distillation from calcium hydride. Dimethyl sulphoxide
-135-
was dried by standing over activated 4 A° molecular sieves. Methanol and ethanol were 
dried by distillation from magnesium turnings. Triethylamine was dried by distillation 
from calcium hydride. Dimethylformamide was dried by standing over activated 4 A° 
molecular sieves. Tosyl chloride was recrystallised from pet. ether prior to use. All 
molecular sieves were activated by heating to at least 150°C overnight. Unless otherwise 
stated, all other solvents and reagents were used as supplied.
Experimental
2-Cyano-A-oxopentanonitrile (165a)
A solution of malononitrile (3.3g, 50 mmol) in dry THF (10 cm3) was added, 
dropwise, to a cooled, stirred suspension of sodium hydride (1.2g, 50 mmol) in dry 
THF (30 cm3) under a nitrogen atmosphere.
After the addition, the ice bath was removed and the reaction mixture stirred for a 
further 30 minutes before the resultant suspension was slowly injected, via a 
cannula, into a cooled solution of chloroacetone (5.3 cm3, 6 6  mmol) in dry THF 
(30 cm3).
The reaction mixture was stirred for lh before the solvent was removed at reduced 
pressure. The residue was purified by bulb to bulb distillation (220°C/0.3 mmHg) 
to yield 4.9g (79%) of colourless crystals which were recrystallised from 
chloroform/pet. ether; m.p. = 55-56°C, (lit134 55-57°C); vmax (CHCl3 )cm" ^ 2 2 0 0  
(O N ), 1700 (C=0); 6 H (CDCI3 ) ppm 4.21 (1H, t, J = 6 Hz, CH), 3.25 (2H, d, J= 
6 Hz, CH2), 2.30 (3H, s, CH3 ); m/z (70eV) 43 (100%), (C.I.), 123 [(M+l)+, 100%].
Ethyl 2-cyano-4-oxopentanoate (165b)
Sodium metal (5g, 0.22 mol) was completely dissolved in absolute ethanol (100 
cm^), with cooling. To this solution was added ethyl cyanoacetate (25 cm?, 0.22 
mol) with the temperature maintained below 20°C.
After the addition, stirring was continued at room temperature for a further 30 
minutes. The resultant suspension was then slowly transferred, via a cannula, into 
a stirred solution of chloroacetone (20 cn?, 0.25 cm^), again keeping the 
temperature below 20°C.
The reaction mixture was stirred for lh before the solvent was removed at reduced 
pressure and the residue partitioned between ethyl acetate ( 1 0 0  cm^) and water 
( 1 0 0  cm^)
The organic extract was washed with water (2 x 100 cm^), dried (MgSC>4 ) and
-137-
evaporated at reduced pressure.
The residue was purified by bulb to bulb distillation (95°C/0.5 mmHg; lit186 
69-72°C/0.01 mmHg) to yield the title compound as a colourless oil (24g, 64%). 
Vmax (thin film) cm’ 1 2260 (O N ), 1745 (C=0), 1725 (C=0); 8 h  (CDCI3 ) ppm 
4.17 (2H, q ,J  = 6 Hz, OCH2 ), 3.82 (1H, t ,J  = 6 Hz, CH), 3.05 (2H, d, /  = 6 Hz, 
CHCH2), 2.18 (3H, s, CH3 C O ), 1.28 (3H, t, /  = 6 Hz, OCHjCBj); m/z (low eV) 
169 (M+, 16%), 43 (100%)
Ethyl 2-Acetyl-A-oxopentanoate (165c)
Sodium metal (5g, 0.22 mol) was completely dissolved in absolute ethanol (100 
cm3), with cooling. To this solution was added, dropwise, ethyl acetoacetate (27.8 
cm3, 0.22 mol) with the temperature maintained below 20°C.
After the addition, stirring was continued at room temperature for a further 30 
minutes. The resultant white suspension was then slowly transferred, via a 
cannula, into a stirred solution of chloroacetone (20 cm3, 0.25 mol) in absolute 
ethanol (100 cm3), again keeping the temperature below 20°C.
The reaction mixture was stirred for 30 minutes before the solvent was removed at 
reduced pressure and the residue partitioned betwen ethyl acetate ( 1 0 0  cm3) and 
water ( 1 0 0  cm3l
The organic extract was washed with water (2 x 100 cm3), dried (MgS04) and the 
solvent removed.
The residue was purified by bulb to bulb distillation (80-81°C/0.2 mmHg, lit135 
126-128°C/14 mmHg) to yield the title compound as a colourless oil (26.7g, 6 6 %), 
vmax (thin film) cm' 1 1688 (C=0), 1713 (C=0); 8 h (CDCl3)ppm 4.18 (2H, q, /  = 
7Hz, OCHj), 3.82 (1H, t, /  = 6 Hz, CH), 3.05 (2 H, d, /  = 6 Hz, CHCHj), 2.34 (3H, 
s, CH3 C=0 ), 2.19 (3H, s, CH3 C=0 ), 1.29 (3H, t, /  = 7Hz, OCH2CH3 ); m/z (70 eV) 
101 (28%), 43 (100%), (C.I.) 187 [(M+l)+, 93%], 169 (58%), 141 (100%), 131 
(22%); C9 H140 4: Requires C 58.1, H 7.5%; Found C 58.2, H 7.8%.
4,4-Dicyano-5-0-indolyl)pentan-2-one (167a)
-138-
A solution of the ketone (165a) (2g, 16.4 mmol) and dimethyl 
acetylenedicarboxylate (2.01 cm3, 16.4 mmol) in dry THF (15 cm3) was added, 
dropwise, to a cooled solution of gramine (2.85g, 16.4 mmol) in dry THF (40 cm3), 
under a nitrogen atmosphere.
The reaction mixture was stirred for 3h. The solvent was removed at reduced 
pressure and the residue purified by column chromatography (pet. ether: ethyl 
acetate/ 50:50, Rf = 0.65). The title compound was isolated as white plates (2.90g, 
71%), recrystallised from ethyl acetate/pet. ether, m.p. = 125-126°C, vmax (CHC13) 
cm' 1 3410 (N-H), 2200 (O N ), 1680 (0=0); 5H (d6acetone) ppm 10.40 (1H, s, 
exchanges, N-H), 7.70 - 6.90 (5H, m, aromatic protons), 3.52 + 3.35 (2 x 2H, 2 x s, 
2 x CH2), 2.10 (3H, s, CH3 ); m/z (low eV) 251 (M+, 75%), 130 (100%), (70eV)
251 (M+, 10%), 130 (100%); Xmax (95% Ethanol) nm 289, 280, 219; C15H 13N30: 
Requires C 71.7, H 5.2, N 16.7%; Found C, 71.7; H, 5.2; N, 16.5%; Acc. Mass; 
Calculated 251.1057; Found 251.0998.
A-Cyano-A-ethoxycarbonyl-5-{3-\ndolyl)pentan-2-one (167b)
The same procedure used for the synthesis of the indole (167a), converted the 
ketone (165b) (1.5g, 8 . 8 8  mmol) to the indole (167b) (2.60g, 98%). The title 
compound was isolated as colourless crystals, recrystallised from ethyl acetate/pet. 
ether, m.p. = 148°C, (lit134 145-146°C); Rf = 0.9 (pet. ether: ethyl acetate : 
triethylamine/80 : 20 : 20), vmax (nujol) cm' 1 3420 (N-H), 2250 ( G e N ) ,  1730 
(C=0), 1710 (C=0); 5h (d6 acetone) ppm 10.50 (1H, s, exchanges, N-H), 7.50-6.70 
(5H, m, aromatic protons), 3.92 (2H, q, /  = 6 Hz, OCH2CH3), 3.40-3.20 (4H, m, 2 
x CH2), 2.07 (3H, s, CH3 C=0), 1.12 (3H, t, /  = 6 Hz, OCH2CH3 ); (95% 
Ethanol) nm (e)289 (2600), 281 (3000), 221 (1400); m/z (low eV) 298 (M+, 61%), 
130 (100%), (70eV) 298 (M+, 10%), 130 (100%), 43 (23%), C17H 18N20 3:




To a stirred solution of gramine (4.35g, 25 mmol) in dry THF (30 cm3), under a 
nitrogen atmosphere, was slowly added a solution of freshly distilled dimethyl 
sulphate (2.4 cm3, 3.14g, 25 mmol) in dry THF (25 cm3). On addition, a pink gum 
was observed.
In a separate flask, a solution of the ketone (165c) (4.23g, 25 mmol) in dry THF 
(35 cm3) was slowly added to a stirred cooled suspension of NaH (0.6g, 25 mmol) 
in dry THF (15 cm3).
After the addition was complete, the ice bath was removed and the mixture stirred 
at ambient temperature for 30 minutes. The resultant purple anion solution was 
then slowly transferred, via a cannula, into the methiosulphate reaction vessel. The 
mixture was shaken until stirring was possible.
The mixture was stirred for 16h before the solvent was removed and the residue 
partioned between chloroform (25 cm3) and 2N HC1 (25 cm3). The aqueous layer 
was washed with chloroform (2x15 cm3) and the combined organic layers were 
washed with water (2 x 25 cm3), brine (25 cm3) and dried (MgS04).
The solvent was removed at reduced pressure and the residue purified by column 
chromatography (pet. ether/ethyl acetate) to yield the title compound as a pale red 
oil (6.22g, 79%).
All attempts to crystallise this product failed. The product was used without 
further purification after column chromatography. Rf = 0.61 (pet. ether: ethyl 
acetate/80:20). vmax (CHC13) cm 1 3400 (N-H), 1710 (C=0), 1750 (C=0); 5h 
(CDC13) ppm 8.83 (1H, s, exchanges, N-H), 7.40-6.78 (5H, m, aromatic protons),
4.13 (2H, q, /  = 7Hz, O C H ^ ) ,  3.50 (2H, q, /  = 4Hz, CHj), 3.05 (2H, s, CHJ,
2.38 + 1.92 (2 x 3H, 2 x s, 2 x CH3C=0 ), 1.16 (2H, t, J  = 7Hz, OO^CHj); 5c 
(CDCI3) ppm 206.9 (C=0), 205.8 (C=0), 171.4 (C02Et), 135.6 (indole C-8 ), 127.7 
(indoleC-9), 123.1 (indoleC-2 ), 121.6,119,117, 111 (indoleC-4, C-5, C-6 , C-7), 
108 (indole C-3), 62.6 [C (COCH3) C0 2Et] 61.3 (CH2), 46.4 (CH2 COCH3), 29.5 
(CH3 C=0), 28.8 (OCH2 CH3), 27.4 (COCH3), 13.5 (CC^CHiCT^); m/z (Cl.) 315 
(M+, 32%), 130 (100%).
-140-
Method B
The same procedure used for the synthesis of the indole (167a) was employed to 
convert the ketone (165c) (1.99g, 10.84 mmol) into the indole (167c).
However, after the work-up procedure and column chromatography 
(pet.ether/ethyl acetate), the product (167c) was found to be contaminated with the 
by-product dimethyl 2-dimethyl aminobutenedioate (182). Extensive column 
chromatography could only partially separate the two compounds. Consequently, 
the method was deemed unsatisfactory and Method A was employed for the 
synthesis of (167c). The enaminoester (182) was isolated as an off-white solid, 
m.p. = 83-85°C (lit185 83-84.5°C); vmax (CHC13) cm' 1 1735 (C=0), 1675 (C=0);
SH (CDC13) ppm 4.6 (1H, s, olefinic proton), 3.9 (3H, s, CO?CHQ, 3.6 (3H, s, 
CO2CH3 ), 2.9 (6 H, s, N(CH3)2); m/z (70 eV) 187 (M+, 40%), 156 (42%), 155 
(43%), 128 (100%), 72 (43%),(C.I.) 188 [(M+l)+, 100%], 187 (M+, 39%), 156 
(77%), 128 (30%).
3,3-Dicyano-l,2,3,4-tetrahydro-l-methylenecarbazole (168a)
A solution of the indole (167a) (1.45g, 5.74 mmol) in 50% aqueous acetic acid
(75 cm^) was heated at reflux for 4h. After cooling, the solvent was removed 
under reduced pressure and the residue partitioned between saturated NaHC0 3  
solution (75 cnv*) and ethyl acetate (3 x 50 cm^). The combined organic layers 
were washed with water (100 cm^), brine (50 cm^) and dried (MgSC>4 ). The 
solvent was removed under reduced pressure to yield the title compound as a 
colourless solid (1.43g, 99%), recrystallised from ethyl acetate, m.p. = 215°C,
(lit1 3 4  226-228°C). Rf = 0.84 (pet.ether: ethyl acetate/50:50). omaI (CHCI3 )
cm' 1 2400 (N-H), 2210 (ON), 1620 (C=C); 8 h (d6  acetone) ppm 10.50 (1H, s, 
exchanges, N-H), 7.60-6.92 (4H, m, aromatic protons), 5.66 + 5.20 (2 x 1H, 2 x s, 
olefinic protons), 3.64 + 3.31 (2 x 2H, 2 x s, 2 x CH?); ^  (95% Ethanol) nm 305, 
272,212; m/z (low eV) 233 (M+, 100%), (70eV) 233 (M+, 100%), 232 (23%), 155 
(57%), 149 (30%), 57 (23%); C15Hn N3: Requires C 77.2, H 4.8, N 18.0%; Found 
C 76.8, H 4.7, N 17.7%.
3-Cyano-3-ethoxycarbonyl-1 t2,3A-tetrahydro-1 -methylenec arbazole (168b)
The procedure used for the synthesis of the tetrahydrocarbazole (168a) was 
employed to convert the indole (167b) (2.0g, 6.71 mmol) into (168b) (1.86g, 99%). 
The title compound was isolated as colourless crystals recrystallised from 
chloroform/pet.ether, m.p. = 133°C, (lit134 133-135°C), Rf = 0.59 (pet. ether: ethyl 
acetate/50:50), vmax (CHC13) cm 1 3400 (N-H), 2250 (O N ), 1720 (C=0), 1630 
(C=C); 8 h (CDC13) ppm 8.32 (1H, br s, exchanges, N-H), 7.50-7.10 (4H, m, 
aromatic protons), 5.20-4.96 (2 x 1H, 2 x s, olefinic protons), 4.30 (2H, q, J  = 7Hz, 
OCH2 CH3), 3.56 + 3.38 (2 x 2H, 2 x s, 2 x CH^, 1.31 (3H, t, /  = 7Hz, OC^CH,); 
m/z (low eV) 280 (M+, 100%), 207 (28%), (70eV), 280 (M+, 48%), 207 (100%); 
Ci7H16N20 2 : Requires C 72.8, H 5.8, N 10.0%; Found C 72.8, H 5.7, N 9.9%;
(95% Ethanol) nm (e) 309 (54 500), 305 (54 900), 252 (21 700).
3-Acetyl-?>-ethoxycarbonyl-?>A-dihydro-1 -methylcarbazole (193).
The procedure used for the synthesis of the tetrahydrocarbazole (168a) was 
employed to convert the indole (167c) (2.0g, 6.35 mmol) into a mixture of the 
dihydrocarbazole (193) and the isomeric tetrahydrocarbazole (168c) (1.36g, overall 
yield of 72%). The mixture was purified by column chromatography 
(pet.ether/ethyl acetate) to yield a mixture of (193) and (168c).5H(CDCl3)ppm;
8.80 (0.5H, s, N-H ),8.30 (0.5H, s, N-H), 7.60 -7.00 (4H,m,rest of aromatic 
protons ), 5.88 (0.5H, d , J  = 1.5 Hz, endocyclic olefinic proton), 5.23 + 5.03 (2 x 
0.5H, 2 x s, 2 x exocyclic olefinic protons), 4.52 - 4.04 (2H, m, 2 x OCH2CH3), 
3.60 - 3.10 (3H, m, 3 x CBj), 2.21 (3H, s, 2 x COCH3 ), 2.05 (1.5H, s, H2 C=CCH3 ),
1.58 - 1.08 (2 x 1.5H, m, 2 x OCH2 CH3). The title compound could be 
obtained as colourless crystals by crystallisation from ethyl acetate/pet.ether, m.p.
= 131°C, Rf = 0.74 (pet.ether: ethyl acetate/50:50), vmax (CHC13) cm-1 3420 
(N-H), 1700 (C=0); 5H(CDC13) ppm 8.10 (1H, s, exchanges, N-H), 7.56-7.08 (4H, 
m, aromatic protons), 5.88 (1H, d, J  = 1.5Hz, olefinic proton), 4.24 (2H, q, /  =
7Hz, OCH2CH3), 3.50 (2H, d, J  = 16Hz, CHJ, 2.21 (3H, s, COCH3 ), 2.11 (3H, d,
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J  = 1.5Hz, CH2  = CCH3 ), 1.23 (3H, t, /  = 7Hz, OCfyCHj); m/z (low eV) 297 (M+, 
58%), 254 (100%), 144 (48%), 120 (25%), 101 (73%), (70eV) 181 (28%), 101 
(34%), 73 (23%), 43 (100%); C18H19N03: Requires C 72.7, H 6.4, N 4.7%; Found 
C 72.4, H 6.4, N 4.6%.
3-Cyano-1 -Methylcarbazole (169a)
The tetrahydrocarbazole (168a) (546 mg, 2.34 mmol) was preabsorbed onto silica 
gel (5.5g) and heated at 250°C under a stream of nitrogen.
After lh, the silica was allowed to cool and then washed with ethyl acetate (4 x 50 
cm3). The solvent was removed at reduced pressure and the residue purified by 
column chromatography (pet.ether/ethyl acetate). The title compound was isolated 
as a pale yellow solid (198 mg, 41%), recrystallised from ethyl acetate/pet.ether, 
m.p. = 193°C (lit134 193-194°C); Rf = 0.42 (pet.ether:ethyl acetate/80:20), vmax 
(nujol) cm' 1 3450 (N-H), 2200 (C=N); 5H (d6 acetone) ppm 10.83 (1H, br.s, 
exchanges, N-H), 8.04 - 6.82 (6 H, m, aromatic protons), 2.50 (3H, s, CH3 );
(95% ethanol) nm (e) 336 (1200), 324 (1600), 310 (1900), 273 (21900), 261 
(17100); m/z (low eV) 206 (M+, 100%), (70 eV) 206 (M+, 100%), 205 (44%), 179 
(62%), 151 (31%); C14H10N2: Requires C, 81.5; H, 4.9; N, 13.6%; Found C, 81.4; 
H, 4.8; N, 13.6%.
3-Ethoxy carbonyl-1 -methylcarbazole (169b)
The tetrahydrocarbazole (168b) (0.39g, 1.39 mmol) was preabsorbed onto silica 
gel (4g) and heated at 250°C under a stream of nitrogen for 2h.
The silica gel was then allowed to cool and washed with ethyl acetate (4 x 50 cm3). 
The solvent was removed and the residue purified by column chromatography (pet. 
ether/ethyl acetate). The title compound was isolated as a pale yellow solid 
(180mg, 50%), recrystallised from chloroform/pet.ether, m.p. = 133-135°C, (lit189 
151°C) Rf = 0.34 (pet. ether: ethyl acetate 80:20), vmax (CHC13) ppm 3450 (N-H), 
1680 (C=0), 1600 (C=C); 6 H (CDC13) ppm 8 . 6 8  (1H, s, H-4 of carbazole), 8.30 
(1H, s, exchanges, N-H), 8.12-7.25 (5H, m, rest of the aromatic protons), 4.37 (2H,
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q, /  = 7Hz, OCH2 CH3), 2.57 (3H, s, CH3), 1.45 (3H, t, /  = 7Hz, OCH2 CH3); Xmax 
(95% ethanol) nm 278, 269, 235; m/z (low eV) 253 (M+, 100%), (70eV) 253 (M+, 
65%), 208 (65%), 180 (29%), 6 8  (32%), 43 (1 0 0 %), 28 (50%); C16H15N 0 2  : 
Requires C, 75.9; H, 5.9; N, 5.5%; Found C, 75.9; H, 6.0; N, 5.6%.
A second product was eluted from the column at Rf = 0.42 (pet. ether: ethyl 
acetate/80:20) and was characterised as 3-cyano- 1 -methylcarbazole (169a) (30mg, 
10%).
1 -methyl-3-(sulphoxymethyl)acetylcarbazole (2 0 2 )
A solution of sodium hydride (103 mg, 4.29 mmol) in dry DMSO (3 cm3) was 
stirred at 60-70°C, under a nitrogen atmosphere, until the evolution of hydrogen 
gas had ceased and the solution had become a clear, dark green colour (approx lh). 
Dry THF (4 cm3) was added to the anion solution and the mixture cooled in an ice 
bath.
A solution of the ester (169b) (363 mg, 1.4 mmol) in dry THF (4 cm3) was added 
over a period of 5 minutes and the reaction mixture stirred for a further 30 minutes 
at room temperature.
The reaction mixture was then poured into aqueous HC1 (pH 4, 35 cm3) and the 
aqueous layer thoroughly extracted with DCM (10 x 50 cm3). Some yellow 
product precipitated and was filtered and washed with diethyl ether.
The combined organic layers were washed with water (3 x 50 cm3), brine (10 cm3) 
and dried (Na2 S04).
The solvent was removed at reduced pressure to yield a yellow solid which was 
triturated with diethyl ether, filtered and combined with earlier product (287 mg, 
72%), m.p. = 231°C, vmax (nujol) cm 1 3140(N-H), 1650 (C=0), 1015 (S=0); 6 H 
(d6 DMSO) ppm 10.00 (1H, s, exchanges, N-H), 8.60-7.27 (6 H, m, aromatic 
protons), 4.58 (2H, ABq, J  = MHz, C H ^ , ^  (3H, s, CH3), 1.25 (3H, s, CH3 );
(95% ethanol) nm 334, 294,275, 236,191; m/z ( lo w  eV) 285 (M+, 95%), 208 
(77%), 194 (63%), 78 (100%), 63 (48%), (70eV) 285 (M+, 17%), 208 (45%), 194 
(47%), 78 (80%), 63 (100%); C16H15N02S : Requires C, 67.4; H, 5.3; N, 4.9%;
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Found C, 66.2; H, 5.5; N, 4.8%.
3-Acetyl-l-methylcarbazole (170)
Method A: Reduction of the B-keto sulfoxide (202):
The p-keto sulfoxide (202) (132 mg, 0.46 mmol) was stirred in 10% aqueous THF 
(9 cm3) and cooled with an ice bath.
Aluminium foil (142 mg, consecutively dipped into solutions of 2% aqueous 
mercury ( 1 1 ) chloride, ethanol and diethyl ether) was added to the reaction mixture 
and stirred for 30 minutes.
The reaction mixture was filtered, washed with THF and the THF removed at 
reduced pressure. The residue was partitioned between water (20 cm3) and ethyl 
acetate (3 x 20 cm3). The combined organic layers were dried (Na2 S04) and 
evaporated. The residue was purified by column chromatography to yield the title 
compound as a colourless solid (84mg, 70%), recrystallised from DCM/pet.ether, 
m.p. = 178-180°C (lit134 193-194°C), Rf = 0.72 (pet.ether: ethyl acetate/50:50). 
vmax (CHC13) cm*1 3400 (N-H), 1650 (C=0), 1600 (C=C); 5H (d6 acetone) ppm
11.19-10.87 (1H, br.s, exchanges, N-H), 8.58-7.10 (6 H, m, aromatic protons), 2.64 
(3H, s, CH3 ), 2.62 (3H, s, CH3 ); (95% ethanol) nm 328,288, 273,236,196;
m/z (low eV) 223 (M+, 100%), 208 (52%), (70eV) 223 (M+, 62%), 208 (100%); 
C15H13NO: Requires C 80.7, H 5.8, N 6.3%; Found C 80.6, H 5.6, N 6.2%.
Method B Reaction of methyl lithium with the nitrile (169a):
To a solution of the nitrile (169a) (50mg, 0.24 mmol) in dry THF ( 6  cm3), cooled 
to -78°C, under a nitrogen atmosphere, was slowly added a solution of methyl 
lithium (0.50 mmol, 1.5m in ether).
After the final addition, the reaction mixture was allowed to warm slowly to room 
temperature (at least 2 h).
The red solution was then cooled with an ice bath and methanol (1 cm3) added 
before the solvent was removed at reduced pressure to leave an orange solid.
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This solid was dissolved in 50% aqueous acetic acid (9 cm3) and gently refluxed 
for 30 minutes.
The solvent was removed at reduced pressure, saturated NaHC03 solution (20 
cm3) added and extracted with ethyl acetate (3 x 10 cm3). The combined organic 
layers were washed with water (2 x 15 cm3), brine (15 cm3) and dried (Na2 S04). 
The solvent was removed and the residue purified by column chromatography to 
yield the title compound (170) as a colourless solid (53 mg, 98%), recrystallised 
from DCM/pet.ether, m.p. = 178°C.
Method C: From a mixture of the B-keto esters (193) and (168c):
An equal mixture of the p-keto esters (193) and (168c) (238mg, 0.80 mmol) was 
stirred in DMSO (1.5 cm3) with water (16 mg, 0.88 mmol) and LiCl (37 mg, 0.88 
mmol) at 120°C for48h.
The mixture was then allowed to cool and was poured into H20  (10 cm3).
The aqueous layer was extracted with ethyl acetate (4x15 cm3), the combined 
organic layers were washed with water (4x15 cm3), brine (10 cm3) and dried 
(Na2 S04).
The solvent was removed and the residue purified by column chromatography to 
yield two products.
The first product eluted had a Rf = 0.40 and the second product had a Rf = 0.34 
(pet.ether: ethyl acetate/80:20).
The first product was identified as the ester (169b) (32 mg, 20%) and the second 
identified as the required title compound (170) (20mg, 15%).
3-Cyano-1,2,3 A-tetrahydro-1 -methylenecarbazole (194)
A mixture of the tetrahydrocarbazole (168b) (300 mg, 1.08 mmol), water (25 mg,
1.39 mmol) and LiCl (45 mg, 1.08 mmol) was stirred in DMSO (2 cm3) at 160°C, 
under a nitrogen atmosphere for 48h.
The reaction mixture was allowed to cool and then poured into water (20 cm3). 
The aqueous layer was extracted with DCM (4x15 cm3) and the combined
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organic layers were washed with water (3 x 15 cm3), brine (10 cm3) and dried 
(Na2 S04).
The solvent was removed and the residue purified by column chromatography to 
yield the title compound as a colourless solid (49 mg, 50%), recrystallised from 
ethyl acetate/pet.ether, m.p. = 145-148°C. Rf = 0.42 (pet.ether: ethyl 
acetate/80:20), vmax (CHC13) cm 1 3450 (N-H), 2200 (teN ), 1630 (C=C); 5H 
(CDC13) ppm 8.18 (1H, s, N-H), 7.48-7.07 (4H, m, aromatic protons), 5.23 + 5.01 
(2 x 1H, 2 x s, olefinic protons), 3.11 (3H, m, CH? + CHCN), 2.79 (2H, m, CH?);
(95% ethanol) nm 308, 242, 239, 206; m/z (low eV) 208 (M+, 100%), (70eV) 
208 (M+, 100%), 207 (28%), 155 (43%), 154 (25%); C14H12N2  : Requires C, 80.8; 
H, 5.8; N, 13.5%; Found C,
80.4; H, 5.7; N, 13.2%.
3-Cyano-l-methylcarbazole (169a)
The crude product (194) (25 mg, 0.12 mmol) was stirred in dry benzene (2 cm3) 
under a nitrogen atmosphere.
DDQ (30 mg, 0.13 mmol) was added and the dark green solution was heated at 
reflux for 14h.
The solvent was removed and the residue purified by column chromatography to 
yield the title compound as a pale yellow solid (20 mg, 75% for the two steps from 
(168b)).
Attempted Preparation of the imine (171)
Method A:
A solution of the ketone (170) (130 mg, 0.58 mmol) and aminoacetaldehyde 
dimethylacetal (367 mg, 0.38 cm3 , 3.5 mmol) in dry toluene (30 cm3), containing 
p-toluene sulfonic acid (10 mg), was heated at reflux, using Dean-Stark apparatus, 
for 2 0 h.
The reaction was followed by i.r. spectroscopy but no reaction was seen to be
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taking place. The solvent was allowed to cool, washed with a saturated solution of 
NaHCC>3 (2x10 cm3), dried (Na2 S04) and evaporated at reduced pressure to yield 
a colourless oil (120 mg, 94%).
The oil was shown by *H n.m.r. analysis to be the starting ketone (170).
Method B:
The ketone (170) (5 mg, 0.02 mmol) was heated in aminoacetaldehyde 
dimethylacetal (40 mg, 0.38 mmol) for 7h. I.r. analysis of the reaction mixture 
indicated that no reaction had taken place.
3-¥ormyl-\-methylcarbazole (205)
To a stirred suspension of the nitrile (169a) (345 mg, 1.67 mmol) in dry benzene (5 
cm3), under a nitrogen atmosphere, was slowly added DiBAL (1.2 cm3 , 1.75 
mmol, 1.5M). The suspension dissolved after the addition and the reaction mixture 
was stirred for 14h at room temperature, giving an orange precipitate.
Water (2 cm3) was added to the reaction mixture, the benzene was removed at 
reduced pressure and the residue gently refluxed in dilute H2S04  (10 cm3) for 2h. 
The reaction mixture was allowed to cool and extracted with ethyl acetate (3 x 30 
cm3). The combined organic layers were washed with brine (30 cm3), dried 
(Na2 S04) and evaporated at reduced pressure.
The residue was purified by column chromatography (pet.ether/ethyl acetate) to 
yield the title compound as a pale yellow solid (340 mg, 94%), recrystallised from 
ethyl acetate/pet.ether, m.p. = 196°C (lit187 206-208°C); Rf = 0.70 (pet.ether: ethyl 
acetate/60:40); vmax (CHC13) cm 1 3450 (N-H), 1670 (C=0); Sh (d6 DMSO) ppm
11.79 (1H, br. s, exchanges, N-H), 10.01 (1H, s, CHO), 8.59 - 7.26 (6 H, m, 
aromatic protons), 2.62 (3H, s, CH3); ^  (95% Ethanol) nm (e) 329 (1300), 290 
(2700) 274 (3300), 236 (3000), 200 (3100); m/z (low eV) 209 (M+, 100%), (70eV) 
209 (M+, 100%), 208 (72%), 180 (46%); C14Hn NO ; Requires C, 80.4; H, 5.3; N, 
6.7%; Found C, 80.0; H, 5.2; N, 7.1%.
-148-
3-[N-(2,2-Dimethoxyethyl)]imino-l-methylcarbazole (206)
A solution of the aldehyde (205) (346 mg, 1.66 mmol) and aminoacetaldehyde 
dimethylacetal (191 mg, 0.2 cm3, 1.82 mmol) in dry benzene (40 cm3) was heated 
to reflux, using a Dean-Stark trap.
The reaction was followed by i.r. spectroscopy, seeing the loss of the carbonyl 
stretch and the emergence of a new imine stretch at 1635 cm'1.
After 4h, the reaction mixture was cooled and the solvent removed at reduced 
pressure to yield the title compound as an orange foam (472 mg, 96%).
Attempts to crystallise the product failed and it was used without further 
purification; vmax (CHC13) cm 1 3450 (N-H), 1635 (ON ); 5H (CDC13) ppm 8.84 
(1H, s, ArCH=N), 8.28 (1H, s, exchanges, N-H), 8.01-7.16 (6 H, m, aromatic 
protons), 4.77 (1H, t, J = 5.3Hz, CH(OCH3 )2), 3.83 (2H, d, /  = 5.3Hz, HC = 
N-CH2 ), 3.45 (6 H, s, (OGIjb)^, 2.38 (3H, s, CH^; (95% ethanol) nm (e) 314 
(15000), 288 (41800), 274 (48100), 238 (38100); m/z ( lo w  eV) 296 (M+, 37%), 75 
(100%), (70eV) 296 (M+, 8 %), 75 (100%); C18H2 0N2O2 ; Acc. Mass : Calculated 
296.3682; Found 296.1523.
3-[N-(2,2-Dimethoxyethyl)ethylamino]-1 -methylcarbazole (207)
A solution of the imine (206) (150 mg, 0.51 mmol) in dry THF (3 cm3) was stirred 
under a nitrogen atmosphere at -78°C.
To this solution was slowly added methyl lithium (0.7 cm3 , 1.11 mmol, 1.5M 
solution in diethyl ether). The mixture was kept at -78°C for 40 minutes and then 
allowed to warm slowly to 0°C.
A solution of saturated ammonium chloride (10 cm3) was added and the mixture 
thoroughly stirred for 1 0  minutes.
The phases were separated and the aqueous phase was extracted with ethyl acetate 
(3 x 10 cm3). The combined organic phases were dried (Na2 S04) and evaporated. 
The residue was purified by column chromatography (pet.ether/ethyl acetate) to 
yield the amine (207) as a pale orange foam, (103 mg, 65%). The product was
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used without further purification. Rf = 0.23 (pet.ether : ethyl acetate/60:40); vmax 
(CHCI3) cm*1 3420 (carbazole N-H), 3260 (aliphatic N-H), 2860 (0-CH3); 8 H 
(CDCI3) ppm 8.20 (1H, s, carbazole N-H), 8.04-7.17 (6 H, m, aromatic protons), 
4.49 (1H, t, /  = 5.5Hz, CH(OCH3)2), 3.92 (1H, q, /  = 6 .6 Hz, CH3 CHNH), 3.35 + 
3.29 (2 x 3H, 2 x s, 2 x OCH3 ), 2.75-2.60 (2H, m, NHCH2), 2.51 (3H, s, C-l CH3 ), 
1.47 (3H, d, /  = 6 .6 Hz, CH3 CHNH), 1.25 (1H, s, CH3 CHN-H); ^  (95% ethanol) 
nm (e) 339 (3500), 326 (3800), 295 (15000), 260 (19900), 249 (27000), 239 
(36600); m/z (low eV) 312 (M+, 27%), 297 (38%), 208 (100%), 99 (39%), (70eV) 
208 (100%), 99( 40%), 98 (28%); C19H2 4N20 2  : Acc. Mass: Calculated 312.1848; 
Found 312.1836.
3-[N-(2,2-dimethoxyethyl)-N-(4-tosyl)ethylamino]-l~ methylcarbazole (172)
Tosyl chloride (460 mg, 2.4 mmol) and sodium carbonate (240 mg, 2.6 mmol) 
were added to a solution of the amine (207) (144 mg, 0.46 mmol) in THF (2 cm3) 
and water (4 cm3).
The reaction mixture was stirred at ambient temperature for 48h. However, t.l.c. 
analysis (pet.ether : ethyl acetate/60:40) indicated the presence of starting material. 
Additional quantities of tosyl chloride (115mg, 0.6 mmol) and sodium carbonate 
(60 mg, 0.57 mmol) were added and the mixture stirred for a further 14h.
The reaction mixture was diluted with H20  (14 cm3) and extracted with ethyl 
acetate (3 x 10 cm3). The combined organic layers were washed with 0.1N HC1 
(10 cm3) H20  (10 cm3), saturated NaHC03 solution (10 cm3), water (10 cm3) and 
dried (Na2 S04).
The solvent was removed at reduced pressure to give a pale yellow oil which was 
purified by column chromatography (pet.ether/ethyl acetate).
The title compound was isolated as a very pale yellow solid (185 mg, 84%), 
recrystallised from chloroform/pet.ether, m.p. = 153-154°C. Rf = 0.52 (pet.ether: 
ethyl acetate/60:40), vmax (CHC13) cm*1 3450 (N-H), 1590 (C=C); 6 H (CDC13) ppm 
7.96 (1H, s, N-H), 7.87-6.81 (10H, m, aromatic protons), 5.24 (1H, q, J -  7.0Hz,
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CH3 CHNTs), 4.32 (1H, m, CH(OCH3)2), 3.33+ 3.16 (2 x 3H, 2 x s, 2 x OCHj),
3.14 (2H, m, NCH2 CH), 2.47 (3H, s, C-l CH3), 2.40 (3H, s, tosyl CBj), 1.65 (3H, 
d, /  = 7.1Hz, CHjCHNTs); xmax (95% ethanol) nm (e) 339 (6300), 324 (6900), 295 
(27500), 260 (52700), 249 (69000), 239 (91000), 234 (81500), 201 (59100); m/z 
(low eV) 466 (M+, 18%), 208 (100%), 75 (78%), (70 eV) 466 (M+, 5%), 208 
(87%), 75 (100%); C2 6H3 0N2O4S : Requires C, 66.9; H, 6.5; N, 6.0%; Found C, 
6 6 .6 ; H, 6.4; N, 5.8%.
1,2-Dihydro-1,5-dimethyl-2-(4-tosyl)-6H-pyrido[4,3-b] carbazole (208)
6 N HC1 (2 drops) was added to a stirred solution of the acetal (172) (97 mg, 0.21 
mmol) in dry dioxan (2 cm3), under a nitrogen atmosphere. The mixture was 
stirred at ambient temperature for 16h.
The reaction mixture was heated at 60°C for 6 h then added to 2N NaOH solution 
(15 cm3) and extracted with ethyl acetate (3 x 15 cm3).
The combined organic layers were washed with water (3x15 cm3), brine (15 cm3), 
dried (Na2 S04) and evaporated at reduced pressure.
The residue was purified by column chromatography (pet. ether: ethyl acetate) to 
yield the title compound as a colourless oil (34 mg, 45%); Rf = 0.79 (pet.ether: 
ethyl acetate/70:30); vmax (CHC13) cm' 1 3460 (N-H); 8 h (CDC13) ppm 7.96 (1H, s, 
N-H), 7.93-6.97 (9H, aromatic protons), 6.80 (1H, dxd, J  = 6.2Hz, TsN-CH=CH),
6.31 (1H, dxd, J  = 7.3Hz, TsN-CH=CH), 5.35 (1H, m, CH3CHNTs), 2.45 (3H, s, 
C-5 CH3), 2.25 (3H, s,TsCHj), 1.43 (3H, d, /  = 6 .6 Hz, CI^CHNTs); ^  (95% 
ethanol) nm (e) 331 (7600), 258 (10600); m/z (low eV) 402 (M+, 100%), 387 
(34%), (70eV), 402 (M+, 10%), 387 (30%), 247 (23%), 232 (30%), 91 (38%), 73 
(26%), 42 (100%); C ^H ^^C ^S  : Acc.Mass: Calculated 402.1391; Found 
402.1400.
\,5-dimethylpyrido[4,3-b]carbazole (Olivacine) (2)
A solution of the tosyl compound (208) (20 mg, 0.05 mmol) was stirred in liquid 
ammonia (3 cm3) at -78°C, under a nitrogen atmosphere.
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Sodium metal (2.0 mg, 0.075 mmol) was added and the mixture was stirred for 40 
minutes.
Ammonium chloride (10 mg) was added and the ammonia evaporated at room 
temperature, under a stream of nitrogen gas.The mixture was dissolved in 
methanol(5 cm3) and 2N H2 S04(1 cm3) and warmed at 50 °C for lh. The methanol 
was then removed at reduced pressure.
The yellow residue was pardoned between diethyl ether (5 cm3) and 2N HC1 (5 
cm3). The acidic layer was basified with solid NaOH (with cooling) and extracted 
with DCM (2x10 cm3). The combined organic layers were dried (Na2 S04) and 
evaporated to yield the title compound as a yellow solid (8.5 mg, 70%). The 
product was found to be identical with an authentic sample. 190 m.p. = 315-320°C 
(lit135 320-324°C); Rf = 0.39 (DCM : ethanol: ammonia /  200:8:1); Acc. Mass. 
Ci7H1 4N2 : Calculated 246.1155; Found 246.1141.
1 -(5-Benzyloxy-3-indolyl)-NJV-dimethylaminoethane (213)
A solution of acetaldehyde (217 mg, 4.93 mmol) in benzene (1 cm3) was added to 
a mixture of 5-benzyloxyindole (l.Og, 4.48 mmol), dimethylaminehydrochloride 
(402 mg, 4.93 mol), K2 C0 3 (124 mg, 0.9 mmol), acetic acid (2 cm3) and propenoic 
acid (1 cm3) at -5°C.
The mixture was kept at -5°C for lh then stirred at 4°C for 5 days.
The mixture was poured into iced water (20 cm3) and extracted with diethyl ether 
(2 x 20 cm3). The aqueous layer was made basic with 10N NaOH and extracted 
with ethyl acetate (2 x 30 cm3). The solvent was dried (Na2 S04) and removed at 
reduced pressure to give an off-white solid (0.43 g, 33%), which was recrystallised 
from ethyl acetate/pet.ether, m.p. = 93-96°C. Rf = 0.35 (DCM : methanol 
:triethylamine/98:2:l); vmax (nujol) cm' 1 1580 (C=C); 8 H (CDC13) ppm 8.69 (1H, 
br s, N-H), 7.46-6.87 (9H, m, aromatic protons), 5.04 (2H, s, OCH2 C6H5), 3.80 
(1H, q, /  = 7.5Hz, CH3CH NMeJ, 2.23 (6 H, s, N(CH3)2), 1.48 (3H, d, /  = 7.5Hz, 
Cf^CHNMeJ; Xmsix (95% ethanol) nm (€) 304 (7700), 294 (8400), 214 (31000); 
m/z (70eV) 249 (42%), 158 (6 6 %), 91 (77%), 44 (100%), (C.I.) 292 (10%), 250
(100%), 249 (98%), 158 (48%), 91 (51%); C19H2 2N20  : Requires C, 77.5; H, 7.5; 
N, 9.5%; Found C, 77.5; H, 7.5; N, 9.4%.
1 -(5-benzyloxy-3-indolyl)aminoethane (219)
Phosphorus oxychloride (10.7 cm3, 0.115 mol) was added dropwise to a cooled, 
stirred solution of N,N-dimethylacetamide (10.7 cm3, 0.115 mol) in dry toluene 
(300 cm3), under a nitrogen atmosphere.
After the addition, the mixture was stirred for lh. 5-Benzyloxyindole (25.632g,
0.115 mol) was added and the mixture stirred for 17h.
On leaving to settle, the mixture separated into two layers. The top layer was 
decanted off and the bottom, orange layer was washed with diethyl ether (4 x 150 
cm3), decanting each time. The last traces of diethyl ether were removed at 
reduced pressure and the remaining orange oil was dissolved in analar methanol 
(800 cm3). 0.88 NH3 (16.5 cm3) was added and the solution became pale green. 
Sodium borohydride (16.5g) was carefully added, portion wise, and the mixture 
stirred for a further 2.5h.
The solvent was removed at reduced pressure and the residue partitioned between 
2N HC1 (400 cm3) and DCM (200 cm3). The layers were separated, the aqueous 
layer made basic with solid KOH (with cooling) and extracted with DCM (3 x 200 
cm3).
The organic layers were combined, dried (Na2 S04) and evaporated to give a brown 
solid. Recrystallisation from ethyl acetate/pet. ether gave the title compound as a 
colourless solid (16.4g, 54%), m.p. = 125-128°C; Rf = 0.21 (DCM : methanol: 
triethylamine/96:4:2); vmax (nujol) cm"1 3345 (indole N-H), 3280 (aliphatic N-H); 
5h (d6 DMSO) ppm 10.66 (1H, br s, exchanges, indole N-H), 7.49-6.76 (9H, m, 
aromatic protons), 5.08 (2H, s, OCH2 C6H5), 4.22 (1H, q, J  = 7.5Hz, CH3CH NH^,
1.79 (2H, br s, exchanges NHj), 1.26 (3H, d, J  = 7.5Hz, CHjCH NH2);Xmax(95% 
EtOH)nm(e) 274(10 100), 250(8 700); m/z (low eV) 249 (100%), (70eV) 249 
(50%), 158 (81%), 130 (28%), 91 (100%); C17H18N20  ; Requires C, 76.7; H, 6 .8 ; 
N, 10.5%; Found C, 76.3; H, 6 .8 ; N, 10.3%.
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Reaction of ethyl bromopyruvate with ethyl cyanoacetate 
Ethyl cyanoacetate (0.64 cm3, 6.02 mmol) was slowly injected into a stirred, 
cooled suspension of NaH (145 mg, 6.04 mmol) in dry DMF ( 8  cm3), under a 
nitrogen atmosphere.
After the final addition, the ice bath was removed, and the mixture was stirred at 
ambient temperature for 30 minutes.
The resultant anion solution was then injected into a cooled solution of ethyl 
bromopyruvate (1.175g, 6.04 mmol) in dry DMF (10 cm3).
The mixture was then stirred for lh. T.l.c. analysis indicated a mixture of 
products. Consequently, the reaction was not worked up.
2-Bromomethyl-2-ethoxycarbonyl-\i3-dioxolane (226)
A solution of ethyl bromopyrurate (l.Og, 0.64 cm3, 5.128 mmol), p-toluene 
sulphonic acid (1.27g, 6 . 6 6  mmol) and ethylene glycol (0.41g, 0.37 cm3, 6.67 
mmol) was heated in refluxing benzene (15 cm3), using a Dean-Stark trap, for 16h. 
The solution was allowed to cool and then washed with saturated NaHC03 
solution (2x10 cm3), water (3 x 10 cm3), brine (10 cm3) and dried (MgS04).
The solvent was removed at reduced pressure and the residue purified by bulb to 
bulb distillation, (110-112°C/0.1 mmHg).
The title compound was isolated as a colourless oil (580 mg, 47%); vmax (thin film) 
cm' 1 1730 (C=0); 5H (CDC13) ppm 4.27 (2H, q, /  = 7.1Hz, OCH2 CH3), 4.18 (4H, 
s, 0CH 2 CH2 0), 3.69 (2H, s, BrCH2), 1.33 (3H, t, / =  7.1Hz, O O ^C f^); 8 C 
(CDC13) ppm 167.3 (C=0), 129.7 (O-C-O), 6 6 . 8  ( O C H ^ ^ ) ,  61.9 (OCH2 CH3), 
33,1 (BrCH2), 13.9 (OCH ^H ^; m/z (70eV) 167 (100%), 165 (100%), 121 (43%), 
29 (32%), (C.I.) 241 [(M+2)+,20%], 239 (M+, 22%), 167 (8 8 %), 165 (100%); 
C17H11Br04  : Requires C, 35.2; H, 4.6%; Found C, 35.9; H, 4.6%.
Attempted reaction of ethyl cyanoacetate with the dioxolane (226)
Sodium metal (140 mg, 6.08 mmol) was completely dissolved in dry ethanol (10
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cm3), under a nitrogen atmosphere, keeping the temperature below 20°C.
Ethyl cyanoacetate (0.65 cm3, 690 mg, 6.11 mmol) was added dropwise, again 
keeping the temperature below 20°C.
After the addition was complete, the ice bath was removed and the mixture stirred 
for 30 minutes.
The white suspension was then slowly transferred, via a cannula, into a cooled 
solution of the dioxolane (226) (1.45g, 6.07 mmol) in dry ethanol (11 cm3). The 
solution was allowed to warm slowly to room temperature and stirred for 18h.
T.l.c. analysis (pet.ether : ethyl acetate/80:20) indicated that no product had 
formed.
The reaction mixture was then heated at reflux for 12h but again t.l.c. analysis 
indicated the presence of starting materials and no product.
The solvent was evaporated and the residue partitioned between ethyl acetate (25 
cm3) and water (20 cm3). The separated organic layer was washed with water (2 x 
20 cm3) and dried (Na2 S04).
The solvent was removed at reduced pressure to yield a pale yellow oil. n.m.r. 
analysis proved the oil to be a mixture of starting materials.
Attempted reaction between ethyl cyanoacetate and ethyl
3-bromo-2-hvdroxyiminopropanoate(227)157 
Method A:
A mixture of ethyl cyanoacetate (3.04 cm3, 28.57 mmol), ethyl
3-bromo-2-hydroxyiminopropanoate (227)157 (2.0g, 9.52 mmol) and anhydrous 
Na2CC>3 (2.019g, 19.05 mmol) in dry DCM (20 cm3) was stirred, under a nitrogen 
atmosphere, for 24h.
The reaction mixture was filtered through celite and the filtrate evaporated at 
reduced pressure.
n.m.r. analysis of the crude oil showed a complex mixture, including the loss of 
the oxime O-H signal.
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Method B:
Sodium metal (44 mg, 1.91 mmol) was completely dissolved in dry ethanol (4 
cm3), under a nitrogen atmosphere.
Ethyl cyanoacetate (216 mg, 0.20 cm3, 1.91 mmol) was added, dropwise, with 
cooling. After the final addition, the ice bath was removed and the mixture stirred 
at ambient temperature for 30 minutes.
The suspension was then cooled, with an ice bath, and injected into a cooled 
solution of the oxime (227)157 (400 mg, 1.91 mmol) in dry ethanol.
The reaction was stirred for 5 minutes before adding water (2 cm3). The ethanol 
was removed at reduced pressure and the residue was partitioned between ethyl 
acetate (20 cm3) and water (20 cm3). The separated organic layer was washed with 
water (2x15 cm3), brine (5 cm3) and dried (Na2S04).
The solvent was removed at reduced pressure to yield a viscous yellow oil. !H 
n.m.r. analysis showed this product to be a mixture of compounds with no 
significant amount of the desired product.
Ethyl-3-bromo-2-methoxyiminopropananoate (229)
A mixture of methoxyamine hydrochloride (3.30 g, 39.46 mmol), ethyl 
bromopyruvate (7.70 g, 39.46 mmol), chloroform (120 cm3) and methanol (80 
cm3) was vigorously stirred at ambient temperature for 16h.
The solvent was removed at reduced pressure, and the residue dissolved in DCM 
(100 cm3). This was washed with water (50 cm3), brine (50 cm3) and dried 
(Na2 S04).
The solvent was evaporated at reduced pressure to give a clear oil which was 
purified by bulb to bulb distillation (120°C/1.2 mmHg) to yield the tide compound 
as a colourless oil (7.8g, 8 8 %). Rf = 0.61 (pet.ether: ethyl acetate/80:20); vmax 
(thin film) cm 1 1720 (C=0), 1592 (ON); 5h (CDC13) ppm 4.38 (2H, q, J  = 7.5Hz, 
OCH2 CH3), 4.20 (2H, s, BrCH2), 4.17 (3H, s, NOCH3 ), 1.38 (3H, t, /  = 7.5Hz, 
OCH2CH3); Xm&x (95% ethanol) nm (e) 234 (3,600); m/z (low eV) 225 [(M+l)+, 
81%],, 223 (90%), 181 (64%), 179 (100%), 144 (60%), 135 (43%), (70eV), 225
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[(M+l)+, 37%), 223 (37%), 181 (60%), 179 (100%), 177 (34%), 144 (89%), 29 
(100%); C16H10BrNO3 : Requires C, 32.2; H, 4.5; N, 6.3:; Found C, 31.7; H, 4.5; 
N, 5.6%.
Diethyl 2-cyano-4-methoxyimino-l,5-pentadioate (230) and Diethyl
4-cyano-4-ethoxycarbonyl-2,6-di(methoxyimino)-l,7- heptadioate (231)
Ethyl cyanoacetate (504 mg, 0.47 cm3, 4.46 mmol) was added dropwise to a 
stirred, cooled suspension of sodium hydride (107 mg, 4.46 mmol), in dry DMF 
( 1 0  cm3), under a nitrogen atmosphere.
After the final addition, the ice bath was removed and the mixture stirred at 
ambient temperature for 30 minutes.
This pale green solution was then slowly injected, via a
cannula, into a solution of the methoxime (229) (l.Og, 4.46 mmol) in dry DMF (10 
cm3).
The reaction mixture was stirred for 10 minutes at ambient temperature and then 
poured into water (60 cm3).
The aqueous phase was extracted with ethyl acetate (60 cm3) and the separated 
organic phase washed with water (3 x 30 cm3) and brine (30 cm3).
The solvent was dried (Na2 S04) and evaporated to give 972 mg (85%) of a yellow 
oil. T.l.c. analysis (hexane : ethyl acetate/2:1) showed the oil to be a mixture of 2 
components.
The mixture was separated by column chromotography. The first compound 
eluted was shown to be the monoalkylated product (230). (Rf = 0.56, hexane : 
ethyl acetate/2:1). However, the product was contaminated by ethyl cyanoacetate 
but pure (230) could be obtained by bulb to bulb distillation (160°C/0.3 mmHg). 
Consequently, the diester (230) was obtained as colourless crystals (302 mg, 26%), 
recrystallised from chloroform/pet.ether, m.p. = 32-33°C. vmax (CHC13) cm' 1 2250 
(O N ), 1745 (0 0 ) ,  1715 (C=0), 1600 (ON ); 6 H (CDC13) ppm 4.36 (2H, q, /  = 
7 .5 Hz, N=C-C02CH2 CH3), 4.26 (2H, q, /  = 7.5Hz, NCCHCOjCfhC^), 4.12
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(3H, s, NOCH3), 4.02 (1H, t, J = 7.5Hz, NCCHC02Et), 3.19 (2H, d, /  = 7.5Hz, 
CHCH2 C=NOCH3), 1.37 (3H, t, /  = 7.5Hz, N=CC0 2CH2 CH3), 1.32 (3H, t, /  = 
7.5Hz, NCCHC0 2 CH2 CH3 ); Xmax (ethanol) nm (e) 227 (4100); m/z (70eV), 225 
(84%), 183 (100%), 155 (83%), 153 (52%), 137 (60%), 125 (94%), (C.I.) 257 
[(M+l)+, 100%], 211 (28%), 153 (22%), 125 (43%), 114 (96%); Cn H16N2 0 5 : 
Requires C, 51.6; H, 6.3; N, 10.9%; Found C, 51.2; H, 6.4; N, 10.7%.
The second compound eluted, Rf = 0.42 (hexane : ethyl acetate/2:1), was shown to 
be the dialkylated product (231). The product was obtained as a colourless oil and 
was purified by bulb to bulb distillation (220°C/0.4 mmHg), (527 mg, 60% gross). 
vmax (thin film) cm' 1 2250 (O N ), 1720 (C=0), 1690 (C=0), 1590 (C=N); 5H 
(CDCI3) ppm 4.35 (4H, q, /  = 7.5Hz, 2 x C ^ O N ^ C O ^ ^ C H y , 4.21 (2H, q, J  
= 7.5Hz, NCCC02 CH2 CH3), 4.07 (6 H, s, 2 x NOCH}), 3.28 (4H, ABq, /  = MHz, 
2 x CH3ON = CCH2), 1.35 (6 H, t, /  = 7.5Hz, 2 x CH3ON = CCC^CT^CH^, 1.30 
(3H, t, /  = 7.5Hz, NCCC0 2 CH2 CH3); (ethanol) nm (e) 227 (7200); m/z 
(loweV)399 (M+, 37%), 368 (100%), 326 (63%), 243 (27%), 145 (91%), (70eV) 
399 (M+, 4%), 145 (100%), 29 (100%); C n H ^ O g  : Requires C, 51.1; H, 6.3; N, 
10.5%; Found C, 51.2; H, 6 .6 ; N, 10.1%.
Ethyl 4,4-dicyano-2-methoxyiminobutanoate (232) and Diethyl
4,4-dicyano-2,6-di(methoxyimino)-lil-heptadioate (233).
A solution of malonoitrile (221 mg, 3.35 mmol) in dry DMF (4 cm3) was added, 
dropwise, to a stirred, cooled suspension of sodium hydride (80 mg, 3.35 mmol) in 
dry DMF (4 cm3), under a nitrogen atmosphere.
After the final addition, the ice bath was removed and the mixture stirred at 
ambient temperature for 30 minutes.
The anion solution was then cooled again and injected into a cooled solution of the 
methoxime (229) (750 mg, 3.35 mmol) in dry DMF ( 8  cm3), under a nitrogen 
atmosphere. The mixture was stirred at 0°C for lh and then added to water (50 
cm3). This was extracted with ethyl acetate (60 cm3) and the organic layer washed 
with H20  (3 x 30 cm3), brine (40 cm3) and dried (Na2 SQ4).
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T.l.c. analysis of the residue revealed it to be a mixture of two components. The 
mixture was separated by column chromatography. The first product eluted (Rf = 
0.51, hexane : ethyl acetate/2:1) was shown to be the monoalkylated product (232), 
purified by bulb to bulb distillation (150°C/1.1 mmHg). The product was isolated 
as a colourless oil (181 mg, 29%); vmax (thin film) cm’ 1 2230 (C^N), 1700 (C=0), 
1590 (C=N); 5h (CDC13) ppm 4.38 (2H, q, J  = 7.5Hz, OCH2CH3), 4.32 (1H, t, J = 
7.5Hz, CH(CN)2), 4.17 (3H, s, C^NOQ^X  3.31 (2H, d, J = 7.5Hz, O ^ C H ^ N )^ , 
1.37 (3H, t, J = 7.5Hz, OCH2CH3 );^nax(95% EtOH)nm(e) 254(3 100); m/z (70eV) 
149 (20%), 136 (58%), 106 (100%), 29 (100%), (C.I.) 210 [(M+l)+, 100%]; 
C9Hn N3 0 3  : Requires, C, 51.7; H, 5.3; N, 20.1%; Found C, 51.7; H, 5.5; N,
19.1%.
The second product eluted (Rf = 0.35, hexane : ethyl acetate/2:1) was an off white 
solid (312 mg, 54% gross), recrystallised from chloroform/pet.ether, m.p. = 
83-85°C. This compound was characterised as the dialkylated product (233); vmax 
(CHBr3) cm’ 1 1720 (C=0), 1600 (C=N); 5H (CDC13) ppm 4.38 (4H, q, /  = 7Hz 2 x 
OCH2CH3), 4.18 (6 H, s, 2 x NOCflj), 3.40 (4H, s, 2 x CH^CN)^, 1.41 (6 H, t, J  = 
7Hz, 2 x OCH2CH3 );Xmax(9 5 % EtOH)nm(€) 252(10 100); m/z (70eV) 145 (60%), 
71, (100%), (C.I.) 353 [(M+l)+, 100%], 145 (40%); C15H2 0N4O6 : Requires C,
51.1; H, 5.7; N, 15.9%; Found C, 51.4; H, 5.8; N, 15.7%.
Attempted preparation of Diethyl 2-cyano-4-oxopenta-l,5-dioate (220)
A mixture of the diester (230) (81 mg, 0.32 mmol), ammonium acetate (380 mg, 5 
mmol) and 50% aqueous AcOH (2 cm3) was stirred in DMF (5 cm3), under a 
nitrogen atmosphere, whilst titanium trichloride (1.5 cm3, 15% solution in 20% 
HC1) was added dropwise.
The mixture was stirred at ambient temperature for 18h but t.l.c. analysis (hexane : 
ethyl acetate/2 :1 ) indicated that no product had formed.
The reaction mixture was then heated at 100°C for 90 minutes. T.l.c. indicated that 
the starting material had been consumed but the product was mainly baseline 
material.
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The reaction mixture was cooled and extracted into diethyl ether (15 cm3). The 
separated organic layer was washed with brine (10 cm3), saturated NaHC03 
solution (2x10 cm3), water (5 cm3), dried (Na2 S04) and evaporated at reduced 
pressure.
*H n.m.r. analysis of the residue showed loss of the CH3 methoxime singlet. 
However, the rest of the spectrum was very complicated and not indicative of the 
required compound.
Ethyl 2-cyano-but-2-enoate (240)
A solution of ethyl cyanoacetate (6.78 g, 6.4 cm3, 0.06 mol) and acetaldehyde 
(3.35 cm3, 0.06 mol) in glacial acetic acid ( 8  cm3) was treated with a solution of 
piperidine (0.2 cm3) in acetic acid (2 cm3). The mixture was stirred at ambient 
temperature for 36h before the reaction mixture was added to water (100 cm3). 
This aqueous phase was extracted with ethyl acetate (3 x 75 cm3) and the 
combined organic layers were washed with saturated NaHC03 solution (2 x 100 
cm3), water (2 x 100 cm3), brine (50 cm3) and dried (Na2 S04).
The solvent was removed at reduced pressure to yield a yellow oil which was 
purified by column chromatography to yield the title compound as a colourless oil 
(3.15g, 38%), Rf = 0.80 (pet.ether : ethyl acetate/70:30). The oil was further 
purified by bulb to bulb distillation (b.p. = 110°C/15mmHg, lit162 
7 l-72°C/2.4mmHg); 5H (CDC13) ppm 7.85 (1 H, q, /  = 7.1Hz, HC), 4.38 (2H, q, J  




Ethyl cyanoacetate (850 mg, 7.52 mmol) was added, dropwise, to a cooled stirred 
suspension of NaH (180 mg, 7.52 mmol) in dry THF (15 cm3). After the final 
addition, the ice bath was removed and the mixture stirred for 30 minutes.
-160-
A solution of the indole (219) (2.0 g, 7.52 mmol) in dry THF (20 cm3) was added 
and the cloudy suspension stirred under a nitrogen atmosphere.
Iodomethane (0.47 cm3, 7.52 mmol) was added, dropwise, and the mixture stirred 
for 24h.
The solvent was removed at reduced pressure and the residue partitioned between 
DCM (30 cm3) and 2N HC1 (30 cm3). The separated aqueous layer was extracted 
with DCM (2 x 15 cm3) and the combined organic layers were washed with water 
(2 x 30 cm3), brine (20 cm3) and dried (Na2 S04).
The solvent was removed at reduced pressure and the residue purified by column 
chromatography to yield the title compound (463 mg, 17%) as a light brown oil Rf 
= 0.65 (pet.ether : ethyl acetate/70:30). The product was found to be a 
diastereomeric mixture (by n.m.r.) and could be used in subsequent reactions 
without further purification.8 H(CDCl3 )ppm 8.20 (1H, br. s, 2 x N-H), 7.49 - 6.93 
(9H, m , rest of aromatic protons), 5.11 (2H, s, 2 x OCH?C;H*)» 4.26 (1.3H, q, /  = 
7.2 Hz, OCH2 CH3 ), 3.98 (0.7H, q, /  = 7.15Hz, OCH2CH3), 3.92 - 3.83 [2H, m, (2 
x CH3 CHCH) + (2 x CH3CHCH)], 1.57 (2H, d, /  = 7.14 Hz, CH3CHCH), 1.53 
(1H, d, J = 6.2 Hz, CH3 CHCH), 1.28 (2H, t, J  = 7.14 Hz, OCH2 CH3 ), 0.98 (1H, t, J 
= 7.14 Hz, CH2CH3 ).
Crystallisation from ethyl acetate/pet.ether yielded a single diastereomer as 
colourless crystals, m.p. = 84-87°C; vmax (CDC13) cm' 1 3450 (N-H), 2250 (C=N), 
1720 (C=0); 8 h (CDCI3) ppm 8.25 (1H, s, exchanges with D20 , N-H), 7.48-6.90 
(9H, m, aromatic protons), 5.08 (2H, s, OCH2C6H5), 4.24 (2H, q, J -  7.2Hz, 
OCH2CH3), 3.83 (2H, m, CH3CH + CH(CN)C02Et), 1.51 (3H, d, /  = 7.0Hz, 
CH3 CH), 1.26 (3H, t , /  = 7.2Hz, OCH2 CH3 ); 3 ^  (95% ethanol) nm (e) 308 
(2200), 295 (3200), 275 (4100); m/z (70eV) 362 (M+, 41%), 271 (41%), 250 
(100%), 159 (59%), 91 (82%), (loweV) 362 (M+, 100%), 250 (33%); C2 2H2 2N2 0 3; 
Acc. mass : Calculated 362.1628; Found 362.1575; Requires C, 72.9; H, 6.1; N, 
7.7%; Found C, 72.8; H, 6.1; N, 7.6%.
Method B:
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A solution of ethyl cyanoacetate (307 mg, 2.72 mmol) and dimethyl 
acetylenedicarboxylate (0.33 cm3, 2.72 mmol) in dry THF (10 cm3) was added 
dropwise, to a cooled, stirred solution of (213) (800 mg, 2.72 mmol) in dry THF 
( 1 0  cm3), under a nitrogen atmosphere.
The reaction mixture was then allowed to warm slowly to room temperature.
After 3h, the solvent was removed and the residue treated and purified as in 
Method A to yield the title diastereomeric mixture as a light brown oil (271 mg, 
28%).
Method C
A solution of 5-benzyloxyindole (0.96 g, 4.31 mmol) and the olefin (240) (0.60 g,
4.31 mmol) in dry DCM (25 cm3) was gently refluxed with K10 Montmorillonite 
clay (0.25g), under a nitrogen atmosphere.
After 48h, t.l.c. analysis (pet.ether: ethyl acetate/70:30) indicated the presence of 
required product (235) along with starting material.
The reaction mixture was allowed to cool, filtered and the solvent removed at 
reduced pressure. The residue was purified by column chromatography to yield 
the indole (235) (411 mg, 26%) along with starting material (1.02 g, 6 6 %).
The same experiment was repeated but with heating in refluxing toluene as the 
solvent. The amount of (235) isolated was 423 mg (27%) with 811 mg (52%) of 
starting material recovered.
Method D:
The olefin (240) (1.20 g, 8 . 6  mmol) was added to a solution of 5-benzyloxyindole 
(0.9 g, 4.31 mmol) in acetic acid (3 cm3) and acetic anhydride (1 cm3), under a 
nitrogen atmosphere.
The mixture was stirred at 90°C for 8 h and then stirred at ambient temperature for 
16h.
The mixture was poured into water (30 cm3) and extracted with ethyl acetate (2 x
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50 cm3). The combined organic extracts were washed with saturated NaHC03 
solution (2 x 50 cm3), water (2 x 50 cm3), brine (50 cm3), dried (Na2 S04) and 
evaporated at reduced pressure.
The light brown residue was purified by column chromatography to yield the title 
compound (235) as a light beige oil (1.04 g, 6 8 %).
Attempted reaction between ethyl bromopyruvate and the indole (235)
A mixture of the indole (235) (111 mg, 0.307 mmol), K2 C0 3 (42 mg, 0.307 mmol) 
and ethyl bromopyruvate (60 mg, 0.307 mmol) in dry DMF (3 cm3) was stirred, 
under a nitrogen atmosphere, for lh.
T.l.c. analysis (pet.ether: ethyl acetate/60:40) indicated that no product had 
formed.
The mixture was then heated at 95°C for 24h. T.l.c. analysis indicated that no 





Dimethylacetylenedicarboxylate (333 mg, 0.29 cm3, 2.34 mmol) was added to a 
cooled, stirred solution of the gramine (213) (760 mg, 2.59 mmol) and the diester 
(230) (600 mg, 2.34 mmol) in dry THF (10 cm3), under a nitrogen atmosphere. 
The ice bath was removed and the mixture was stirred at ambient temperature for 
16h. The solvent was removed and the residue partitioned between 2N HC1 (40 
cm3) and ethyl acetate (40 cm3). The organic layer was washed with water (2 x 30 
cm3), brine (30 cm3) and dried (Na2 S04). The solvent was removed at reduced 
pressure and the residue purified by column chromatography (pet.ether/ethyl 
acetate). The title compound was isolated as a light brown oil (487 mg, 41%). 
n.m.r. indicated that the product was an equal mixture of two diastereomers. Rf =
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0.32 (hexane : ethyl acetate/2:l); vmax (CDC13) cm 1 3450 (N-H), 2200 (O N ),
1720 (C=0); 5h (CDC13) ppm 8.44 + 8.31 (2 x 0.5H, 2 x br. s, 2 x N-H), 7.51- 6.87 
(9H, m, other aromatic protons), 5.12 + 5.10 (2 x 1H, 2 x s, 2 x OCH?C^H^), 4.37 
(1H, q, /  = 7.5Hz, OCH2CH3), 4.19 (1H, q, J  = 7.5Hz, OCH2 CH3), 4.07 + 3.93 (2 
x 1.5H, 2 x s, 2 x NOCHj), 3.68 (2H, m, 2 x CH2), 3.43 (1H, m, 2 x CH3CH), 1.67 
(1.5H, d, /  = 7.5Hz, CH3CH), 1.46 (1.5H, d, /  = 7.5Hz, CH3CH), 1.21 (1.5H, t, /  = 
7.5Hz, OCH2CH3), 0.70 (1.5H, t, /  = 7.5Hz, O C ^O fc); 3 ^  (95% ethanol)nm(e) 
307(10 100), 285(13 250), 276(15 800), 251(13 700); m/z (loweV) 505 (M+,
30%), 249 (55%), 145 (38%), 106 (100%), (70eV) 505 (M+, 2%), 354 (8 %), 250 
(50%), 145 (72%), 91 (100%), 43 (70%), 29 (100%); Cn H3lN30 6 : Acc. mass: 
Calculated 505.2211; Found 505.2162.
Method B:
The indole (235) (150 mg, 0.41 mmol) and K2 C03 (57 mg, 0.41 mmol) were 
stirred in dry DMF (3 cm3) under a nitrogen atmosphere.
The methoxime (229) (93 mg, 0.41 mmol) was added and the mixture stirred at 
ambient temperature for 24h. However, t.l.c. analysis (pet.ether: ethyl 
acetate/60:40) indicated the presence of starting material (27). A further amount of 
the methoxime (229) (50 mg, 0.22 mmol) was added and the reaction mixture was 
heated at 100°C for 7h.
The reaction mixture was allowed to cool and then poured into water (15 cm3).
The aqueous phase was extracted with ethyl acetate (2 x 20 cm3) and the combined 
organic layers were washed with water (3x15 cm3), brine (10 cm3) and dried 
(Na2 S04).
The solvent was removed and the residue purified by column chromatography 
(pet.ether/ethyl acetate) to yield the title diastereomeric mixture (154 mg, 74%) as 




A solution of the mixture (234) (175 mg, 0.35 mmol) in 4N HC1 in dioxane (2 cm3) 
was stirred under a nitrogen atmosphere for 36h.
The solution was neutralised with saturated NaHC03 solution, water (20 cm3) was 
added and the mixture extracted with ethyl acetate (30 cm3). The organic layer 
was washed with water (3 x 10 cm3) and dried (Na2 S04).
The solvent was evaporated and the residue purified by column chromatography 
(pet.ether/ethyl acetate).
The title compound was isolated as a yellow oil (33 mg, 21%). 1H n.m.r. analysis 
proved the product to be a mixture of 2 diastereomers; Rf = 0.56 (hexane : ethyl 
acetate/2:1); vmax (CHBr3) cm 1 3440 (N-H), 2200 (CsN), 1740 (C=0), 1710 
(C=0); 6 h (CDC13) ppm 9.40 + 9.39 (2 x 0.5H, 2 x br. s, 2 x N-H), 7.52 - 6.93 (8 H, 
m, aromatic protons), 6.92 + 6.70 (2 x 0.5H, 2 x s, 2 x olefinic protons), 5.11 (2H, 
s, 2 x OCH2C6H5), 4.38 + 4.26 (2H, m, 2 x 3.94 (1H, m, 2 x O^CH),
1.52 (1.5H, d, J  = 7.5Hz, CHjCH), 1.41 (1.5H, t, J  = 7.5Hz, OCH2 CH}), 1.24 
(1.5H, t, J  = 7.5Hz, OCH2 CH3 ), 1.08 (1.5H, d, /  = 7.5Hz, CH3 CH);Xmax(95% 
EtOH)nm (e) 284(2 700), 246(3 000); m/z ( lo w e V )  458 (M+, 100%), (70eV) 458 
(M+, 28%), 367 (25%), 149 (77%), 91 (100%); C27H2 6N20 5 : Acc. Mass : 
Calculated 458.1840; Found 458.1885.
There was a complex mixture of other products from this reaction but these could 
not be identified.
Method B:
A solution of (234) (480 mg, 0.95 mmol) in CHC13 (6.5 cm3) containing 
polyphosphate ester (2 0 % w/v) was heated at reflux, under a nitrogen atmosphere, 
for 51h.
The solvent was removed at reduced pressure and the dark red residue was stirred 
with water (10 cm3) for 30 minutes.
The aqueous layer was then extracted with ethyl acetate (2 x 10 cm3) and the 
combined organic layers were washed with water ( 2  x 1 0  cm3), brine ( 1 0  cm3) and
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dried (Na2S 0 4).
The solvent was evaporated at reduced pressure and the dark residue purified by 
column chromatography (pet. ether/ethyl acetate). Again, the reaction yielded a 
complex mixture of products and the required diastereomeric mixture of (241) was 
isolated as a yellow oil (91 mg, 22%).
6-Benzyloxy-3-cyano-1 -ethoxycarbonyl-4-methylcarbazole (221)
A mixture of the dihydrocarbazole (241) (11 mg, 0.024 mmol), LiCl (1 mg, 0.024), 
water (0.43 mg, 0.024 mmol) and DMSO (0.5 cm3) was heated at 100°C, under a 
nitrogen atmosphere.
After 26h, the mixture was allowed to cool and water (5 cm3) added.
The mixture was extracted with ethyl acetate (3 x 20 cm3) and the combined 
organic layers were washed with water (3 x 10 cm3), brine (10 cm3) and dried 
(Na2 S04).
The solvent was removed at reduced pressure and the residue purified by column 
chromatography (pet.ether/ethyl acetate) to yield the title compound as a pale 
yellow solid (4 mg, 45%), recrystallised from ethyl acetate/petrol, m.p. =
178-181°C; Rf = 0.66 (hexane : ethyl acetate/2:1); vmax (CHC13) cm"1 3350 (N-H), 
2210 (O N ), 1705 (C=0); 8 H (CDC13) ppm 10.20 (1H, br. s, N-H), 8.29 (1H, s, 
C-2H), 7.74-7.23 (8 H, m, other aromatic protons), 5.20 (2H, s, OCH2 C6H5), 4.48 
(2H, q, /  = 7.1Hz, OCH2CH3), 3.05 (3H, s, CH3), 1.48 (3H, t, /  = 7.1Hz, 
OCH2CH3 ); Xmax (95% ethanol) nm (e) 371 (1800), 294 (16600), 263 (10200), 250 
(8100); m/z (low eV) 384 (M+, 100%), 293 (63%), (70eV) 384 (M+, 46%), 293 
(89%), 247 (100%), 149 (21%), 91 (90%); C2 4H2 0N2 O3 : Acc. Mass: Calculated 
384.1472; Found 384.1447; Requires C, 75.0; H, 5.2; N, 7.3%; Found C, 74.9; H, 
5.1; N, 7.2%.
5-Benzyloxygramine (236)
A solution of 5-benzyloxyindole (8.9 g, 39.9 mmol) in dioxane (40 cm3) was 
added, dropwise over 30 minutes, to a cooled, stirred mixture of 36% aqueous
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formaldehyde (3.2 cm3), 25% aqueous dimethylamine (8 . 8  cm3), acetic acid (40 
cm3) and dioxane (40 cm3).
The clear solution was stirred and cooled for 2h and then left to slowly warm to 
room temperature overnight (14h).
The reaction mixture was poured into water (500 cm3) and the mixture filtered 
after stirring with charcoal and celite for 2 0  minutes.
The filtrate was made alkaline with an excess of dilute NaOH solution (400 cm3) 
and the title compound precipitated as a colourless solid. The mixture was cooled 
and filtered to yield (32) (9.5 g, 85%) as an off-white solid which was dried, in 
vacuo, over P2O5 .
The product was recrystallised from ethyl acetate to give colourless crystals, m.p.
= 124-126°C (lit188 1 38-139°C), Rf = 0.29 (DCM ; methanol: 
triethylamine/96:4:2); 8 H (CDC13) ppm 8.91 (1H, br. s, N-H), 7.44 - 6 . 8 6  (9H, m, 
other aromatic protons), 5.00 (2 H, s, OCH?C^HQ, 3.58 (2 H, s, CH?NMe7 ), 2.27 
(6 H, s, N(CH3)2); m/z (70eV) 236 (42%), 235 (22%), 91 (100%), Oow eV) 280 
(M+, 100%), 235 (79%); C18H2 0N2O: Requires C, 77.1; H, 7.2; N, 10.0%; Found 
C, 76.8; H, 7.2; N, 9.9%.
Ethyl 3-{5-Benzyloxy-3-indolyl)-2-cyanopropanoate (237)
Method A:
A solution of ethyl cyanoacetate (806 mg, 0.76 cm3, 7.14 mmol) and dimethyl 
acetylenedicarboxylate (0.88 cm3, 7.14 mmol) in dry THF (20 cm3) was slowly 
added to a stirred solution of 5-benzyloxygramine (236) (2.0 g, 7.14 mmol) in dry 
THF (20 cm3), under a nitrogen atmosphere.
The resulting yellow solution was stirred at ambient temperature for lh.
The solvent was removed at reduced pressure and the residue partitioned between 
2N HC1 (20 cm3) and ethyl acetate (3 x 20 cm3). The combined organic layers 
were washed with water (2 x 50 cm3), brine (25 cm3), dried (Na2 S04) and 
evaporated at reduced pressure.
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The residue was purified by column chromatography to yield the title compound as 
a pale yellow oil (480 mg, 19%). Rf = 0.45 (pet.ether: ethyl acetate/60:40); vmax 
(CHC13) cm 1 3450 (N-H), 2250 (O N ), 1735 (C=0); SH (CDC13) ppm 8.08 (1H, 
br. s. N-H), 7.50 - 6.92 (9H, m, aromatic protons), 5.11 (2H, s, OCH?CaHQ, 4.20 
(2H, q, /  = 7.1Hz, OCH2CH3), 3.78 (1H, dxd, J  = 6.0Hz, CH(CN)C02Et), 3.39 
(2H, m, CH2 CH(CN)C02Et), 1.23 (3H, t, /  = 7.1Hz, OCH2 CH3 ); ^ ( 9 5 %  
EtOH)nm(e) 275(8 100), 250(5 800); m/z (low eV) 348 (M+, 100%), (70 eV) 348 
(M+, 42%), 257 (74%), 236 (23%), 145 (26%), 91 (100%), 6 8  (43%), 29 (100%); 
C2 1H2 0 N2O3 : Acc. Mass: Calculated 348.1471; Found 348.1490.
Method B:
To a stirred solution of 5-benzyloxygramine (236) (7 g, 25 mmol) in dry THF (50 
cm3) and HMPA (5 cm3), under a nitrogen atmosphere, was slowly added a 
solution of freshly distilled dimethyl sulphate (3.15g, 2.4 cm3, 25 mmol) in dry 
THF (25 cm3).
In a separate flask, a solution of ethyl cyanoacetate (2.6 cm3, 24.5 mmol) in dry 
THF (35 cm3) was slowly added to a cooled, stirred suspension of NaH (0.59 g, 25 
mmol) in dry THF (15 cm3), under nitrogen, in an ice bath.
After the addition was complete, the ice bath was removed and the reaction 
mixture stirred for 30 minutes.
The resultant suspension was then slowly transferred, via a cannula, into the 
methiosulfate reaction vessel. After the addition, the pale yellow solution was 
stirred for 2.5h before the solvent was removed and the residue partitioned between 
2N HC1 (125 cm3) and ethyl acetate (125 cm3).
The aqueous layer was extracted with ethyl acetate (2 x 50 cm3) and the combined 
organic layers washed with water (2 x 75 cm3), brine (50 cm3), dried (Na2 S04) and 
evaporated at reduced pressure.
T.l.c. analysis of the residue (pet.ether/ethyl acetate/60:40) indicated the presence 
of two compounds. These were separated by column chromatography.
The first compound eluted (Rf = 0.46, pet.ether/ethyl acetate/60:40) was a pale
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yellow oil (1.93g, 24%) and was characterised as (237).
The second compound eluted (Rf = 0.38) was a colourless solid (3.39g, 47%) 
recrystallised from ethyl acetate/pet.ether, m.p. = 93°C. This compound was 
characterised as ethyl 2-Cyano-2,2-di(5-benzyloxy-3-indolyl)ethanoate (238); vmax 
(CHC13) cm 1 3450 (N-H), 2220 (O N ), 1720 (C=0); 8 H (CDC13) ppm 8.14 (2H, 
br. s, 2 x N-H),7.47 - 6 . 8 6  (18H, m, aromatic protons), 5.09 (4H, s, 2 x 
OCH2C6H5), 3.80 (2H, q, /  = 7.1Hz, OCH2CH3), 3.41 (4H, ABq, J  = 14.1Hz, 2 x 
CH2 (CN)C02Et), 0.74 (3H, t, /  = 7.1Hz, OCH2CH3 ); ^  (95% ethanol) nm (e) 
306 (7500), 295 (10650), 276 (13300), 248 (7800); m/z (70 eV) 91 (100%), (C.I.) 
349 (76%), 348 (51%), 257 (25%), 236 (46%), 146 (42%), 91 (100%);
C3 7H3 3 N3O4  : Requires C, 76.1; H, 5.7; N, 7.2%; Found C, 75.5; H, 5.7; N, 7.0%.
3-Bromo-2,2-dimethoxypropanal (252)
3-Bromo-2,2-dimethoxypropanol164 (5.0 g, 25 mmol) was dissolved in dry ether 
(50 cm3) at 0°C, under a nitrogen atmosphere.
DCC (15.5 g, 75 mmol), anhydrous DMSO (1.95 cm3, 27.5 mmol), dry pyridine 
(1.0 cm3 , 12.5 mmol) and trifluoroacetic acid (0.95 cm3, 12 mmol) were added and 
the mixture stirred at 0°C for 10 minutes before stirring at ambient temperature for 
2 h.
The ether was removed at reduced pressure and the residue distilled to yield the 
title compound (b.p. = 45°C/0.4 mmHg, lit164 30-32°C/0.2 mmHg) as a colourless 
oil (2.4 g, 45%). vmax (CHCI3 ) cm' 1 1745 (C=0); 5H (d6
DMSO) ppm 9.47 (1H, s, CHO), 3.71 (2H, s, BrCFy, 3.27 (6 H, s, 2 x OCH3 ); m/z 
(70eV) 169 (81%), 167 (100%), 73 (42%), 43 (53%), (C.I.) 167 (100%), 165 
(65%), 79 (34%).
3-Bromo-2,2-dimethoxy-N-(propyl)iminopropane (255)
A solution of n-propylamine (1.20 g, 1.7 cm3 , 20.3 mmol) and the aldehyde (252) 
(2.0 g, 10.2 mmol) in dry benzene (40 cm3), under a nitrogen atmosphere, was
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heated at reflux (using Dean-Stark apparatus) for 3.5h before being allowed to cool 
The benzene was removed at reduced pressure to leave a pale orange oil and 
colourless crystals. The oil was dissolved in ethyl acetate and the crystals filtered. 
The ethyl acetate was evaporated at reduced pressure to yield the title compound 
(1.9 g, 79%) as a pale orange oil. The compound was used without further 
purification; vmax (CHC13) cm' 1 2800 (C-O), 1670 (C=N); 6 H (CDC13) ppm 7.55 
(1H, s, HC=NPr), 3.58 (2H, s, BrCH2), 3.53 (2H, m, N O ^ O ^ C H ^ , 3.31 (6 H, s,
2 x OCH3 ), 1.71 (2H, m, NCH2 CH2CH3), 0.92 (3H, t, J  = 7.3Hz, NCH2 CH2 CH3 ); 
m/z (70eV) 167, 169 (40%), 8 8  (100%), 43 (42%), (C.I.) 208 (92%), 206 (100%), 
169 (52%), 167 (54%), 158 (24%), 8 8  (100%).
3-Bromo-2,2-dimethoxy-N-(propyl)propanamine (251)
Method A:
Sodium cyanoborohydride (159 mg, 2.5 mmol) and the imine (255) (500 mg, 2.1 
mmol) were stirred in dry methanol (10 cm3), with 4A° molecular sieves, under a 
nitrogen atmosphere.
Acetic acid (1 cm3) was added and the mixture stirred at ambient temperature for 
2 0 h before the methanol was removed at reduced pressure and the residue 
partitioned between 2N HC1 (15 cm3) and diethyl ether (15 cm3).
The layers were separated and the aqueous layer further extracted with diethyl 
ether (2 x 1 0  cm3).
The aqueous layer was then made basic with solid KOH (with cooling) before 
being extracted with DCM (3 x 30 cm3). The combined organic layers were dried 
(Na2 S04) and evaporated to yield the title compound as a pale yellow oil (380 mg, 
76%). (Rf = 0.61 (DCM : methanol: ammonia/200:8:l); vmax (CHC13) cm' 1 3310 
(N-H), 2820 (C-O); 5H (CDC13) ppm 3.55 (2H, s, BrCH2), 3.25 (6 H, s, 2 x OCH^,
2.86 (2H, s, NCH2 CH(OMe)2), 2.62 (2H, t, /  = 7.0Hz, NCH2 CH2 CH3), 1.49 (3H, 
m, NCH2CH2CH3 + N-H, exchanges with D20), 0.92 (3H, t, /  = 7.3Hz, 
NCH2CH2 CH3 ); m/z (70eV) 8 8  (80%), 43 (100%), 33, 31 (100%), (C.I.) 160
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(28%), 158 (40%), 128 (100%), 8 8  (100%).
Method B:
A solution of the aldehyde (252) (0.9 g, 4.57 mmol), n-propylamine (2.25 cm3,
27.4 mmol), sodium cyanoborohydride (252 mg, 4 mmol) and acetic acid (1.5 cm3) 
in dry methanol (15 cm3) was stirred with 4A° molecular sieves, under a nitrogen 
atmosphere, at ambient temperature for 7h.
The solvent and excess propylamine were removed at reduced pressure and the 
residue treated as in Method A to yield the amine (251) as a pale yelllow oil (750 
mg, 62%). The compound was used without further purification.
2-(N ,N-Dibenzylamino)ethanal(25Q)
Dibenzylamine (7.0 g, 35.5 mmol) and glycidol (2.63 g, 35.5 mmol) were stirred at 
100°C, under a nitrogen atmosphere, for 2h before being allowed to cool and 
diluted with CHC13 (100 cm3).
The solution was then treated with NaI04  (0.1M in water, 42 cm3), whilst being 
vigorously stirred.
After the addition was completed, the pH of the 2-phase system was adjusted to 8  
with 2N NaOH.
The system was then vigorously stirred for 3h before the CHCI3 layer was 
separated, dried (Na2 S04) and evaporated at reduced pressure to yield (250) as a 
light orange oil. The compound was unstable and was used immediately after 
synthesis. Rf = 0.89 (pet.ether: ethyl acetate/70:30); vmax (CHCI3) cm' 1 1725 
(C=0); 8 h (CDCI3) ppm 9.46 (1H, t, J = 1.7Hz, CHO), 7.36 - 7.09 (10H, m, 
aromatic protons), 3.65 (4H, s, 2 x CH2C6H5), 3.13 (2H, d, /  = 1.7Hz, NCH2 CHO); 





A mixture of the amine (251) (0.9 g, 4.57 mmol), the aldehyde (250) (0.9 g, 4.57 
mmol), sodium cyanoborohydride (252 mg, 4.0 mmol) and acetic acid (1.5 cm3) 
were stirred in dry methanol (15 cm3), with 4A° 
molecular sieves, under a nitrogen atmosphere.
After 120h, the solvent was removed at reduced pressure and the residue stirred 
with 2N HC1 (40 cm3) for 20 minutes.
The aqueous layer was extracted with diethyl ether (3 x 20 cm3), made basic with 
solid KOH (with cooling) and then extracted with DCM (3 x 35 cm3).
The combined DCM extracts were dried (Na2S04) and evaporated to yield a pale 
yellow oil Rf = 0.44 (DCM : methanol: ammonia/200:8:l).
The yellow oil solidified when triturated with diethyl ether (5 x 30 cm3) to yield a 
pale cream solid (1.11 g, 65%); vmax (CHC13) cm"1 2800 (C-O); 8 H (CDC13) ppm 
7.40 - 7.29 (10H, m, aromatic protons), 4.44 (4H, AB, /  = 12.6Hz, 2 x CH?C^Ha),
3.75 (2H, t, Bn2 NCH2 CH2), 3.64 (4H, s, BrCH2  + (MeO^CCFhN), 3.22 + 3.19 (2 
x 3H, 2 x s, 2 x OCH3 ), 2.85 (4H, m, NCH2 CH2NBn2  + N O ^ O ^ O ^ ) , 1.43 (2H, 
m, NCH2CH2 CH3), 0.75 (3H, t, /  = 7.2Hz, NCH2 CH2 CH3 ); 3 ^  (95% ethanol) 
nm (e) 268 (2600), 262 (4500), 257 (6100); m/z (70eV) 295 (24%), 210 (6 8 %), 208 
(43%), 91 (100%), (C.I.) 465 [(M+2)+, 4%], 463 (M+, 5%), 419 (8 %), 295 (61%), 
210 (60%), 208 (22%), 91 (100%);
C2 4H3 5 BrN20 2  : Requires : C, 62.2; H, 7.6; N, 6.0%; Found C, 62.0; H, 7.7; N, 
6.1%.
Attempted preparation of the ketone (249)
Method A:
A solution of the acetal (257) (116 mg, 0.25 mmol) in 98% formic acid (3 cm3), 
under a nitrogen atmosphere, was heated at 85°C for 3 days.
The mixture was allowed to cool and then added to water (10 cm3) . The solution 
was neutralised with saturated NaHC03 solution. The aqueous phase was 
extracted with DCM (3x15 cm3) and the combined organic extracts were washed
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with saturated NaHC03 solution (10 cm3), water (15 cm3) and dried (Na2S04).
The solvent was removed at reduced pressure to yield a brown oil (51 mg, 45%). 
n.m.r. analysis showed this oil to be the starting material (257).
Method B:
Iodotrimethylsilane (95 mg, 0.475 mmol) was stirred in dry DCM (1 cm3), under a 
nitrogen atmosphere, at ambient temperature.
A solution of the acetal (257) (180 mg, 0.388 mmol) in dry DCM (2 cm3) was 
added and the resulting mixture was stirred at ambient temperature for 90 minutes. 
T.l.c. analysis (DCM : methanol: ammonia/200:8:l) indicated the presence of a 
new product (Rf = 0.73) and the total consumption of starting material.
5% aqueous NaHC03 (5 cm3) was added to the reaction mixture, followed by 10% 
aqueous Na2 S20 5 solution (5 cm3). The layers were separated and the aqueous 
layer saturated with NaCl. The aqueous layer was then extracted with DCM (2 x 
10 cm3) and the combined organic layers dried (Na2 S04) and evaporated at 
reduced pressure to yield the acetal (258) (188 mg, 95%) as a colourless foam.
The reaction was repeated with 2.2 equivalents of iodotrimethylsilane. The 
product on work-up again proved to be the actal (258) (140 mg, 99%); vmax 
(CHC13) cm' 1 2810 (C-O); 8 H (CDC13) ppm 7.35 - 7.22 (10H, m, aromatic 
protons), 4.33 (4H, ABq, /  = 12.5Hz, 2 x C ^ C H ^ , 3.65 (2H, t, J  = 5.7Hz, 
Bn2NCH2), 3.59 [4H, s, NCH2 C(OMe) 2  + (MeO)2 CCH2I], 3.17 + 3.14 (2 x 3H, 2 x 
s, 2 x OCH^, 2.77 (4H, m, NCH2 CH2 CH3 + NCH2CH2NBn2), 1.34 (2H, m, 
NCH2CH2 CH3), 0.69 (3H, t, /  = 7.3Hz, NCH2CH2 CH3 ); m/z (70eV) 210 (76%),
91 (100%), 84 (63%), 49 (100%); (C.I.) 511 [(M+l)+, 8 %], 351 (23%), 295 (80%), 
210 (63%), 91 (100%).
Attempted preparation of N-(3-Chloro-2-oxopropyl)phthalimide (263)
A solution of potassium phthalimide (1.13 g, 6.09 mmol) and 1,3-dichloroacetone 
(1.16 g, 9.13 mmol) in dry DMF ( 8  cm3), under a nitrogen atmosphere, was heated 
at 100°C for 19h.
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The reaction mixture was cooled and water (30 cm3) added. This was extracted 
with ethyl acetate (3 x 40 cm3) and the combined organic extracts were washed 
with water (4 x 40 cm3), brine (10 cm3) and dried (Na2 S04).
The solvent was evaporated at reduced pressure. JH n.m.r. analysis of the residue 
showed no significant amount of the required product but mainly a mixture of the 
starting materials.
N-(3-Chloro-2-oxopropyl)phthalimide (263)
N-(2>-Chloro-2-hydroxypropyl)phthalimidel*° (50.0 g, 0.21 mol) was stirred in 
acetone ( 1 0 0 0  cm3) and cooled with an ice bath.
Jones Reagent [Cr03(132 g), H20  (380 cm3) and conc. H2 S0 4  (110 cm3)] was 
added, dropwise, in such a manner that the temperature did not rise above 30°C. 
After the addition was completed, the mixture was stirred at ambient temperature 
for 45 minutes.
The solvent was then evaporated at reduced pressure and iced water (3000 cm3) 
added to the residue.
The green precipitate was filtered and washed with water until most of the green 
colour had been removed. The solid was then partitioned between ethyl acetate 
(500 cm3) and water (250 cm3). After separation the organic layer was washed 
with water (250 cm3) and dried (Na2 S04).
The solvent was removed to yield the title compound (23.0g, 48%) as colourless 
crystals, recrystallised from ethyl acetate/pet.ether, m.p. = 124-126°C. Rf = 0.74 
(pet.etheriethyl acetate/60:40); vmax (CHC13) cm' 1 1780 (C=0), 1720 (C=0); (d6
DMSO) ppm 7.96 - 7.84 (4H, m, aromatic protons), 4.83 (2H, s, CH?C1), 4.77 (2H, 
s, NCH2 C=0); Xmax (95% ethanol) nm (e) 294 (2800), 252 (1600); m/z (70eV) 160 
(100%), (C.I.) 238 [(M+l)+,81%], 160 (100%); Cn H8N 0 3C l: Requires C, 55.6;
H, 3.4; N, 5.9%; Found C, 55.6; H, 3.4; N, 6.0%.
Attempted reaction between the ketone (259) and the indole (235)
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Methcxi A:
A mixture of the ketone (259)179 (0.5 g, 1.77 mmol), the indole (235) (0.64 g, 1.77 
mmol), anhydrous K2 C0 3 (0.245 g, 1.77 mmol) and dry DMF (7 cm3) was stirred 
at 65°C, under a nitrogen atmosphere.
After 40h, t.l.c. analysis (pet.ether : ethyl acetate/60:40) indicated that mostly 
starting material remained, with only a slight amount of slower running product 
The reaction mixture was then heated to reflux. After 2h, t.l.c. analysis indicated 
that all the starting material had been consumed and the presence of a new, faster 
running spot.
The reaction mixture was cooled, added to water (60 cm3) and extracted with ethyl 
acetate (2 x 40 cm3). The combined organic extracts were washed with water (4 x 
20 cm3), brine (10 cm3) and dried (Na2 S04).
The solvent was removed at reduced pressure and the residue purified by column 
chromatography to yield a white crystalline solid.
This compound was characterised as 5-benzyloxyindole (125 mg, 48%).
Method B:
A mixture of the ketone (259)179 (0.5 g, 1.77 mmol), the indole (235) (0.6 4 g, 1.77 
mmol), tetra n-butyl ammonium hydroxide (1.7 cm3 ,1.54M in water, 2.5 mmol) 
was stirred in DCM (5 cm3) and water (2 cm3) for 36h.
The solvent was removed at reduced pressure and water (10 cm3) added. The 
mixture was extracted with diethyl ether (3 x 30 cm3). The combined organic 
layers were dried (Na2 S04) and evaporated at reduced pressure.
However, t.l.c. and !H n.m.r. analysis indicated that no reaction had occurred.
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Method C:
A solution of the indole (235) (500 mg, 13.8 mmol) in dry DMF (5 cm3) was 
slowly injected into a cooled suspension of NaH (33 mg, 1.38 mmol) in dry DMF 
(5 cm3). After the final addition, the ice bath was removed and the mixture stirred 
at ambient temperature for 40 minutes.
The green, anion solution was then slowly injected into a cooled, stirred solution of 
the ketone (263) (328 mg, 1.38 mmol) in dry DMF (10 cm3), under a nitrogen 
atmosphere.
The mixture was allowed to warm slowly to room temperature and then stirred for 
14h.
T.l.c. analysis however showed no reaction had occurred.
The reaction mixture was heated at 60°C for 16h but again no reaction occurred.
Ethyl 2-cyano-4-oxo-5-(N-phthalimidy[)pentanoate (266)
Ethyl cyanoacetate (0.45 cm3, 4.2 mmol) was added, dropwise, to a stirred, cooled 
suspension of NaH (100 mg, 4.2 mmol) in dry DMF (10 cm3), under a nitrogen 
atmosphere.
After the final addition, the ice bath was removed and the reaction vessel stirred at 
ambient temperature for 30 minutes.
This solution was then slowly injected, via a cannula, into a cooled, stirred 
suspension of the ketone (263) (1.0 g, 4.21 mmol) in dry DMF (10 cm3), under 
nitrogen.
After the addition, the mixture was allowed to warm slowly to room temperature. 
After 4h, the reaction mixture was added to water (120 cm3) and extracted with 
ethyl acetate (2 x 75 cm3). The combined organic extracts were washed with water 
(4 x 50 cm3), brine (10 cm3) and dried (Na2 SC>4 ).
The solvent was evaporated at reduced pressure to yield the title compound as a 
white solid. This solid was collected, washed well with pet.ether and necrystallised 
from ethyl acetate/pet.ether to yield colourless crystals, (1.09 g, 82%), m.p. =
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140-142°C; RF = 0.46 (pet.ether: ethyl acetate/60:40); vmax (CHCI3 ) cm"1 1730 
(C=0), 1720 (C=0); 5H (CDC13) ppm 7.89-7.78 (4H, m, aromatic protons), 4.70 
(2H, s, NCH2), 4.31 (1H, t, J  = 5.5Hz, NCCHC02Et), 4.21 (2H, q, J  = 7.0Hz, 
OCH2CH3), 3.40 (2H, d, J = 5.4Hz, 0=CCH2 CH), 1.28 (3H, t, J  = 7.0Hz, 
OCH2CH3 ); Xmax (95% ethanol) nm (e) 294 (1900), 250 (1100); m/z (70eV) 160 
(100%), (C.I.) 315 [(M+l)+, 40%], 238 (62%), 160 (30%), 148 (100%); 
Ci6H14N20 5 : Requires C, 61.1; H, 4.5; N, 8.9%; Found C, 60.7; H, 4.3; N, 8.7%.
5-(5-Benzyloxy-3-indolyl)-4-cyano-4-ethoxycarbonyl-\-(N-phthalimidyI)pentan-2- 
one (267)
A solution of the ketone (266) (12.8 g, 0.04 mol) and DMAD (5.0 cm3, 0.04 mol) 
in dry THF (300 cm3) was added, dropwise, to a cooled, stirred solution of the 
gramine (236) (11.47 g, 0.04 mmol) in dry THF (200 cm3), under a nitrogen 
atmosphere.
After the final addition, the ice bath was removed and the reaction mixture stirred 
at ambient temperature for 3.5h.
The solvent was removed, at reduced pressure, and 2N HC1 (25 cm3) added. This 
was extracted with ethyl acetate (2 x 25 cm3) and the combined organic layers 
were washed with water (2 x 40 cm3), brine (10 cm3) and dried (Na2 S04).
The solvent was removed, at reduced pressure, to yield an orange foam. 
Crystallisation of this foam (ethyl acetate/pet.ether) produced a pale yellow solid 
(18.0 g, 80%), recrystallised from ethyl acetate/pet.ether. m.p. = 165-170°C; Rf =
0.26 (pet.ether : ethyl acetate/60:40); vmax (CHC13) cm' 1 3460 (N-H), 2200 (w, 
C=N), 1720 (C=0); 8 H (d6 DMSO) ppm 10.28 (1H, br. s, N-H), 7.84-7.75 (4H, m, 
phthalimidyl protons), 7.48-6.80 (9H, m, other aromatic protons), 5.08 (2H, s, 
OCH2C6H5), 4.59 (2H, d, /  = 2.6Hz, Cl^phth.), 4.02 (2H, q, J  = 7.2Hz, 
OCH2CH3), 3.55-3.34 (4H, m, 2 x CH^, 1.05 (3H, t, /  = 7.2Hz, OCH2 CH3); ^  
(95% ethanol) nm (e) 294 (6000), 277 (6500), 253 (4000); m/z (70eV) 160 (100%), 
43 (70%), (C.I.) 315 (100%), 204 (22%), 160 (85%), 148 (56%); C32H2 7N30 6 : 
Requires C, 69.9; H, 5.0; N, 7.7%; Found C, 69.7; H, 4.9; N, 7.5%.
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6-Benzyloxy-A-cyano-A-ethoxycarbonyl-1,2,3,4-tetrahydro-1 - (N -phthalimidylmethy -  
lene)carbazole (269)
A mixture of the indole (267) (500 mg, 0.9 mmol) and p-toluene sulphonic acid (15 
mg) was heated in refluxing toluene (60 cm3), employing Dean-Stark apparatus.
The dark green solution was allowed to cool after 30 minutes.
The mixture was washed with saturated NaHC03 solution (3 x 20 cm3), water (30 
cm3) and brine (20 cm3). The dried (Na2S04) organic phase was then evaporated 
at reduced pressure. The residue was purified by column chromatography 
(pet.ether/ethyl acetate) to yield a yellow oil (464 mg, 96%).
*H n.m.r. analysis indicated that this product was a mixture of the exo-cyclic and 
endo-cyclic double bond compounds, (269) and (268) respectively.5 H(CDCl3 )ppm; 
8.99 (0.88H, s, N-H), 8.56 (0.12H, s, N-H), 7.85 - 7.71 (4H, m, phthalimidyl 
protons), 7.49 - 6.87 (8 H, m, other aromatic protons), 6.63 (0.88H, s, endocyclic 
olefinic proton), 6.10 (0.12H, s, exocyclic olefinic proton), 5.05 (2H, s, 2 x 
OCH2C6H5), 4.35 (0.24H, q, /  = 7.2 Hz, OCH2CH3), 4.23 (1.76H, q, /  = 7.14 Hz, 
OCH2CH3), 3.22 (1.76H, s, O^-phthalimide), 3.18 - 2.96 (2.24H, m, 3 x O ^ ) ,
1.35 (3H, m, 2 x O O ^C H ^.
However, crystallisation from ethyl acetate/petether yielded a pale yellow solid 
m.p. = 240°C, dec., which was exclusively the exo-cyclic double bond product 
(269). The mixture was used in subsequent experiments. Rf = 0.64 (pet.ether: ethyl 
acetate/50:50); vmax (CHC13) cm 1 3450 (N-H), 2210 (w, O N ), 1720 (C=0), 1600 
(C=C); 5h (d6 DMSO) ppm 10.65 (1H, br. s, exchanges with D20 , N-H), 7.94 -
7.86 4H, m, phthalimidyl protons), 7.48 - 6.81 (8 H, m, other aromatic protons),
6.18 (1H, s, olefinic proton), 5.10 (2H, s, OCH?C^H^), 4.31 (2H, q, /  = 7.3Hz, 
OCH2CH3), 3.44 + 3.21 (2 x 2H, 2 x ABq, J  = 15.5Hz, 2 x CH2), 1.29 (3H, t, /  = 
7.3Hz, OCH2CH3); Xmax (95% ethanol) nm (e) 324 (5450), 252 (3600); m/z (low 
eV) 531 (M+, 42%), 155 (100%), 120 (22%), (70 eV) 531 (M+, 5%), 440 (8 %), 155 
(92%), 127 (54%), 99 (100%); C32H2 5N30 5 : Requires C, 72.3; H, 4.7; N, 7.9%; 
Found C, 71.9; H, 4.7; N, 7.8%.
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6-Benzyloxy-4-cyano-4-ethoxycarbonyl-l ,2 3 ,4-tetrahydro-l-{N-[2-(methoxycarbo— 
nyI)-benzoyl]amino methylene}carbazole.(273)
A solution of the indole (269) (120 mg, 0.23 mmol) and p-toluene sulphonic acid 
(10 mg) in dry methanol (5 cm3) was stirred, under a nitrogen atmosphere, for 24h.
The solvent was evaporated at reduced pressure and the residue purified by column 
chromatography (ethyl acetate/pet. ether) to yield the title compound as a bright 
yellow solid (74 mg, 93% based on recovered starting material), recrystallised 
from ethyl acetate/pet. ether, m.p. = 145 - 148°C. Rp = 0.73 (pet. ether : ethyl 
acetate/50:50); \)max (nujol) cm-1 3350 (N-H), 1720 (C=0), 1645 (C=0); 5„ (d6 
DMSO) ppm; 11.25 (1 H, s, indole N-H), 10.30 (1H, d, J  = 10.3Hz, amide N-H), 
7.89-6.78 (13H, m, other aromatic protons + olefinic proton), 5.09 (2H, s, 
OCH2C6H5), 4.30 (2H, q, /  = 7.0Hz, OCH2CH3), 3.81 (3H, s, OCH3), 3.54-2.88 
(4H, m, 2 x CH2), 1.31 (3H, t, /  = 7.0Hz, OCH2CH3 ); 3 ^  (95% EtOH) nm (e)
337 (32 500), 313 (27 500), 250 (20 000); m/z (70 eV), 279 (4%), 149 (30%), 119 
(39%), 105 (43%); (C.I.) 391 (5%), 149 (42%), 100 (100%), 91 (78%);
C3 3H2 9N30 6 : Requires C, 70.3, H, 5.2, N, 7.5%; Found C, 70.1, H, 5.1, N, 7.4%.
6-Benzyloxy-4-cyano-4-ethoxycarbonyl-l ,2 j  ,4-tetrahydro- 
l-{N-[2-(hydrazino)-benzoyl]aminomethylene]carbazole (274).
A mixture of (269) (320 mg, 0.60 mmol) and 85% aqueous hydrazine hydrate (0.5 
cm3) was heated in refluxing methanol ( 1 0  cm3), under a nitrogen atmosphere, for 
15 minutes.
The solution was cooled and the yellow precipitate was filtered, washed with water 
(5 cm3) and dried over P20 5 (in vacuo) to yield the title compound as a bright 
yellow solid (138 mg, 41%), m.p. = 150 - 153°C (dec.). *H n.m.r. analysis 
indicated approximately 25% conversion to the corresponding methyl ester.
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RF = 0.19 (DCM : methanol: ammonia/200 : 8  : 1); 0)max (CHC13) cm' 1 3300 (br,m 
N-H), 1730 (C=0); sH (d6 DMSO) ppm; 11.29 (1H, s, exchanges with D20 , indole 
N-H). 10.32 (1H, d, exchanges with D20 , J  = 10.3Hz, ArCONHC=CH), 9.67 (1H, 
s, exchanges with D20 , ArCONHNH2), 7.60-6.79 (13H, m, other aromatic protons 
+ olefinic proton), 5.10 (2H, s, OCH2 C6H5), 4.45 (2H, br, s, exchanges with D20 , 
ArCONHNH2), 4.39 (2H, q, /  = 7.0Hz, OCH2CH3), 3.65-2.83 (4H, m, 2 x CH^,
1.28 (3H, t, J  = 7.0Hz, OCH^Hj); (95% EtOH)nm (e) 337 (38 300), 300 (33 
800), 247 (34 900); m/z (70 eV) 162 (100%), 104 (83%), (C.I.) 163 (100%), 162 
(84%), 104 (58%), 76 (24%).
6-Benzyloxy-3-cyano-l-methylcarbazole (276).
A solution of (269) (212 mg, 0.4 mmol) and potassium cyanide (26 mg, 0.4 mmol) 
in hexamethylphosphoramide (5 cm3) was heated at 125°C, under a nitrogen 
atmosphere, for 48h.
The mixture was allowed to cool and added to water (20 cm3). This was extracted 
with ethyl acetate ( 2  x 2 0  cm3) and the combined organic layers were washed with 
water (3 x 10 cm3) and dried (Na2 S04). The solvent was removed at reduced 
pressure and the residue purified by column chromatography (pet.ether/ethyl 
aacetate) to yield the title compound as a colourless oil. (15 mg, 12%); RF = 0.68 
(pet. ether: ethyl acetate/70 : 30); \)max (CHC13) cm 1 3450 (N-H), 2220 (ON); 5h 
(d6 DMSO) ppm 11.63 (1H, s, N-H), 8.50 (1H, s, C-4H), 7.93 (1H, d, J = 2.6Hz, 
C-2H), 7.53 - 7.17 (8 H, m, other aromatic protons), 5.19 (2H, s, OCH?CsHQ, 2.56 
(3H, s, CH3 ); m/z (low eV) 312 (M+, 84%), 221 (49%), 147 (100%), 108 (40%), 
91 (36%), (70 eV) 312 (M+, 38%), 221 (75%), 147 (100%); C ^ H ^ O  : 
Calculated 312.1261; Found 312.1268.
Methyl 3-(Benzyloxy-3-indolyl)butanoate (285).
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5-Benzyloxyindole (2.23 g, 0.01 mol), acetaldehyde (1.1 cm3, 0.02 mol), 
Meldrum’s Acid (1.44 g, 0.01 mol) and proline (58 mg) were stirred in acetonitrile 
( 2 0  cm3) for 28h, before the solvent was removed at reduced pressure and the 
residue was dissolved in pyridine ( 2 0  cm3) and methanol ( 2  cm3).
A small amount of copper powder was added and the mixture heated at reflux for 
2.5h. The solvent was allowed to cool and then removed at reduced pressure. The 
residue was purified by column chromatography to yield the title compound as a 
light brown oil (360 mg, 12%); Rp = 0.60 (pet.ether: ethyl acetate/70 : 30); t>max 
(CHC13) cm*1 3460 (N-H), 1725 (C=0); 5H (CDC13) cm' 1 8.14 (1H, s, N-H), 7.45 -
6.76 (9H, m, other aromatic prtoons), 5.04 (2H, s, OCH^C^HQ, 3.58 (3H, s, OCH3 ) 
3.62 - 3.49 (1H, m, CH3 CHCH2), 2.79 - 2.46 (2H, m, CH3CHCH2 ), 1.34 (3H, d, /  
= 7.0Hz); Xmax (95% EtOH) nm (e) 265 (5700), 248 (4350); m/z (low eV) 323 (M+, 
100%), 208 (24%), (70 eV) 323 (M+, 21%), 232 (30%), 208 (49%), 205 (31%), 91 
(56%); C2 0H2 1 NO3 : Calculated 323.1520, Found 323.1511.
Attempted preparation of
5-(5~Benzyloxy-3-indolyl)-4-methoxycarbonyl-hexan-2-one r(282),Rs = H, Rn= 
CH3I
A mixture of the ester (285) (350 mg, 1.08 mmol), chloroacetone (0.2 cm3, 2.53 
mmol) and sodium carbonate (299 mg, 2.16 mmol) was stirred in dry DMF (10 
cm3) for 55 minutes. However, t.l.c. analysis (pet. ether : ethyl acetate/ 70 : 30) 
indicated that no reaction had occurred. The mixture was heated at 100°C for lOh 
but again t.l.c. analysis indicated that no reaction had occurred.
Attempted preparation of 4-ethoxycarbonyl-5-(3-indolyl)hexan-2-one
A solution of Ethyl 3-(3-indolyl)butanoate (286)183 (610 mg, 2.64 mmol) in dry
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THF (5 cm3) was added to a solution of lithium diisopropylamide (5.28 mmol) in 
THF/pentane (12 cm3) at -78°C.
The mixture was stirred, under a nitrogen atmosphere, for lh before a solution of 
chloroacetone (0.50 cm3, 5.8 mmol) in dry hexamethylphosphorous triamide 
(HMPT) (2 cm3) was introduced at -78°C. The mixture was allowed to warm 
slowly to room temperature but t.l.c. analysis (pet.ether : ethyl acetate/60 : 40) 
indicated that no reaction had occurred.
3-(3-1ndolyl)butanoic acid (287).
A solution of the ester (286) (350 mg, 1.51 mmol) in DMSO (1 cm3) was added to 
a 50% aqueous solution of sodium hydroxide (1 cm3). Benzyltriethylammonium 
chloride (3.5 mg, 0.015 mmol) and chloracetone (0.24 cm3, 3.02 mmol) were 
added. The solution became quite hot and after 80 minutes, t.l.c. analysis (pet. 
ether : ethyl acetate/70 : 30) indicated total consumption of the starting ester (286) 
and the appearance of a more polar product.
Water (5 cm3) was added and the mixture was extracted with diethyl ether (3x5 
cm3).
The aqueous layer was acidified with 2N HC1 and extracted with diethyl ether (2 x 
10 cm3). The combined, second organic extracts were removed at reduced pressure.
The residue was purified by column chromatography (pet. ether/ethyl acetate) to 
yield the title compound as a light brown oil (200 mg, 65%), which crystallised 
overnight to afford light beige crystals; m.p. = 85-88°C; RF = 0.18 (pet. ether :ethyl 
acetate/70 : 30); \)max (CHC13) cm 1 3460 (N-H), 3400 (br. O-H), 1700 (C=0); 5H 
(CDC13) ppm 10.02 (1 H, br. s, COjH), 7.89 (1H, s, N-H), 7.64 - 6.87 (5H, m, other 
aromatic protons), 3.65 - 3.52 (1 H, m, CH3CHCH2), 2.88 - 2.53 (2 H, m,
- 182 -
CH3 CHCH2), 1.40 (3H, d, J = 7.0Hz, CH3 CHCH2 ); m/z (70 eV) 203(M+,29%),144(100%); 
C12H13N 02, Calculated 203.0946found 203.0959.
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